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Abstract
Tagetitoxin is a phytotoxin which was first isolated in 1981 from a strain of 
Pseudomonas syringae pv. tagetis. It is viewed as a challenging synthetic target for a 
variety of reasons:
- The molecule shows a unique biological activity as a specific inhibitor of 
RNA polymerase HI. It has found some use within the biological community in the 
study of transcription.
- Its structure is assigned upon spectroscopic and chemical analysis of 
biological extracts, and has some ambiguities.
- Its probable structure contains a unique bicyclic ring system which has never 
been synthesised before.
- The natural product itself has never been synthesised.
In this thesis, we report an efficient, high-yielding and short synthetic route to 
the core structure of tagetitoxin from simple carbohydrate starting materials.
The initial research focused on the ring expansion of a bicyclic 1,3-oxathiolane 
to the corresponding 1,4-oxathiane using metallocarbene chemistry via Stevens 
rearrangement. This reaction proved not to be feasible on the studied precursors; 
possible reasons for this failure are discussed herein.
The second route investigated involved the intramolecular cyclisation of a 
thiol onto an electron-deficient ketone. Initial studies on unfunctionalised substrates 
proved unsuccessful, however, the use of a carbohydrate as starting material was more 
efficient and the core structure of tagetitoxin was synthesised from D-glucose in 32% 
yield over 15 steps.
Studies towards a more complex substrate were carried out and key 
intermediates were successfully synthesised. Future plans towards the total synthesis 
of tagetitoxin are laid out based on the findings of this thesis.
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Ac acetyl
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DCM dichloromethane
DMAP 4-(dimethylamino)pyridine
DMF dimethylformamide
DMP Dess-Martin periodinane
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eq equivalent
ESI electrospray ionisation
Et ethyl
FAB fast atomic bombardment
hfacac hexafluoro acetylacetonate
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HMBC heteronuclear multiple bond connectivity
HMQC heteronuclear multiple quantum coherence
HRMS high resolution mass spectroscopy
Hz hertz
IR infra red
J  coupling constant
L ligand
m meta
m/z mass to charge ratio
Me methyl
mM milimolar
Ms methylsulfonyl
NBS A-bromosuccinimide
NMR nuclear magnetic resonance
Nu" Nucleophile
o ortho
p  para
PG protecting group
Ph phenyl
PMB /xara-methoxybenzyl
PPTS pyridinium /?ara-toluenesulfonate
i-Pr isopropyl
pyr pyridine
R alkyl
RT room temperature
s singlet
SM starting material
t triplet
TBAF tetra w-butylammonium fluoride
TBDMS tert-butyldimethylsilyl
TBDPS terf-butyldiphenylsilyl
TES triethylsilyl
Tf trifluoromethanesulfonyl
TFA trifluoroacetic acid
THF tetrahydrofuran
THP tetrahydropyran-2-yl
TLC thin layer chromatography
TMS trimethylsilyl
TOF time of flight
Ts / 7-toluenesulfonyl
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1 1ntroduction
This thesis describes attempts to synthesise the structurally unique RNA 
polymerase inhibitor tagetitoxin 1 (Figure 1).
/ \
-O OH
1a: R1=CONH2, R2=COOH 
1b: R1=COOH, R2=CONH2
Figure 1: Tagetitoxin structure
In this introduction, the mode o f action of tagetitoxin will be reviewed, along 
with its characterisation and attempted total synthesis. In order to understand the 
mechanism of action of tagetitoxin, it is necessary to fully appreciate the process of 
RNA transcription, which is carried out by RNA polymerases.
1.1 Genetic information
Life relies on the ability of cells to store, retrieve and translate the genetic 
instructions to make and maintain a living organism. This hereditary information is 
passed to daughter cells at cell division, and from generation to generation of 
organisms through reproductive cells. These instructions are stored within every 
living cell in its genes and determine the characteristics of a particular individual. 
Essentially, genetic information consists of instructions for making proteins. The 
latter are of an enormous importance to the cell. Proteins enable cells to move and 
communicate with each other, are the precursors of enzymes which catalyse a cell’s 
chemical reactions, and regulate gene expression. 1
1.1.1 DNA structure and Gene expression
The genetic information is carried in DNA (deoxyribonucleic acid) whose 
structure is based on a double-stranded helix, each strand being a long polynucleotide 
chain. Nucleotides are composed o f three different parts (Figure 2):
• a five carbon-sugar (2-deoxyribose in the case of DNA);
• a phosphate group;
• a base that can be either adenine (A), thymine (T), cytosine (C) or 
guanine (G).
The backbone of one strand o f DNA is made up of alternating phosphate and 
sugar groups. All the bases are contained within the interior of the helix, and are 
bound together by hydrogen bonding whereas the sugar-phosphate backbones are on 
the outside. The bases pair in a strictly ordered manner: adenine only pairs up with 
thymine whereas cytosine only associates with guanine. Thus a purine always pairs up 
with a pyrimidine making the most favoured energetic arrangement in the DNA helix 
(Figure 2).
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Guanine Cytosine
-O
H—N
AdenineThymine
Figure 2: Base pairing in DNA
1.1.2 DNA transcription
Although DNA stores the genetic information, it does not actually direct protein 
synthesis itself.2 When a particular protein is needed by the cell, the appropriate 
portion of the DNA is first copied into another type of nucleic acid called ribonucleic 
acid (RNA), which then induces protein synthesis in the cell. The mechanism of 
copying the information of the DNA into RNA is called transcription, whereas the 
process where RNA is used to produce proteins is called translation.
RNA molecules which serve as templates for protein synthesis are called 
messenger RNA (mRNA). Ribosomal RNA (rRNA) forms part of the structure of the 
ribosomes, on which mRNA is translated into a protein and transfer RNA (tRNA) 
forms the adaptors that select amino acids and hold them in place on a ribosome for 
their incorporation into a protein.
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RNA is very similar in structure to DNA. It is made of a five-carbon sugar 
(ribose rather than deoxyribose in DNA), a phosphate group and one of the four 
following bases: adenine, guanine, cytosine and uracil (U) (instead of thymine in 
DNA) (Figure 3). Complementary base-pairing applies in the same ways as for DNA, 
the difference being that base pairing occurs between A and U whereas it is between 
A and T in DNA.
* /v w
HO
'= N
0 * / °  HO
Uracil Adenine
Figure 3: Base pairing in RNA
Despite these relatively small chemical differences, DNA and RNA differ 
quite dramatically in overall structure. DNA always occurs in cells as a double­
stranded helix, whereas RNA exists as single-stranded chains and can therefore fold 
up into a variety of shapes.
Transcription begins with the opening and unwinding of a small portion of the 
DNA double helix so that the bases on each strand are exposed.3 One strand of the 
DNA then acts as a template for the synthesis of an RNA molecule. The nucleotides 
then add sequentially to the growing RNA chain through complementary base-pairing 
with the DNA template. Each incoming nucleotide is covalently bound to the RNA 
chain in an enzymatically catalysed reaction, and the resulting sequence is called the 
transcript. The RNA strand does not remain hydrogen-bonded to the DNA template;
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as soon as a nucleotide has been transcribed, the RNA molecule is released as a single 
strand.
The enzymes that carry out transcription are called RNA polymerases. Their 
role is to catalyse the formation of the phosphodiester bonds that link the nucleotides 
together and form the sugar-phosphate backbone of the RNAchain.3 The enzymes 
move stepwise along the DNA, unwinding the DNA helix just ahead o f the active site 
for polymerisation, so exposing a new region of the template strand for 
complementary base-pairing. The growing RNA chain is therefore extended one 
nucleotide at a time. In both prokaryotes and eukaryotes, RNA polymerase binds 
tightly to the DNA strand when it encounters a promoter, which is the sequence of 
nucleotides that indicates the starting point of RNA synthesis.4' 6 When the RNA 
polymerase encounters a sequence o f nucleotides that indicate the termination of the 
RNA synthesis (a terminator), the polymerase halts and releases both the DNA 
template and the newly made RNA chain.3 During transcription, non-coding 
nucleotide sequences called introns are removed, and coding nucleotides called exons 
are joined together; this phenomenon is known as splicing.
There are major differences between prokaryotic and eukaryotic RNA 
polymerases. In prokaryotes, only a single type of RNA polymerase is found, whereas 
three different kinds o f RNA polymerase are found in eukaryotes. Bacterial RNA 
polymerase is made of four subunits and an additional fifth subunit called the sigma 
factor; the latter is responsible for the recognition of a promoter and therefore 
initiation of transcription.7
The three eukaryotic RNA polymerases (RNA pol I, RNA pol n, RNA pol III)
o Q
are responsible for transcribing different kind of genes. ’ They consist of large multi­
subunit enzymes that have several common subunits.
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•  RNA pol I is in charge of the transcription of most ribosomal RNA.
• RNA pol II deals with messenger RNA.
• RNA pol HI is responsible for transfer RNA as well as some small 
structural RNAs, including the 5S ribosomal RNA subunit.
RNA polymerases themselves are not responsible for recognizing the DNA 
sequences that control gene transcription. Initiation of transcription is triggered by 
proteins known as transcription factors. Most of these factors contain domains that 
can bind specifically to short regions of DNA that have a particular base sequence. 
They in turn recruit RNA polymerases to the appropriate sites, in order that 
transcription can begin.
1.1.2.1 RNA polymerases I and II
RNA pol I is responsible for the transcription of most genes encoding 
ribosomal RNA. Although accounting for the synthesis of only one product, RNA pol 
I is responsible for 70% of all nuclear transcription. The promoter DNA sequence is 
located within the 50 bases immediately upstream of the start site.
In vertebrates, at sequences around -50, the first protein transcription factor 
involved is known as UBF (Upstream Binding Factor), a modular polypeptide. 10 
Another regulatory protein, SL1, is then recruited via protein-protein interaction with 
UBF forming a complex. RNA pol I can only enter the complex at this moment and 
thus initiates transcription. 11 Termination occurs when a termination factor known as 
TTF-I is recruited. 12’14
RNA pol II transcribes the majority of genes, generating messenger RNA 
which is in turn translated to produce proteins. Therefore, the wide variety of RNA
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pol II templates is reflected in a diversity of promoter structure. Generally, these sites 
are found within a few hundred base pairs upstream o f the transcription start site and 
can contain binding sites for various transcription factors. Two general motifs can be 
seen in a large proportion o f cases; 15 firstly, the region immediately upstream of the 
transcriptional start site of genes transcribed by RNA pol II is made of a sequence of 
bases rich in A and T nucleotides, the so-called TATA box ; 16,17 the second common 
feature is the initiator which is centred at the transcription start site. The commonality 
between these initiators is the presence of a large number of pyrimidine bases, their 
sequence varying between each gene. Binding to the promoter and transcription 
initiation requires a large family o f transcription factors.
Elongation factors that can facilitate transcript synthesis have also been 
identified. Their main role is to suppress pausing in the transcription. Termination 
occurs in most cases upon encountering the sequence AAUAAA.
This complex system is well understood due to the contributions o f Komberg 
et al., who developed an in vitro yeast transcription system based on Saccharomyces 
cerevisiae. 18,19 Structural elucidation o f RNA pol 13 complexed with the template 
DNA and product RNA were achieved by Komberg et al. using a combination of 
electron microscopy and X-ray crystallography.20,21 It showed the binding site o f the 
nucleic acid as a cleft bridged by an a-helix passing through the active site for RNA 
chain elongation.
Komberg’s remarkable contribution provided molecular understanding of the 
initiation,20' 22 the DNA-RNA hybrid translocation20,22 and the separation of the RNA 
strand from the DNA template.23 This contribution was recognised through the award 
of the 2006 Nobel Prize in Chemistry to Komberg, “for his studies of the molecular 
basis of eukaryotic transcription”.
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1.1.2.2 RNA polymerase III
RNA polymerase ID is responsible for the production of transfer RNA and 
some other small structural RNA molecules. In RNA pol III, a specific transcription 
factor is involved to recruit both the polymerase and other specific factors, as is the 
case for RNA pol I.24,25
The essential promoter DNA sequences, which are recognised by the 
transcription factors that recruit the RNA pol III, can be located either upstream or 
downstream of the transcribed region. Downstream promoters, specific to RNA pol 
IE, have been characterised on the basis of studies focusing on the genes encoding the
9 f\ribosomal 5S RNA. It has been demonstrated that the entire upstream region of this 
particular gene could be deleted without drastic effect on the gene expression until it 
crosses a boundary of 40 bases within the transcribed region. This means that the 
promoter for this gene was located entirely in the transcribed region.
This particular region was shown to bind first to the transcription factor 
TFLHA.27 Subsequently another factor called TFIIIC binds to the DNA next to 
TFIIIA; this in turn recruits TFHIB to form a stable transcription complex. It is this 
particular complex, stable through many cell divisions, that promotes the binding of 
RNA pol ID and consequently, transcription is not dependent on the precise sequence 
of the DNA to which it binds.
After formation of a closed complex consisting of the transcription factors, 
RNA pol III and the DNA, the DNA helix around the initiation site is broken down, 
resulting in an open-strand complex which allows the enzyme to move along the gene. 
Nonetheless, elongation does not proceed at a uniform rate, due to pausing of the 
transcription complex at internal sites. The rate of extension at individual nucleotides 
can vary 31 fold. No elongation factors have been identified for RNA pol III.
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During elongation, the enormous factor TFIIIC (one of the largest and most 
complex transcription factors that have been studied) is located in the transcribed 
region and it is not clear how a small class El gene can be expressed in its presence. 
The voluntary removal of TFIIIC does not make any significant difference to the rate 
of RNA elongation. It is thought that RNA pol III displaces a given factor from its 
binding site after transcription of a particular region but this factor still remains stable 
through protein-protein interaction with other factors bound to the DNA template.
Whereas RNA pol I and RNA pol II require additional factors to terminate 
transcription, RNA pol in recognises clusters of at least four T residues as termination 
signals. After an initial round of transcription, the polymerase can be recycled 
without being released from the template, due to the stability of the pre-initiation 
complex. Multiple transcriptions are therefore possible, and occur at a greater rate, 
allowing for the efficient production of RNA transcripts necessary to the further 
processing of the genetic information.
1.2 Tagetitoxin
Tagetitoxin is a phytotoxin isolated from the bacterium Pseudomonas syringae pv. 
tagetis, which induces chlorosis (the yellowing or whitening of normally green plant 
tissue because of a decreased amount of chlorophyll) in host plants.28 This is due to 
the inhibition of transcription in chloroplasts. Tagetitoxin has also been shown to 
specifically inhibit Escherichia coli RNA polymerase as well as RNA pol III from 
yeast, insects and vertebrates at micromolar levels in vitro. Its isolation and chemical 
structure have been the source of much debate and its final characterisation is still 
tentative.
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The production of tagetitoxin from a selected strain of Pseudomonas syringae pv. 
tagetis and its use as a plant-growth regulator have been patented.29 Furthermore, 
tagetitoxin has been an object of growing interest to the biological community for its 
use in the study of DNA transcription, with a particular emphasis on the discovery 
and characterisation of new promoters. While tagetitoxin is commercially available 
(cost: £300 for 30 pg, August 2007),30 a synthetic route to tagetitoxin would provide 
larger quantities of the compound and would also give access to analogues, which 
could be tested as potential herbicides31 or antibacterial agents.32
In the next section, the methods used to isolate a purified fraction of tagetitoxin 
and the interpretation of spectroscopic data for the characterisation of tagetitoxin will 
be discussed. Finally, the biological activity of tagetitoxin will be reviewed.
1.2.1 Isolation and characterisation
The natural product tagetitoxin was first isolated, purified and partially 
characterised by Mitchell and Durbin in 1981 from liquid cultures of the plant- 
pathogenic bacterium Pseudomonas syringae pv. tagetis by a sequence of 
precipitation, solvent extraction and chromatography steps. The purified toxin was 
unreactive towards treatment with strong acid but dilute acids generated a new 
inactive component.
The initial interpretation of chemical and spectroscopic data led to the 
proposed 8 -membered ring structure 2 (Figure 4) .33 Mass spectrometry gave a 
molecular mass of 435 which was consistent with the molecular formula 
C nH 18NO,3PS.
19
Figure 4: Initially proposed tagetitoxin structure
In 1989, the same group of researchers conducted further analysis using FAB 
mass spectrometry that gave a high resolution molecular ion (MH+) peak at 417.0361. 
This result ruled out the original structure 2 but was in accordance with a molecular 
formula of C n H n ^O u P S . This data, in conjunction with *H, 13C and 31P NMR 
studies led to four new postulated structures la , lb , 3a and 3b (Figure 4) .34 The 
absolute configuration was not assigned.
Strong nuclear Overhauser enhancements were observed between the vicinal 
protons at H-5 and H-6 , and also between one of the protons at H-2 and H-7, hence 
showing a spatial proximity between these two positions which are far from each 
other in the bonding framework (Figure 6 ). This, together with the large vicinal
/  \
-O OH +
1a: R1=CONH2, R2=COOH 3a: R1=CONH2, R2=COOH
1b: R 1=COOH, R2=CONH2 3b: R 1=COOH, R2=CONH2
Figure 5: Revised structures of tagetitoxin
coupling constant between H- 6  and H-7 led the authors to favour structure la  or lb
over 3a or 3b.
O A cJ7
NH
90
1a: R1=CONH2, R2=COOH 
1b: R1=COOH, R2=CONH2
Figure 6 : NOE interactions
The assignment of the conformation of the oxathiane ring and the orientation 
of its substituents was based on vicinal coupling constants along the carbon
framework. Coupling between H-6 and H-7 (V = 12.4 Hz) suggests that these two 
protons are in a diaxial relationship, while couplings between H-5 and H-6 (3J  = 3.6 
Hz) and between H-7 and H-8 (V = 6.0 Hz) show axial-equatorial arrangements 
(Figure 7).
R1 OH
NH
90
12- ^  OPO-iH-
3.6 Hz
1a: R1=CONH2, R2=COOH 
1b: R 1=COOH, R2=CONH2
Figure 7: Three-bond coupling constants
21
1 “2 1 , ,
Long range C- H shift correlation experiments were run in order to deduce
the connectivity through multiple bonds (Figure 8 ). There was a very strong
correlation between the quaternary carbon C-4 at 85.7 ppm and both protons of the
SCH2 group, indicating a thioacetal or hemithioacetal. The acetate carbonyl signal at
174.1 ppm, had strong correlations with H-5 and H-6 , the carbonyl at 174.5 ppm
correlated strongly with H-8 , and that at 171.2 ppm correlated with H5. Hence, the
quaternary centres at C-l and C-4 must bear a carboxylic acid and an amide. The
assignment of these functional groups is not definitive; the authors speculate that the
amide is more likely to be attached at C-4 on the basis of the lower chemical shift of
the carbonyl carbon, but the small difference between the two chemical shifts means
that this assignment should be viewed as tentative.
11
R1 OH
AwHh
OCOCH
NH
1a: R1=CONH2i R2=COOH 
1b: R1=COOH, R2=CONH2
Figure 8: 13C-’H shift correlation
In 2005, Gronwald et a l carried out a different purification protocol to isolate 
tagetitoxin.35 The initial methanol precipitation and organic solvent partitioning steps 
used by Mitchell and Durbin were substituted by anion exchange chromatography 
(QAE-Sepharose). The remaining purification steps were unaltered. These authors
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concluded, on the basis of TLC staining, that tagetitoxin contains a phosphate ester 
but lacks a primary amine.
Positive ion electrospray ionisation (ESI) mass spectrometry was applied to 
the purified sample. It showed a molecular weight of 678 (MH+, m/z = 679.5216). 
MS-MS experiments suggested that the species at m/z = 417 observed by Mitchell and 
Durbin (and interpreted as the molecular ion of tagetitoxin) is in fact a fragmentation 
product of an ion with m/z = 453. This species in turn arises from fragmentation of the 
ion at m/z = 679. A commercially available preparation of tagetitoxin was subjected to 
similar analysis; the only biologically active component gave the same spectrometric 
results.
Additional high resolution experiments showed that a fragment ion at m/z = 
417.3316 was generated from the ion at m/z = 679.5216 but that the ion with m/z = 
417.0361 reported by Mitchell et al. was not. The latter ion was only ever observed in 
partially purified tagetitoxin fractions as a fragmentation product of ions at m/z = 
531.9 and 647.5. Therefore, Gronwald et a l deduced that the ion interpreted by 
Mitchell and Durbin as the molecular ion of tagetitoxin was due to contaminants.
Gronwald et al. also carried out ID and 2D NMR studies. The NMR spectra 
were very similar to those from Mitchell and Durbin, although the absence of any 
reported coupling constants makes a direct comparison difficult. One discrepancy was 
the presence of additional singlets at 8  = 1.75 and 2.53 ppm in the ]H NMR and 
signals at 8  = 23.2 and 181.5 ppm in the 13C NMR. While these ’H NMR signals are 
reported as “3H, s”, the ID NMR spectrum reproduced in the publication suggests 
that these peaks are much larger than those arising from tagetitoxin. Although
1 TGronwald does not suggest this possibility, it seems likely that the extra C signals
23
and the *H NMR signal at 8  = 1.75 ppm are due to ammonium acetate, which was 
used as a chromatographic eluent.
Despite obtaining high resolution mass spectra, Gronwald et a l did not report a 
revised empirical formula for tagetitoxin, nor do they suggest a new structure. They 
suggest that the extra 244 mass units are “from atoms undetectable by NMR, i.e. N, 
O, S”.
The reasons for the discrepancy between Gronwald’s and Durbin’s mass 
spectrometry results are not clear. The NMR data of both groups are consistent with 
the bicyclic structure 1 and, in the absence of an alternative structure, this compound 
will form our synthetic target. However, the controversy over the structure 
undoubtedly strengthens the case for structural confirmation by total synthesis.
Recently, the X-ray crystal structure of tagetitoxin bound to an enzyme active 
site has been published (see section 1.2.2.3) .36 However, the resolution of the structure 
is insufficient to clarify the structural ambiguity surrounding tagetitoxin.
1.2.2 Biological activity
In the next section, the biological studies carried out on tagetitoxin will be 
reviewed. Its inhibition of RNA synthesis and in particular, its specific inhibition of 
RNA pol III will be considered from a mechanistic viewpoint.
1.2.2.1 Inhibition of RNA synthesis
In 1990, Durbin and Mathews reported studies on the biological effects of 
tagetitoxin and its mechanism of action.37
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In contrast to other chlorosis-inducing plant phytotoxins from Pseudomonas 
bacteria,38 an interesting feature of tagetitoxin is that the chlorosis it causes is 
confined to the apex of the plant. Indeed, tagetitoxin treatment prevents new 
chlorophyll accumulation but does not reduce existing chlorophyll levels. It was 
shown that in tagetitoxin-treated plants, proplastids did not differentiate into 
chloroplasts and failed to develop. Plastid 70S ribosomes failed to accumulate and 
consequently plastid-encoded polypeptides usually translated on these ribosomes 
could not be detected. Moreover, the amount of both ribosomal chloroplasts and 
messenger RNAs were greatly reduced in leaves of toxin-treated plants.
The authors isolated intact chloroplasts and carried out in organello 
incorporation reactions in which they recorded the rate of incorporation of 
radiolabelled uridine, thymidine and methionine into nucleic acids. The rate of 
incorporation of thymidine into DNA decreased only by a small amount; in contrast, 
uridine incorporation into RNA was quickly reduced, and ceased completely at a 
tagetitoxin concentration of 1 mM.
Durbin and Mathews subsequently studied in vitro transcription in 
chloroplasts.39 It was shown that the addition of tagetitoxin to in vitro transcription 
reactions resulted in a decreased rate of UTP incorporation into RNA, and such 
incorporation was negligible at a tagetitoxin concentration of 10 pM. From these 
results, it was clear that in vitro chloroplast transcription was more sensitive than in 
organello chloroplast transcription to inhibition by tagetitoxin, suggesting that the 
chloroplast envelope may present a partial barrier to tagetitoxin. It was also shown 
that tagetitoxin reduces UTP incorporation by inhibiting RNA synthesis rather than by 
enhancing RNA degradation in the chloroplast extracts.
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1.2.2.2 Specific inhibition of RNA polymerase III
Experiments on the effect of tagetitoxin on RNA synthesis directed by 
eukaryotic RNA polymerase enzymes in vitro showed tagetitoxin potency to be 
dependent on the nature of the RNA polymerase.40 Inhibition is specific for RNA 
polymerase ID at levels similar to that required for the corresponding inhibition of E. 
coli RNA polymerase. The inhibition of promoter-directed RNA polymerase III by 
tagetitoxin occurs in a wide range of organisms (yeast, insects and vertebrates).
Differences were found in the extent of tagetitoxin inhibition in the 
transcription of different genes by RNA polymerase III. The nature of the promoter 
elements of these genes may therefore play a role in the mechanism of inhibition.
In conclusion, tagetitoxin is the first example of an RNA polymerase inhibitor 
that acts against bacterial RNA polymerases and is specific for one of the nuclear 
RNA polymerases.
1.2.2.3 Mechanism of inhibition
Tagetitoxin shows a unique profile of RNA polymerase inhibition and studies 
reveal that the toxin interacts with the enzymes at highly specific sites. RNA 
polymerase enzymes that are sensitive to tagetitoxin consist of multimeric enzymes 
found for example in archaebacteria, eubacteria, chloroplasts and the eukaryotic 
nucleus.
Steinberg and Burgess observed template-dependence in the inhibition of 
transcription by yeast nuclear extracts or purified polymerase III.41 Transcription of 
tRNA genes resulted in the accumulation of full-length precursor tRNA along with 
low molecular weight RNAs resulting from transcription complex pausing or 
premature RNA release.
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In order to establish which stage of the transcription cycle is affected by 
tagetitoxin, transcription experiments were limited to a single round by addition of 
heparin to prevent reinitiation. It was found that as more tagetitoxin was included in 
the reaction mixture, less full-length product accumulated, accompanied by an 
increase in smaller RNAs. The authors suggested that these low molecular weight 
RNAs arose from pausing or stalling of transcription complexes at particular sites 
rather than from premature release of nascent RNA.
It was indicated that the inhibitor binds most efficiently to the transcription 
complex when it is already paused, resulting in an increased stability of intrinsic 
pausing.
Mathews and Durbin investigated the tagetitoxin inhibition of in vitro RNA 
synthesis by E. coli RNA polymerase.40 This inhibition could not be circumvented by 
increasing the DNA template concentration, thus indicating that the toxin interacts 
with RNA polymerase or the enzyme-template complex but not with the DNA 
template alone.
The inhibition of E. coli RNA polymerase during the elongation phase of RNA 
synthesis by tagetitoxin showed that the toxin can affect the ternary complex (enzyme, 
DNA template and nascent RNA chain). The toxin seems neither to compete with 
nucleotide substrates for binding to the polymerase nor to affect phosphodiester bond 
formation 42 Other modes of action have been suggested such as interference with the 
binding of oligonucleotides to the enzyme-template complex. Binding enhancement 
of dinucleotide tetraphosphate and of longer oligonucleotides to the complex should 
slow the rate of product formation. On the other hand, tagetitoxin could interfere with 
translocation of the catalytic active centre with respect to the 5’-OH of the nascent 
oligonucleotide and substantially inhibit the nascent RNA chain elongation.
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In 2005, Vassylyev et al. produced an X-ray crystal structure at a resolution of
2.4 A of the complex between tagetitoxin and the RNA polymerase from Thermus 
thermophilus. In the structure, the binding site for tagetitoxin is located at the base 
of the RNA polymerase secondary channel, adjacent to the enzyme’s active site. The 
binding is mediated by polar interactions between 9 of the 11 oxygen atoms of
9+ •tagetitoxin and the adjacent protein side chains. A Mg ion coordinated to 
tagetitoxin’s phosphate group and to two protein residues enhances the binding 
further. Tagetitoxin’s binding site does not interfere with that of the natural substrate. 
However, the spatial proximity between the tagetitoxin binding site and the enzyme 
active site suggests how the toxin may act in inhibiting RNA synthesis and also other 
reactions catalysed by RNA polymerase (exonuclease activity, pyrophosphorolysis).
Vassylev et a l have proposed that three different sites are involved during 
nucleotide triphosphate loading onto the RNA polymerase. On a structural basis, all 
three of these sites are in the vicinity of the tagetitoxin binding site and hence, each of 
them could be a potential reason for the toxin’s inhibition of the enzyme. Homology 
modelling experiments suggested that the activity of tagetitoxin is not due to 
competition between tagetitoxin and the substrate, but rather to the stabilisation of 
some inactive intermediate during substrate loading into the active site.
1.2.3 Other Polymerase III inhibitors
In 2003, McGovern et al. found that anti-fungal compounds ML-60218 4 and 
UK-118005 5 (Figure 9) inhibited RNA polymerase III in S. cerevisiae^ These are 
the first synthetic compounds found to specifically inhibit this enzyme.
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ML-60218 4 UK-118005 5
Figure 9: RNA pol ID inhibitors ML-60218 4 and UK-118005 5
1.2.4 Previous synthetic approaches to tagetitoxin
Prior to our group’s research, only two research groups had published studies 
towards the synthesis of tagetitoxin. The earlier one involved the cyclisation of a fully 
functionalised linear precursor while a more recent approach centred on the use of 
carbohydrate starting materials.
1.2.4.1 From a linear precursor
Sammakia et al. proposed an approach to tagetitoxin utilising olefm 
dihydroxylation and enzyme-catalysed aldol reaction as key steps.44 Treatment of 
phosphonate 6 with sodium tert-butylthiolate in the presence of aldehyde 745,46 
afforded alkene 8 as a mixture of geometric isomers. Osmium-catalysed 
dihydroxylation of the alkene led to diol 9 with 25:1 dr (Scheme 1). The use of 
potassium ferricyanide as the stoichiometric co-oxidant in this reaction and the bulky 
tert-b\xXy\ protecting group were found to be essential in avoiding competitive 
oxidation of the sulfur.
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PO(OEt) 2  Me 
C 0 2Me
~  M e^ - N B o c  f-BuSH / NaH, THF, 0°C  ^ M8^ - N B o c  C 0 2Me
CHO
6
0 s 0 4  (cat) 
K3 Fe(CN ) 6  
K2 C 0 3
RT, 72h 
1:1 f-BuOH/H20
Me
Me
1 -  NBoc C 0 2Me
S*fBu
i  OH 
HO
Scheme 1 : Route to diol 9
No further progress on this synthesis has been published; however the planned 
route involved conversion of diol 9 to aldehyde 10, followed by enzymatic coupling 
with dihydroxyacetone phosphate 11 to afford ketone 12. Cyclisation and functional 
group manipulation would lead to tagetitoxin (Scheme 2).
NBoc C 0 2Me
h 2n h o c o 2h
OH H2N H 0 C 0 2H
1a: R 1=CONH2, R2=COOH 1 2
1b: R 1 =COOH, R2 =CONH2
Scheme 2: Planned synthetic route to tagetitoxin from diol 9
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1.2.4.2 From carbohydrates
Fumeaux et a l envisaged synthetic strategies to both the core structures of
Starting from l,6-anhydro-3-deoxy-3-nitro-D-gulose 15, which bears the same 
configuration at C-2, C-3 and C-4 as tagetitoxin, reduction of the nitro group to an 
amine was followed by Boc protection, giving carbamate 16. Protection of the amine 
and alcohol groups as an TV-benzyloxazolidinone and subsequent THP-protection of 
the free alcohol gave advanced intermediate 17. Alkaline cleavage of the carbamate, 
followed by A-benzylation offered the opportunity to functionalise the free alcohol at 
C-2 as a phosphate giving 18. Finally, THP-deprotection at C-4 and subsequent 
acetylation at the same position followed by hydrogenolysis afforded 13a (Scheme 3).
These compounds were tested for herbicidal activity against a range of 
agriculturally important weeds at 1000 g ha’1. No herbicidal activity was observed.
tagetitoxin and its oxo-analogue. Their plan was to synthesise the two D-sugar 
derivatives 13 and 14 where X = O or S (Figure 10).
o p o 3 h - OPO3H-
13a: X =0 
13b: X=S
14a: X =0 
14b: X=S
Figure 10: Fumeaux’s targets
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SU (ii) Bu2 SnO, Bu4 NBr, BnBr, PhMe
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(iv) MCPBA
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(i) 2M HCI 
(ii) Ac^O, pyridine
(iii) H2  Pd/C, 50 p.s.i. 
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AcO
+
h 3n °x-o 
o p o 3 h ~
13a
Scheme 3: Synthetic route to tagetitoxin analogue 13a
In a second route to compounds of structure 13, 1,6-anhydro-D-galactose (19, 
X = O) or 1,6-anhydro-6-thio-D-galactose (20, X = S) were used as the starting 
materials. This required differential functionalisation of 0-2 and 0-4  and installation 
of a good leaving group at C-3 that would allow the introduction of the amino 
function with inversion of configuration.
Thus in the first step, 0-3 and 0-4 were protected as an acetal, and this was 
followed by protection of 0-2 by a tert-butyldimethylsilyl group (Scheme 4). Then, 
regioselective reductive cleavage of the acetal, followed by acetylation and cleavage 
of the PMB group, offered the opportunity to activate 0-3 as a sulfonate. However,
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azide substitution at C-3 was not possible, which was ascribed to the very bulky
substituent at C-2 (Scheme 4).
19: X =0 
20: X=S
(i) p-M eOC 6 H4 CH(OMe)2l TsOH 
(ii) TBDMSCI, imidazole, DMF r o 2 SOOAc
(iii) LiAIH4, AICI3, THF
(iv) Ac2 0 ,  pyridine
(v) DDQ, CH2 CI2, H20  
(vi) Tf2 0 ,  MsCI or TsCI, pyridine
OTBDMS
NaN 3
DMF, HMPA or DMSO
O P 0 3H OTBDMS
13a: X =0 
13b: X=S
Scheme 4: Second synthetic route to target structures 13a and 13b
Finally, the attempted synthesis of analogues of tagetitoxin of the closely 
related structure 14 was reported (Scheme 5). /?-Cyano-D-galactopyranose 
tetraacetate 21 was synthesised in two steps from an anomeric mixture of D- 
galactopyranose pentaacetates. The nitrile was hydrolysed to give initially a 6-lactone, 
which, upon hydrolysis, reduction and peracetylation, afforded pentaacetate 22. 
Following methanolysis, selective tosylation of both primary alcohols and protection 
of the secondary alcohols 0-3 and 0-4 as an acetal gave tetrahydropyran 23. 
However, attempted sulfur installation and cyclisation using lithium or sodium sulfide 
was not successful. It was thought that steric hindrance due to the isopropylidene 
acetal was inhibiting the reaction.
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A coA Hf AC| \  OAc
AcO
21
(i) MeONa, MeOH
(ii) 25% w/v NaOH
(iii) Ac2 0 , pyridine 
(iv) UAIH4
(v) Ac2 0 , pyridine
AcO A H,2° ACI \  OAc
AcO CH2 OAc
22
(i) MeONa, MeOH
(ii) TsCI, pyridine
(iii) Me2 C(OMe)2, TsOH
AcO j-pX
,H*N^ t V 0
O P 0 3 H-
14a: X =0 
14b: X=S
Scheme 5: Synthetic route to target structures 14a and 14b
1.3 Aims of this research
The aim of this research is to establish a viable synthetic route to the postulated 
core structure of tagetitoxin. Tagetitoxin was viewed as an interesting target for 
several reasons:
■ The molecule has unique biological activity.
■ Its characterisation is based upon spectroscopic and chemical analysis of 
biological extracts, and is still somewhat ambiguous.
■ Its probable structure consists of a challenging and unique 9-oxa-3- 
thiabicyclo[3.3.1]nonane ring system.
■ It has never been synthesised.
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These features make tagetitoxin a truly attractive and challenging synthetic target.
2 RESULTS AND DISCUSSION
2.1 Sulfur ylide approach
2.1.1 Ring expansion of 1.3-oxathiolanes
Generation of sulfur ylides through metal-catalysed reaction of diazo 
compounds with sulfides has been extensively reported in the literature.47'52 These 
species readily undergo a variety of rearrangements including intramolecular [1,2]- 
,53,54 intermolecular [1,2]-,55-57 intramolecular [2,3]-,58,59 intermolecular [2,3]-,60 and 
[l,4]-shifts,61-63 or react with carbonyls to form epoxides.64 A variety of metal 
catalysts have been used but the most commonly employed ones are Rh(II), Cu(II) 
and Cu(I).
As part of the project on the synthesis of tagetitoxin, Porter et al. developed a 
metal-catalysed ring expansion reaction of 1,3-oxathiolanes with diazo 
compounds.65,66 Porter et al. postulated that treatment of oxathiolane 24 with ethyl 
diazoacetate in the presence of an appropriate metal catalyst would lead to sulfur ylide 
25 through sulfur alkylation. Electron donation from the oxygen into the C-0 bond 
would break the C-S bond to give the oxonium ion 26. Ring closure would then lead 
to 1,4-oxathiane 27 (Scheme 6). This [1,2]-rearrangement corresponds to an overall 
insertion of the CH-CC^Et moiety into a C-S bond, and hence a one-carbon ring 
expansion of the original 1,3-oxathiolane 24.
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o' s Et° 2C^ ^ N 2 o ^s
Y
R
24
MLn H
R C 0 2Et 
27
S-alkylation Cyclisation
^  C 0 2Et
/“ A
t o .  S ^ -
^  C 0 2Et
25
R
26
Scheme 6: Mechanism of the ring expansion of 1,3-oxathiolane 24
Mechanistic studies into the generation of sulfur ylides by copper carbenoids 
have shown that the active catalyst is a Cu(I) species when copper (II) salts are used. 
The diazo compound is believed to act first as a reducing agent for the precatalyst; it 
is therefore used in slight excess. The copper (I) species acts as a Lewis acid and so 
can accept electron density from the diazo carbon at a vacant coordination site. Back- 
donation of electron density from the metal and nitrogen loss yields a stabilised 
transient metallocarbene intermediate, which can then accept electron density from a 
nucleophilic heteroatom to yield the desired ylide. Regeneration of the copper catalyst 
completes the catalytic cycle (Scheme 7).
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N'
CuL
R2 C —CuLn-*—► R2 O CuL,CuL,
XYR2C-X-Y
Scheme 7: Catalytic cycle of the ring expansion reaction
The initial investigations of Porter et al. were conducted using 2-phenyl-1,3- 
oxathiolane 28, ethyl diazoacetate and copper(H) acetylacetonate in benzene at reflux: 
an isomeric mixture of ring expanded products 29 and 30 was obtained in 19 % 
combined yield (Scheme 8).65
o' S Et°2C^ N 2 o ^S 0 S^
Y Cu(acac)2 ’  )Y. ) “ (
p h PhH, reflux Ph c ° 2 Et Ph c ° 2 Et
19%, 2:1
28 29 30
Scheme 8: Ring expansion of 2-phenyl-1,3-oxathiolane 28
Under these conditions, substantial amounts of diethyl fumarate, diethyl 
maleate and unreacted 1,3-oxathiolane were also observed.49 The addition of further 
diazo compound led to complex mixtures of unidentified products presumed to arise 
from reaction of 1,4-oxathianes 29 and 30 with further diazo compound. It was 
concluded firstly that ethyl diazoacetate tends to form alkene by-products, and 
secondly, that the metal carbene lacks discrimination between the sulfur atoms in
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starting material and products. When a 2-alkyl-substituted 1,3-oxathiolane 31 was 
subjected to these conditions, a competitive elimination reaction of the sulfur ylide 
species 32 occurred in preference to ring expansion leading to a mixture of alkene 
geometric isomers 33 (Scheme 9).
32
Scheme 9: Elimination reaction of sulfur ylide species 32
tendency to form side-products and more importantly, the desired products do not 
react further. It was found that acceptable yields were obtained only when a silylated 
diazoester was used.
R eagents and conditions: (i) R=Me: ethyl diazo(TM S)acetate (1.04 eq), 
C u(acac ) 2  (2 mol%), PhH, reflux, 29 h, 46% 34, 10% 35;
(ii) R=Et: ethyl diazo(Et3 Si)acetate (1.2 eq), C u(acac ) 2  (10 mol%), 
PhH, reflux, 22 h, 67% (36:37 8:1)
Scheme 10: Use of silylated diazo compounds
C u(acac ) 2
31 33
The use of silylated diazo compounds, as reported by Van Vranken67 and 
Aggarwal, overcame the problem of multiple addition because they have less
28 R=Me: 34 35
R=Et: 36 37
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The relative stereochemistries of these compounds 34, 35 and 36, 37 were 
identified using NMR spectroscopy. It was found that the major stereoisomers (34 
and 36) were those with the phenyl and trialkylsilyl groups in a cis disposition. 
Furthermore, the phenyl group occupied an axialposition and the silyl group an 
equatorial position.
It is thought that the major improvement made to the reaction yield by using 
silylated diazoesters is due to their increased steric bulk. While the carbene derived 
from ethyl diazoacetate did not discriminate between the sulfur atom of the starting 
material and that of the products, the reaction of the bulkier silylated metal carbene 
with the more sterically hindered sulfur of 1,4-oxathiane 36 or 37 (R = SiEt3) was 
markedly slower than its reaction with the starting material 1,3-oxathiolane 28 
(Scheme 11).
R=H: 29/30 
2 8  R=SiEt3: 36/37
Scheme 11: Rationalisation of the use of silylated diazo compounds
Varying the nature of the substituent at the 2-position, it was demonstrated that 
better yields were obtained with an aryl group than with an alkyl group. The authors 
attribute these results to the additional stabilisation of the oxonium ion intermediate 
provided by the aromatic ring.
Zhu et a l have reported the stereoselective ring expansion reaction of various 2- 
aryl 1,3-oxathiolanes 38 with methyl 2-diazo-3,3,3-trifluoropropanoate (Scheme 
12).69 The mechanism of the reaction is believed to be the same as in Scheme 6.
unhindereH
sterically 
hindered if 
R=SiEt3
39
c f3
/— \ A/ Et02C ^ N 2 o
Rh2 (OAc) 4  
PhH, reflux Ar C 0 2Et 
Ar=p-PhN02: 39 
Ar=p-PhOMe: 40
)  ^ c f 3
38
Scheme 12: Use of silylated fluoro diazo compounds
The use of Rh2(OAc)4 as a catalyst in this system gave a better result than
X-ray crystallography showed that the aromatic and the carbmethoxy groups were 
trans and equatorial in the major isomer. It was found that higher yields were 
obtained, but with a lower diasteromeric ratio for electron-deficient aromatic 
substituents. For example, the /7-nitrophenyl substituted product 39 was obtained in 
100 % yield as a 2:1 trans/cis ratio whereas the p-methoxyphenyl compound 40 was 
obtained as a 99:1 trans/cis ratio but in only 83% yield. It was speculated that the 
electronic repulsion between the nitrophenyl and the trifluoromethyl groups lead to a 
lower diastereomeric ratio. The ring expansion of a 2-spiro-1,3-oxathiolane using the 
same experimental conditions was also reported.
In contrast to Porter’s result, Kostikov and co-workers demonstrated the ring 
expansion of 2-phenyl-1,3-oxathiolane 28 with methyl diazoacetate in the presence of 
Rh2(OAc)4 leading to the corresponding 1,4-oxathiane 41 and 42 in 48 % yield 
(Scheme 13) with the trans-isomer favoured in a 1.8:1 ratio.70 The equivalent reaction 
of 2,2-diphenyl-1,3-oxathiolane with methyl diazoacetate afforded the corresponding 
oxathiane in 51 % yield.
Cu(acac)2, although yields were not published. NMR spectroscopic analysis and
40
Y Rh2 (OAc) 4  
PhH, reflux Ph C 0 2Me Ph
41 42
Ph
28
C 0 2Me
Scheme 13: Use of methyl diazoacetate in a ring expansion reaction
2.1.2 Strategy and retrosvnthesis
As discussed previously, this project has been directed towards the synthesis of 
the structure of tagetitoxin, la , that best fitted the chemical and spectroscopic data.
The most significant challenge for the synthesis of tagetitoxin appeared to be 
the construction of the 9-oxa-3-thiabicyclo[3.3.1]nonane ring system. This bicyclic 
system can be viewed as a 1,4-oxathiane ring, bridged with a tetrahydropyran ring 
(Figure 11).
Initial efforts were directed towards the synthesis of a model 9-oxa-3- 
thiabicyclo[3.3.1]nonane. It was postulated that a ring expansion reaction of a bicyclic 
1,3-oxathiolane 43 would secure the corresponding 1,4-oxathiane 44 when the 1,3- 
oxathiolane 43 was treated with a metallocarbene formed from a diazoester. 
Following ylide formation, the neighbouring oxygen atom and the positive charge on 
the sulfur should induce cleavage of the C-S bond giving the oxonium ion 45 which 
can reclose to the corresponding 1,4-oxathiane 44 (Scheme 14).
1 a
Figure 11: Target structure for tagetitoxin
Scheme 14: Mechanism for the formation of bicyclic 1,4-oxathiane 44
Should the generation of sulfur ylide 46 (R = H) via a metallocarbene not be 
possible, it could be obtained through sulfur alkylation and a-deprotonation of the 
resulting sulfonium salt 47 (Scheme 15).
E t0 2C E t0 2C X"
46 47 43
Scheme 15: Retrosynthesis of sulfur ylide 46
2.1.3 Results
2.1.3.1 Use of D-mannose as a starting material
2.1.3.1.1 Strategy and retrosynthesis
A cheap readily available starting material with suitable functionalities would 
be an aldohexose. We started our investigations with D-mannose 48 as its 
stereochemistry corresponds to that of tagetitoxin, and thus it was felt to be the best 
model system.
Excision of the sulfur atom in the target compound 49 gives anomeric bromide 
50 and a sulfur nucleophile. This anomeric bromide could be obtained from the tetra-
n i
acetate 51 which can in turn be derived from D-mannose 48 (Scheme 16).
OH 
/  OH
HO—
HOO!^ -1^ ,
48
D -m annose
OH
Scheme 16: Retrosynthesis of 1,3-oxathiolane 49 from D-mannose 48
2.1.3.1.2 Results
The primary hydroxyl of commercially available D-mannose 48 was tosylated 
in pyridine, and addition of acetic anhydride yielded a mixture of anomeric acetates 
51 in 86 % yield. The crude mixture was then treated with hydrogen bromide in acetic 
acid yielding 90 % of the a-anomeric bromide 50. Presumably, rapid equilibration 
occurs under the acidic reaction conditions, leading to the formation of the 
thermodynamically favoured a-anomer 50. Reaction with potassium ethyl xanthate 
afforded the bicyclic 1,3-oxathiolane 49 in very low yield (10-12 %) (Scheme 17).
43
(i) TsCI, pyridine
AcOH
90%
D-m annose
OAc
49
Scheme 17: Synthesis of tri-acetate 49 from D-mannose 48
In this reaction, the first step is presumed to be the loss of bromide leading to 
oxonium ion 52. The participation of the acetate protecting group at C-2 leads to a 
lower energy cation 53, in which the charge is delocalised over two oxygen atoms. 
The low yield of cyclised product can perhaps be explained by the fact that this cyclic 
oxonium ion 53 can then only be opened from the a-face by the xanthate ion, to give a 
xanthate 54 which is unable to cyclise onto C-6. However, none of this a-xanthate 54 
was isolated from the reaction mixture (Scheme 18).
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Scheme 18: Mechanism of the reaction between bromide 50 and potassium ethyl
xanthate
The isolation of the 1,3-oxathiolane 49 in 12 % yield suggests that cyclisation 
can occur to some extent. Although neighbouring group participation from the acetate 
at C-2 favours nucleophilic attack of the xanthate from the a-face, it is possible that a 
small amount of the initial oxonium ion 52 is attacked by the xanthate to give the 
desired p-xanthate. An alternative explanation was that initial displacement of the 
tosylate at C-6 may occur.
The mannose configuration (i.e. axial group at C-2) was therefore disfavouring 
the desired cyclisation. We postulated that an equatorial acetate at this position would 
favour the formation of a p-xanthate and hence cyclisation could occur.
2.1.3.2 Use of D-glucose as a starting material
2.1.3.2.1 Results
The same reaction sequence that had been applied to D-mannose 48 (Scheme 
17) was repeated with D-glucose 55 as the starting material. Using the same reaction
conditions, tosylate 56 was obtained in 84 % yield as a mixture of anomers. This was 
then converted to the a-bromide 57 in 87 % yield. Treatment with potassium ethyl 
xanthate in DMF at 60 °C gave 38 % of bicycle 58 (Scheme 19). However, by raising 
the temperature to 80 °C, a yield of 64 % could be obtained. Acetone was also tried 
as a solvent, but was less effective (42 % yield of 58).
.O H  .O T s  OTs
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55 56 57
D-glucose
Sx
K+ -S x  ^O E t
DMF
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Sv OAc
A /AcO I 
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Scheme 19: Synthesis of bicycle 58 from D-glucose 55
This reaction is presumed to proceed through 1,4-P-addition of the xanthate 
anion on oxonium species 59 to afford 60a. Equilibration between 4Cj chair 60a and 
!C4 chair 60b allows attack from the sulfur atom onto the carbon bearing the tosylate 
moiety, leading to bicyclic sulfonium salt 61. Bromide anion in solution then removes 
the ethoxythiocarbonyl group to afford bicycle 58 (Scheme 20). Alternatively, 
removal of the thiocarbonyl group could precede cyclisation.
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Scheme 20: Mechanism of the cyclisation of bromide 57 with potassium ethyl
xanthate
2.1.3.2.2 Ring expansion reactions
Ring expansion reactions on tri-acetate 58 were investigated (Scheme 21). The 
first ring expansion reaction attempted was based on the methodology developed for 
simple 1 ,3 -o x a th io la n e s  (Table 1). Therefore, bicycle 58 was treated with ethyl 
diazo(triethylsilyl)acetate and Cu(acac)2 in refluxing benzene under an inert 
atmosphere (entry 1). Unfortunately, a mixture of unidentified products was observed 
upon *H NMR spectroscopy of the crude material and purification by column 
chromatography (Florisil®) did not give any identifiable product.
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Scheme 21: Ring expansion reactions
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Entry Reagents*’b Solvent Result
1
Ethyl (TES)diazoacetate, 
Cu(acac)2
Benzene, reflux, 20 h
Unidentified
products
2
Ethyl (TES)diazoacetate, 
Cu(acac)2
Benzene, reflux, 20 h, 
phenylhydrazine
No reaction
3
Ethyl (TES)diazoacetate, 
Cu(hfacac)2
Benzene, reflux No reaction
4
Ethyl (TES)diazoacetate, 
Cu(hfacac)2
MeCN, reflux No reaction
5
Ethyl (TES)diazoacetate, 
Rh2(OAc)4
Benzene, reflux, 20 h 62 34 %
6
Ethyl (TES)diazoacetate, 
Rh2(OAc)4
Benzene, RT—>40°C 
—>60°C
No reaction
7
Ethyl (TES)diazoacetate, 
Rh2(OAc)4
DCM, reflux No reaction
8
Diethyl diazomalonate, 
Cu(acac)2
Benzene, reflux, 20 h No reaction
9
Diethyl diazomalonate, 
Cu(MeCN)4PF6
Benzene, reflux, 20 h No reaction
10
Diethyl diazomalonate, 
Rh2(OAc)4
Benzene, reflux 20 h 65 44 %
11
Diethyl diazomalonate, 
Rh2(OAc)4
Benzene, RT—»40°C 
—»60°C
No reaction
a 1.2-1.5 equivalents of diazo compound were employed. b Catalyst loadings: 
Cu(acac)2, Cu(hfacac)2 -  10 %; Rh2(OAc)4, Cu(MeCN)4PF6 -  5 %. 
Table 1: Reaction conditions for the ring expansion reaction
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The use of a separate reducing agent (phenylhydrazine, entry 2), with the aim 
of converting the Cu(II) to Cu(I), led to over-reduction to a Cu(0) species and no 
consumption of the starting bicycle. The use of Cu(hfacac)2 as a catalyst in either 
boiling benzene (entry 3) or acetonitrile (entry 4) did not produce any reaction.
When a ring expansion reaction was attempted using Rh2(OAc)4 as a catalyst 
(entry 5), the only identifiable product isolated from the reaction mixture was alkene 
62. To explain the formation of this unexpected product, it is proposed that formation 
of ylide 63 occurs as expected, and electron donation from the oxygen opens the C-S 
bond yielding oxonium ion 64a (Scheme 22). At this point, the conformation of the 
tetrahydropyran ring as a pseudo !C4 chair with all its substituents axial is no longer 
locked. 1,3-Diaxial interactions between acetates at C-2 and C-4, and between acetate 
at C-3 and sulfide at C-5, make this conformer unstable, and so the ring flips to the 
more stable conformation of 64b bearing its substituents equatorial and thus 
precluding any subsequent ring closure. Loss of a proton from C-2 yields the 
corresponding alkene 65. This reaction can be compared with the elimination product 
33 isolated after the attempted ring expansion of 2-isobutyl-substituted-1,3- 
oxathiolane 31 reported by Porter et al. discussed in section 2.1.2.
50
EtOoCOAc
OAcOAcSiEt-
EUSiEt3Si
AcO +0
AcOOAc
OAcOAc
6358
ring flip
OAc
»OAc
+0 OAc
—OAc
OAc
SiEt-
''OAc
S
E ^ C ^ ^ S iE ta
62 64b
Scheme 22: Formation of enol ether 65
On carrying out the same reaction at lower temperature, from RT increasing to 
40 °C and then to 60 °C, no reaction was observed, with starting material being 
recovered (entry 6). Switching to DCM as solvent led to the same result (entry 7).
The reaction of diethyl diazomalonate with bicycle 58 was also investigated. 
With Cu(acac)2 (entry 8) or Cu(MeCN)4PF6 (entry 9) as catalyst, no reaction occurred 
and starting bicycle 58 was recovered (entry 9).
However, use of Rh2(OAc)4, in benzene at reflux (entry 10) led to the 
corresponding enol ether 65 (Scheme 23). Again, attempting the same reaction at 
lower temperatures led to the recovery of starting material only (entry 11).
M ?ACn 2
S OAc II >O A cA  A y '
E t0 2C C 0 2Et | |
° ' 7 w ir f  ------------------------- ► Y ' ' '  OAc
OAc Rh2 (OAc) 4  1
UAC PhH, reflux ^
44% I
EtOj-C^XOsEt
58 65
Scheme 23: Formation of enol ether 65
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From this initial set of results, it was concluded that the ring expansion 
reaction of bicyclic 1,3-oxathiolane 58 was unlikely to succeed. The only isolated 
products were the alkenes 62 and 65 generated by proton transfer in zwitterionic 
species of the type 64b. From the mechanism detailed above, the crucial factor is the 
conformational flexibility and instability of intermediate 64a bearing all its 
substituents in axial positions.
It was proposed that with fewer axial substituents in the starting material, the 
corresponding oxonium ion intermediate would be more stable in its *C4 conformation 
and hence, ring expansion would be more likely to proceed. These further studies 
were carried out using a bicycle derived from D-altrose.
2.1.3.3 Use of D-altrose as a starting material
2.1.3.3.1 Strategy
The configuration of the D-altrose derived bicycle 66 differs from that of D- 
glucose derivative 67 at C-2 and C-3, therefore, its derivative bicyclic oxathiolane 
would only have one axial substituent, and thus, the corresponding zwitterion would 
be more conformationally stable (Figure 12).
OPG OPG
67 6 6
D-gluco configuration D-altro configuration
Figure 12: D-gluco and D-altro configuration
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2.1.3.3.2 Results
D-Altrose is available commercially but is very expensive. Hence, a 
carbohydrate interconversion sequence was carried out from the inexpensive a-methyl
72glucopyranoside 68 to access the altrose configuration (Scheme 24).
D-gluco configuration
OH
H O '
HO
HO
OMe
68
(i)ZnCI2
PhCHO
RT
68%  »
(ii)TsCI 
pyridine 
0°C to RT 
96%
TsO 1
NaOMe
MeOH
DCM 
OMe RT 
100%
69 70
KOH
h 2o
RT
89%
D-altro configuration
Ph^
OH OMe
72
Scheme 24: Carbohydrate Interconversion: From D-gluco to D-altro confirguration
a-Methyl glucopyranoside 68 was treated with benzaldehyde and anhydrous 
zinc chloride to produce a-methyl 4,6-O-benzylideneglucopyranoside in good yield. 
The two remaining secondary alcohols were tosylated in pyridine affording di-tosylate 
69 in 96 % yield. This was then treated with sodium methoxide in methanol to 
produce epoxide 70 quantitatively. Here, the sulfonyloxy group at position 2 
undergoes cleavage via addition/elimination at the sulfur atom to yield anion 71 
(Scheme 25); the oxyanion then attacks C-3 in an Sn2 manner with loss of tosylate to 
form a-methyl 2,3-anhydro-4,6-benzylidene-allopyranoside 70. This sequence 
proceeds through the unfavourable B2,5 boat conformation 71 in order that the 
stereoelectronic requirements for the reaction are met (i.e. <2«/z'-periplanar). The
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epoxide ring of the 2,3-anhydro sugar 70 was then opened with potassium hydroxide 
in water to secure the altro-configured sugar 72 in 89 % yield.
T sO -A  --
Ts°  OMe 0  OMe
69 71a
OTs,
OMe
.0"
71b
70
Ph
0 ^ 0 /  OMe
70
Scheme 25: Mechanism for the formation of epoxide 70
The acetal protecting group of a-methyl 4,6-benzylidenealtropyranoside 72 
was oxidatively cleaved with NBS in 80 % yield73 (Scheme 26) and the remaining 
secondary alcohols were acetylated74,75 affording primary bromide 73 in 96 % yield. 
The bromide was then displaced by thioacetate yielding thioester 74 in 68 % yield.76 
Upon treatment with acetic anhydride in acidic conditions, not only was the anomeric 
acetate 75 isolated in 58 % yield but also, gratifyingly, a small amount of bicyclic 1,3- 
oxathiolane 76 (9 %).
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Scheme 26: Synthetic route to 1,3-oxathiolane 76
The first step in the conversion of 74 to 76 is the cleavage of the anomeric 
methyl ether under acidic conditions (Scheme 27). The resulting oxonium ion exists 
in equilibrium between 4Cj chair conformation 77a and 1Ca chair conformation 77b 
which, due to the disposition of substituents, are similar in energy (NB stabilisation of 
these oxonium ions by the neighbouring acetate may also occur). In pathway A, 
nucleophilic attack of acetic acid onto 77a yields a mixture of anomeric acetates 75 
which are the major products. Alternatively (pathway B), intramolecular nucleophilic 
attack of the thioacetate onto oxonium ion 77b yields sulfonium salt 78. Removal of 
the acetate affords the bicyclic 1,3-oxathiolane 76 as a minor product. Pathway A is 
favoured because the reaction is carried out in a large excess of acetic acid as solvent, 
therefore, it is more likely to attack as a nucleophile rather than the thioacetate in 
pathway B.
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Scheme 27: Different pathways to anomeric acetate 75 and 1,3-oxathiolane 76
2.1.3.3.3 Attempted ring expansion reactions
Ring expansion reactions were carried out using the standard experimental 
conditions described in Table 1. However, the use of Rh2(OAc)4, Cu(acac)2, 
Cu(hfacac)2, Cu(MeCN)4PF6, as catalysts along with either diethyl diazomalonate or 
ethyl (triethylsilyl)diazomalonate in toluene or benzene left diacetate 76 untouched. It 
was thought that the use of a catalyst bearing electron withdrawing ligands would 
increase the reactivity of the metallocarbene species. Therefore, Rh2(02CC3F7)4 was 
used as a catalyst77 with diethyl diazomalonate. Unfortunately, ring expansion of 
bicyclic 1,3-oxathiolane 76 did not prove successful. Indeed a mere 8 % yield of the 
elimination product 78 was obtained along with a mixture of unidentified products 
(Scheme 28).
N2 C (C 0 2 Et) 2  
Rh2 (0 2 CC3F 7 ) 4
OAc
C
S
76
OBz
OAc
PhH
reflux
8% C 0 2Et
C 0 2Et
Scheme 28: Formation of enol ether 78
Although the 1,3-diaxial interactions present in the intermediate oxonium ion 
of the type 64a have been removed, it seems that the preferred course of reaction is 
still elimination to the enol ether 78.
2.1.3.4 Introduction of a conformational lock
2.1.3.4.1 Strategy
In order to overcome the problem of ring-flipping of the intermediate 
zwitterion 79, our next strategy was to install a tether between the hydroxyls at C-2 
and C-4 in a D-g/wco-configured tricycle 80 (Scheme 29). When subjecting this 
substrate to the ring expansion reaction conditions, the oxonium intermediate 79 
would not be able to convert to a conformation with its substituents equatorial, and 
would, we hoped, instead undergo C-C bond formation to yield bicyclic 1,4-oxathiane 
81. Various tethers were considered for linking the two hydroxyl groups; our initial 
plan was to synthesise a benzylidene acetal.
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Scheme 29: Introduction of a conformational lock
2.1.3.4.2 Results
Triacetate 58 was treated with aqueous ammonia in methanol yielding the 
corresponding triol 82 in 77 % yield (Scheme 30).78
s OAc s o h
MeOH
OAc 77% OH
52 82
Scheme 30: Acetates removal
However, attempted protection of hydroxyls at C-2 and C-4 with a cyclic
7Q 81tether proved to be more challenging than expected (Scheme 31).
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Scheme 31: Attempts for the installation of a conformational lock
Even under forcing conditions (high temperature, long reaction time), triol 82 
appeared to be peculiarly unreactive. Protection of the 2- and 4-hydroxyls as an acetal 
was attempted with a variety of reagents (PhCHO,79 PhCH(OMe)2,84 4- 
MeOC6H4CH(OMe)2,80 CH2=C(OMe)Me85, Me2C(OMe)2) under a variety of acidic 
conditions (ZnCh, PPTS, BF3.Et20, CSA, TsOH) in different solvents (benzene, 
toluene, DMF, DMSO, methanol, DCM), but none of the desired product was 
isolated.
Switching from benzaldehyde to benzaldehyde dimethyl acetal did not prove 
successful, with starting material 82 always being recovered. It was hoped that using 
anisaldehyde dimethyl acetal would stabilise the carbocation in the acetal formation 
step through electron donation from the methoxy group. However, starting material 
was always recovered from these reactions. Acetal formation attempts using 2- 
methoxypropene86 or 2,2-dimethoxypropane87 were also unsuccessful.
Cyclic carbonate synthesis using carbonyl diimidazole and DMAP88 as a 
catalyst also proved to be fruitless. An analogous reaction with triphosgene as the
on t
carbonyl precursor yielded a complex mixture of polymers, presumably arising from 
intermolecular reaction of intermediate chloroformates with further starting material, 
rather than the desired cyclisation.
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One difficulty in working with triol 82 was its poor solubility because of its 
three hydroxyl groups. It was apparently not soluble at all in benzene and soluble in 
toluene only at reflux.
In order to overcome these problems, we decided to functionalise the non­
participating hydroxyl at C-3 as a methyl ether. The selective protection of this 
secondary alcohol in the presence of two others at C-2 and C-4 cannot be achieved on 
triol 93. Indeed, the hydroxyl at C-3 is the most hindered of the three, and likely to be 
the least reactive. Its protection must therefore be accomplished at an earlier stage.
Thus, D-glucose 55 was protected as its diacetonide in 52 % yielding 1,2:5,6- 
di-O-isopropylidene-D-glucofuranose 8490 (Scheme 32). Methylation of the remaining 
alcohol afforded methyl ether 85 in 97 %,91 and deprotection of the two acetonide 
groups under acidic conditions yielded 3-methyl-D-glucose 86 as an anomeric mixture 
in 99 %. The reaction sequence outlined in Scheme 19 was adapted to 3-methyl-D- 
glucose with similar yields to finally afford methyl ether 87.
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Scheme 32 : Synthetic route to diol 87
As with triol 82, protection of both C-2 and C-4 hydroxyls of diol 87 as a 
cyclic acetal or carbonate proved to be troublesome.
Experiments using benzaldehyde and an acid catalyst all gave recovered 
starting material. When subjecting diol 87 to cyclohexanone and />-toluenesulfonic 
acid, aldehyde 88 was isolated in 45 % yield (Scheme 33). In a postulated mechanism 
for formation of aldehyde 88, it is proposed that the first step involves cyclohexyl 
acetal formation between hydroxyls at C-2 and C-4. Then electron donation from the 
sulfur would yield sulfonium cation 89. Hydrolysis (water being generated in the 
acetal formation step) of the C=S+ bond afforded aldehyde 90 via an acid catalysed
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addition/elimination mechanism. Protonation of the secondary alcohol at C-3 and 
subsequent elimination finally yields aldehyde 88.
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Scheme 33: Mechanism for the formation of aldehyde 88
When changing the solvent to DCM, a completely different outcome was 
observed with cyclic sulfide 91 being isolated in 28 % (Scheme 34).
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Scheme 34: Mechanism for the formation of sulfide 91
In product 91 the 1H NMR chemical shift of the CH2 of the ethyl group was 
measured at 2.74 ppm, clearly indicating that it is attached to a sulfur atom. Accurate 
mass measurement using FAB spectrometry confirmed the presence of a second sulfur 
atom in the molecule. It is proposed that hemiacetal formation at C-2 of diol 87 occurs 
as a first step. Then, nucleophilic attack from the sulfur onto C-2 occurs yielding epi- 
sulfonium salt 92 and liberating cyclohexanone dihydrate. Electron donation from the 
oxygen yields oxonium ion 93. The next step involves nucleophilic attack of 
ethanethiol to give P-sulfide 94. Ei elimination afforded secondary alcohol 95, which 
then undergoes intramolecular acetal formation yielding olefin 91. The origin of the 
ethanethiol is not known as it was not a reagent used in the experiment.
Even more puzzling is that an analogous result can be achieved when diol 87 
was treated with triphosgene89 in an attempt to protect the 1,3-diol motif as a cyclic 
carbonate (Scheme 35), sufide 96 was isolated in 43 %. Again, the ]H NMR chemical
63
shift of the CH2 of the ethyl group was measured at 2.72 ppm, clearly indicating that it 
is attached to a sulfur atom. This was confirmed by HRMS using FAB spectrometry 
with a mass of 285.02368 g.mol’1 which is in accordance with formula CioHi4 0 4 NaS2. 
It is proposed that carbonate formation at C-2 occurs as a first step. Then, nucleophilic 
attack from the sulfur onto C-2 yielding epi-sulfonium salt 97 and liberating carbon 
dioxide and a chloride anion. Electron donation from the oxygen yields oxonium ion 
98. The next step involves nucleophilic attack of ethanethiol to give P-sulfide 99. E2 
elimination afforded secondary alcohol 100, which then undergoes intramolecular 
carbonate formation yielding olefin 96. Again, the origin of the ethanethiol is not 
known as it was not a reagent used in the experiment.
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Scheme 35: Mechanism for the formation of sulphide 96
Attempted conversion of the diol to a cyclic boronate with 4-chloroboronic
93acid in benzene proved to be unsuccessful.
At this point, another method was envisaged to protect both C-2 and C-4 
hydroxyls of diol 87. It was hoped that initial protection of one hydroxyl group as a 
methyl carbonate could be accomplished giving 101. Then treatment with a non- 
nucleophilic base would accomplish deprotonation of the remaining secondary 
alcohol, which would then cyclise onto the ester, yielding a cyclic carbonate 102 
(Scheme 36).
Scheme 36: Retrosynthesis of carbonate 102
Diol 87 was treated with one equivalent of methyl chloroformate and 
triethylamine in DCM. Along with the two regioisomers 101 and 103 isolated in 35 % 
and 32 % respectively, di-protected product 104 was also obtained in 9 % yield 
(Scheme 38).
S OMe MeOCOCI
Jj \ Et3N
102
Scheme 37: Unsuccessful attempts for the formation of carbonate 102
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Cyclisation of 101 and 103 using either K2CO3 in methanol, NaH in THF or 
DMF, or /-BuOK in THF proved to be unsuccessful, with ester deprotection observed 
in all cases leading to the recovery of diol 87 quantitatively.
At this point, the low reactivity of both triol 82 and diol 87 to protection with a 
cyclic tether was very concerning. Takagi had reported an X-ray crystallographic data 
on the structure of triol 82 (figure 12).94
Figure 13: X-ray structure of triol 82
It was found that the introduction of the sulfur as a bridge between C-l and C- 
6 had imposed a considerable distortion in the tetrahydropyran ring. The presence of 
this 1,3-oxathiolane as a five-membered ring makes the hydroxyls at C-2 and C-4 
spread apart as shown in figure 13. The actual distance between the two oxygen atoms 
is 3.04 A; the distance between 1,3-diaxial oxygen atoms in an unstrained 
carbohydrate would be expected to be around 2.4 A. Therefore, protection of the 1,3- 
diol as a cyclic acetal would introduce considerable strain into the molecule, and this 
is likely to be the main reason why diol 87 and triol 82 are so resistant to such 
protection. The solution to this problem would be to introduce a silylene acetal as the 
protecting group. The longer silicon-oxygen bonds would allow the formation of a
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tether between the two hydroxyls at C-2 and C-4 without introducing too much strain 
in the molecule.95,96
As a consequence, diol 87 was treated with di-tert-butylsilyl ditriflate and 2,6- 
lutidine in DCM, yielding silylene bis-ether 105 in 86 % (Scheme 38).97 The product
was acid-sensitive and purification had to be performed on base-washed silica.
Sv OMe (t-Bu)2 Si(OTf) 2  OMe
2 ,6 -lutidine
0 Hof °  O
OH 0°C to rt 1,0
86% / SiN
f-Bu f-Bu
87 105
Scheme 38: Protection of diol 87 as a silylene bis-ether
2.1.3.4.3 Ring expansion reactions
The silylene bis-ether 105 was then subjected to the ring expansion reaction 
conditions described in table 2.
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Entry Conditions Solvent Result
1
Ethyl (TES)diazoacetate, 
Cu(acac)2
Benzene, reflux No reaction
2
Ethyl (TES)diazoacetate, 
Cu(hfacac)2
Benzene, reflux No reaction
3
Ethyl (TES)diazoacetate, 
Rh2(OAc)4
Benzene, reflux No reaction
4
Ethyl (TES)diazoacetate, 
Rh2(OAc)4
Benzene,
RT—>40 °C—>60 °C
No reaction
5
Ethyl (TES)diazoacetate, 
Cu(MeCN)4PF6
Benzene, reflux 12 h 106 15% 107 13%
6
Ethyl (TES)diazoacetate, 
Rh2(02CC3F7)4
Benzene, reflux 14 h 108 21 %
7
Ethyl (TES)diazoacetate, 
Rh2(OAc)4
DCM, reflux No reaction
8
Diethyl diazomalonate, 
Cu(acac)2
Benzene, reflux No reaction
9
Diethyl diazomalonate, 
Rh2(OAc)4
Benzene, reflux No reaction
10
Diethyl diazomalonate, 
Rh2(OAc)4
Benzene,
RT—>40 °C—>60 °C
No reaction
Table 2: Experimental conditions for the ring expansion reaction
68
None of these experimental conditions gave the desired ring-expansion 
product, with starting material generally being recovered. One of the occasion on 
which a new product was isolated was upon treatment of silylene bis-ether 105 with 
ethyl(triethylsilyl)diazoacetate and Cu(MeCN)4PF6: from this reaction, a mixture of 
regioisomeric fluorosilyl ethers 106 and 107 could be isolated in 15 % and 13 % 
yields respectively. Due to the strong silicon-fluorine bond formed, the counteranion 
of the metal catalyst attacks the silylene bis-ether protecting group and cleavage 
occurs to yield a secondary alcohol at either C-2 or C-4 (Scheme 39). The 
ethyl(triethylsilyl)diazoacetate is believed to be acting as a triethylsilyl group donor.
S- 0M e N2 C ((C 0 2 Et)(TES))
Cu(MeCN)4 PF 6
O '
OMe OMe
+
OSiEt;
7-Buf-Bu
f-Bu f-Bu
° o  phH
Si' reflux
f-B u ' \ - B u
105 106 107
15% 13%
Scheme 39: Formation of fluorosilyl ethers 106 and 107
It was thought that using a catalyst with electron withdrawing ligands would 
make the metal carbene more reactive. Hence, ring expansion was attempted with 
diethyl diazomalonate and Rh2(02CC3Fy)4 as a catalyst in benzene (Scheme 40). In 
this case, the only isolable product from the reaction was the primary alcohol 108 in 
21 % yield. It is supposed that sulfur alkylation occurs as expected to yield sulfur 
ylide 109. However, this species does not rearrange and persists until workup, when 
attack of water at C-6 afforded primary alcohol 108. Adventitious water in the 
reaction was thought to be less likely due to the care taken in ensuring anhydrous 
conditions (freshly distilled solvents, use of glove bag).
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Scheme 40: Mechanism for the formation of alcohol 108
2.1.4 Tandem alkvlation I deprotonation
2.1.4.1.1 Strategy and retrosynthesis
Another method to generate a sulfur ylide 110 would be initial alkylation of 
the sulfur with ethyl bromoacetate followed by deprotonation of 111 (Scheme 41).
OMe
f-Bu f-Bu
OMe
f-Buf-Bu'
OMe
f-Buf-Bu'
110 111 105
Scheme 41: Tandem alkylation/deprotonation strategy
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2.1.4.1.2 Results
Silylene bis-ether 105 was hence treated with ethyl bromoacetate in DCM 
/MeCN. This did not yield the expected sulfonium salt, but rather the primary 
bromide 112 in 72 % yield. Clearly the sulfur undergoes alkylation as expected, 
affording sulfonium salt 113 as an intermediate, but the bromide counteranion then 
attacks as a nucleophile at C-6, yielding the observed primary bromide 112 (Scheme 
42).
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Scheme 42: Formation of bromide 112
In order to circumvent the inconvenient nucleophilic attack of the bromide,
two strategies were investigated. Firstly, the bromide ion could be trapped with a
• 08silver salt to form insoluble silver bromide. The reaction was repeated with the 
stoichiometric addition of either silver nitrate, silver triflate or silver 
tetrafluoroborate," with the reaction mixtures being shielded from light. In all cases, 
primary bromide 112 was isolated in similar yields (75 %, 64 % and 61 %
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respectively). Attempts to treat the primary bromide 112 with the same silver salts 
were unsuccessful, with starting bromide always being recovered quantitatively.
The second approach was to substitute the alkylating agent for one bearing a 
less nucleophilic leaving group, therefore the corresponding mesyl, trifyl and tosyl 
acetates were employed instead. When the mesylate was used, the reaction did not 
proceed, with starting material 105 being recovered. Using the triflate or the tosylate 
led to a mixture of unidentified products.
2.1.5 Sulfur vlide chemistry: Conclusions
In this first set of investigations, efforts were directed towards the synthesis of a 
model 9-oxa-3-thiabicyclo[3.3.1]nonane ring system 44 through ring expansion of the 
corresponding bicyclic oxathiolane 43. The plan was to adapt experimental conditions 
developed on simple 1,3-oxathiolanes to bicyclic substrate.
Initial results starting with D-mannose 48, which bears the same configuration 
as tagetitoxin 1, showed that the conversion of the D-sugar to the bicyclic oxathiolane 
was not favoured; however the synthesis of the corresponding bicyclic oxathiolane 58 
from D-glucose 55 could be carried out it 64 % yield. Unfortunately, when attempting 
ring expansion reactions, it was found that the intermediate oxonium ion 64a 
undergoes a ring flip, precluding subsequent ring closure. The only isolable products 
were the corresponding elimination products.
Increasing the stability of the oxonium ion by switching to D-altrose, which has 
fewer axial substituents did not prove successful, with the corresponding alkene 78 
isolated after attempted ring expansion reaction.
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Another path to circumvent the ring flip of the intermediate zwitterion species 
was investigated. The introduction of a conformational lock between hydroxyls at C-2 
and C-4 as a cyclic tether was effected. Most of the experimental conditions employed 
for the ring expansion reaction left the tricycle 105 untouched. The most notable 
result is when Rh2(02CC3F7)4 was used as a catalyst. It is presumed that the sulfur 
ylide is generated but ring closure does not occur and a water molecule eventually 
relieves the strain in the tricycle. The reasons for the difference in reactivity of bicycle 
82 and tricycle 87 are not clear
Finally, a tandem alkylation of the sulfur followed by deprotonation was 
investigated in order to generate a sulfur ylide species. Alkylation proceeded 
effectively but unfortunately, the counteranion of the alkylating agent attacked as a 
nucleophile and opened the oxathiolane.
Overall, it was demonstrated that the ring expansion reaction, which operates 
nicely on simple 1,3-oxathioanes, was not feasible on bicyclic substrates. As a 
consequence, we decided to focus on another path to secure the 9-oxa-3- 
thiabicyclo[3.3.1]nonane ring system 44 and eventually, tagetitoxin 1.
2.2 Cyclisation of a thiol onto an a-ketoester
The second approach to be investigated involved the cyclisation of a thiol onto 
an electron-deficient ketone. As seen in the retrosynthetic Scheme 43, it is reasonable 
to think that in tagetitoxin structure la , the bond between the sulfur atom and the 
quaternary carbon bearing the amide and hydroxyl functionalities could arise from 
nucleophilic attack of a thiol onto a ketone, giving a hemithioacetal and thus should 
exist in equilibrium with its open form 114. The next question then is: if it is possible
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to synthesise an a-ketoamide such as 114, under which experimental conditions does 
the equilibrium favour the bicyclic hemithioacetal?100,101
OH
OAc
NH
HO
1 a
CONH
OPO 3H
n h 3+
AcQ
114
,xOP03H
. > >c o 2h
Scheme 43: Tagetitoxin retrosynthesis
2.2.1 Simple substrates
2.2.1.1 Strategy and retrosynthesis
Rather than devising a synthetic route to the fully functionalised precursor 
114, it was thought that this end-game strategy should be tested on simpler substrates 
to demonstrate its validity. Preliminary efforts were concentrated on the 
intramolecular cyclisation of unfunctionalised thiol 115. (Scheme 44).
. .  n « COpMeMe02C ^ O H  Q /  *
s03 ^  —  =
116 115
Scheme 44: Retrosynthesis of a simple bicyclic 1,4-oxathiane 115
Key steps to produce the model thiol 115 are highlighted in Scheme 46. It was 
expected that thiol 115 could be derived from protected alcohol 117. The a-dicarbonyl 
functionality of this molecule would be produced by oxidation of an acetylene in 
compound 118, which in turn would arise from the corresponding lactone 119. The 
latter could be secured from enol ether 120, which would in turn be obtained from 
acrolein dimer 121 (Scheme 45).
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Scheme 45: Retrosynthesis of 1,4-oxathiane 116 from acrolein 122
O PG 1
2.2.1.2 Results
Acrolein 122 was self-condensed to its dimer 121 in a microwave reactor
(Scheme 46). The best result (85 % yield)102 was obtained using 2 mol % of
hydroquinone, in a concentrated benzene solution (17 M) with catalytic amount of
DMF. The aldehyde 121 was then reduced to the corresponding alcohol 120 using
1 01sodium borohydride in ethanol (97 % yield), and protected with a tert- 
butyldiphenylsilyl group in near quantitative yield yielding 123. The alkene 124 was 
hydrated in dilute acid to afford a mixture of diastereomeric lactols 125 in 95 %
yield. 104
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Scheme 46: Synthetic route to lactol 124
The next step was the oxidation of lactol 124 to the corresponding lactone 125. 
Initial investigations using a Swem oxidation protocol105 were unsuccessful, with 
starting material being recovered. Using pyridine-sulfur trioxide complex in DMSO 
led to the re-formation of enol ether 123 in 24 % yield along with 72 % o f recovered 
starting material.106 The next oxidizing agent used was Dess-Martin periodinane in 
DCM;107 however, this reaction did not produce any sign of the desired lactone but 
rather a mixture of anomeric acetates 126 in 83 % yield (Scheme 47). It is suspected 
that upon attack of the alcohol onto the hypervalent iodine of Dess-Martin 
periodinane 127 and release of an acetate giving 128, electronic donation from the 
ring oxygen yields oxonium ion 129. Acetate then attacks to yield the observed 
mixture of anomeric acetates 126.
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Scheme 47: Mechanism for the formation of anomeric acetate 128
When sodium bicarbonate was added with the Dess-Martin periodinane 127, 
the reaction proceeded as before leading to anomeric acetates 126 in similar yield; 
however, using excess pyridine, lactone 125 was secured in 83 % yield (Scheme
48). 108
HO O 
124
OTBDPS
DMP
pyridine
0°C to rt C T ^ O
OTBDPS
DCM
85% 125
Scheme 48: Oxidation of lactols 124 to lactone 125
The next step was the addition of a TMS-protected cerium acetylide onto the 
carbonyl group of lactone 125. Cerium was chosen because it is less electropositive 
than lithium and magnesium, and the resulting organocerium compouds are 
comparatively less basic and rather more nucleophilic. Initial attempts involved the 
use of n-BuLi as a base to generate lithiated TMS-acetylene,109 which was then added 
to anhydrous cerium chloride (prepared by drying the heptahydrate under high 
vacuum at 150 °C). However, using these conditions, the reaction did not go to 
completion even with a large excess of reagents (up to six equivalents). The starting
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material was recovered in 43 % yield, along with 39 % of carboxylic acid 130 
(Scheme 49), resulting from simple hydrolysis of lactone 125.
cr 'o
125
OTBDPS
CeCI3
n-BuLi
TMS— = — H HOOC
-78°C to rt 
THF
OTBDPS SM
125
43%
Scheme 49: Formation of acid 130
Further attempts were made using tert-BuLi as a base instead of «-BuLi 
(Scheme 50). No desired product was observed, but instead enol ether 131 and ketone 
132 were isolated in 47 % and 7 % yield respectively. It is thought that for both 
products, the first intermediate is the expected 1,2-addition product 133. At this point, 
the intermediate either dehydrates to form the enol ether 131, or ring opens to form 
ketone 132.
OTBDPS
•OLi
TMS
133
TMS
OTBDPS
CeCI3, 2eq O OH
OTBDPS
125
OTBDPS
TMS 131
47%
TMS
OTBDPS
OLi
133
Scheme 50: Formation of ketone 132 and enol ether 131
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It was found that if  a large excess of base, cerium chloride and TMS-acetylene 
were used, the reaction outcome was completely different. Indeed, using six 
equivalents of the above-mentioned reagents yielded a mixture of the desired addition 
product 134 in 61 % yield along with enol ether 131 in 15 % yield (Scheme 51).
CeCI3l 6 eq 
f-BuLi, 6 eq 
TMS— = — H, 6 eq
O ' 'O 
125
OTBDPS -78°C to rt
THF TMS
OTBDPS OTBDPS
Scheme 51: Synthesis of lactol 134
The next step was deoxygenation of lactol 134. The use of triethylsilane along 
with a Lewis acid has been reported. Thus lactol 134 was treated with either BF3.Et20 
or TMSOTf110 in either DCM, MeCN or a mixture of the two, affording a mixture of 
three different products: enol ether 135, terminal alkyne 136 and alcohol 137 in 
varying ratios. The best yield of terminal alkyne 136 achieved was 30 %, using 
BF3.Et20 in DCM. This was accompanied by 16 % of enol ether 135 and 23 % of 
alcohol 137 (Scheme 52).
TMS
OTBDPS
Et3SiH
BF3 .Et20
-10°C to rt 
DCM 
83%
OTMS
135
16%
136
30%
OH
TMS
TMS
137
23%
Scheme 52: Synthesis of enol ether 135, terminal alkyne 136 and alcohol 137
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In enol ether 135, elimination of water has occurred, along with deprotection 
of the acetylene and the primary alcohol, and conversion of the alcohol to a TMS 
ether. Terminal alkyne 136 results from deoxygenation along with deprotection of 
both acetylene and primary alcohol. Alcohol 137 is the most peculiar of the three. A 
TMS-protected acetylene fragment has been added a- to the ring oxygen along with 
deprotection of the primary alcohol. A tentative mechanistic proposal to explain the 
formation of this product is outlined in Scheme 53. It is assumed that the anomeric 
hydroxyl in the starting lactol 134 can coordinate the Lewis acid, making it a good 
leaving group. Electronic donation from the ring oxygen yields oxonium ion 138 
which, in the desired reaction, is reduced by triethylsilane. It is thought that proton 
loss from some unreacted starting material 134 releases a TMS-acetylide fragment, 
possibly coordinated to the Lewis acid that can in turn attack as a nucleophile onto 
oxonium species 138 to yield intermediate 139. At some point during the process, the 
primary alcohol protecting group is cleaved. The final product isolated is alcohol 155 
in 23 % yield.
OTBDPS
.OTBDPS •OTBDPS
TMS' TMS TMS'
138 134
OTBDPS
TMS'
TMS
•OH
TMS'
TMS
137 139
23%
Scheme 53: Mechanism for the formation of alcohol 137
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For all these compounds, it is proposed that the desilylation of the primary 
alcohol and acetylene is due to the presence of the traces of fluoride from the Lewis 
acid in the reaction mixture,111 although it is unclear why the trimethylsilyl groups are 
not cleaved from alcohol 135.
These unexpected results and unsatisfactory yields at this stage of the synthesis 
are not compatible with the aim of producing a simple model substrate. Hence it was 
decided to switch the study of the model substrate cyclisation to carbohydrate-based 
models for which the chemistry is more well-documented.
2.2.2 Carbohydrate-based approach 
2.2.2.1 Model substrate
2.2.2.1.1 Strategy and retrosynthesis
The revised strategy was next to develop a model carbohydrate-based substrate 
bearing an a-ketoester in the p-orientation at C-l and a free thiol at the 6 position.1 It 
was hoped that the sulfur atom would cyclise onto the ketone to generate the desired 
bicyclic 1,4-oxathiane. The retrosynthetic plan to tribenzyl ether 140 is shown below 
(Scheme 54). Thiol 141 will be prepared from its corresponding protected alcohol. 
The a-dicarbonyl moiety should be secured from bromoalkyne 142, which should 
arise from the TMS-protected alkyne 143. In turn, 143 should be secured from lactol 
144, the latter being obtained from lactone 145. Lactone 145 can be prepared in seven 
steps from D-glucose via standard carbohydrate chemistry.
1 Although systematic nomenclature would mean that the anomeric position o f glucose becomes C-3 in 
compounds such as 141, the original sugar numbering is used throughout.
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Scheme 54: Retrosynthesis of tri-benzyl ether 140 from lactone 145
2.2.2.12 Results
D-Glucose 55 was peracetylated with acetic anhydride in pyridine yielding 
peracetate 146 quantitatively (Scheme 55). The anomeric acetate of 146 was displaced 
with thiophenol, in the presence of boron trifluoride etherate, to yield p-thioglycoside 
147 exclusively in 88 % yield.112 It is noteworthy that this 1,2-trans isomer is formed 
exclusively via neighbouring group participation of the C-2 acetate. Removal of the 
acetates was effected using sodium methoxide in methanol affording tetraol 148 in 
quantitative yield followed by selective protection of the primary alcohol to give t- 
butyldiphenylsilyl ether 149 in 99 % yield. The remaining secondary hydroxyls were
1 1 Tthen protected as benzyl ethers (97 % yield) and the thioglycoside bond of 150 was 
cleaved using A^-bromosuccinimide in a mixture of acetone and water. The resulting 
mixture of lactols 151 was isolated in 94% yield. These isomers were oxidised with
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Dess-Martin periodinane 127 in the presence of pyridine to secure gluconolactone 145 
in .90 % yield. Overall, lactone 145 was synthesised from D-glucose 55 in 71% yield
over seven steps.
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Scheme 55: Synthetic route to lactone 145 from D-glucose 55
Lactone 145 was then treated with excess cerium TMS-acetylide formed from 
n-BuLi, TMS-acetylene and cerium chloride.114 In contrast to the simpler substrates 
discussed earlier, the 1,2-addition proceeded very efficiently to give lactol 144 in 96 
% yield (Scheme 56). Deoxygenation of lactol 144 proceeded with exclusive p- 
selectivity leading to 143. Cleavage of the TMS protecting group of 143 in dilute 
sodium hydroxide occurred quantitatively yielding terminal alkyne 152. Subsequent 
bromination using 7V-bromosuccinimide yielded alkynyl bromide 142 in 98%.115
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Scheme 56: Synthetic route to bromoalkyne 142
The Lewis acid-promoted, triethylsilane reduction of lactol 144 occurred with 
exclusive p-selectivity i.e. the hydride is delivered from the a-face. Shuto et al. have 
proposed that the stereoselectivity observed in the Lewis acid-promoted silane 
reduction of the anomeric position of a carbohydrate derivative is due to 
conformational preferences.116 Substrate 144 is conformationally more stable as a 4Ci 
chair form, bearing all its substituents equatorially. As a result, during the 
triethylsilane reduction, the transition state would assume a low energy 4Ci-chairlike 
form 153, where the anomeric centre would be pyramidal. Triethylsilane hydride 
delivery from the a-face is dictated because the transition state form 153 would then 
be stabilized via hyperconjugation between the nonbonding orbital of the ring oxygen
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lone pair nQ and the antibonding orbital of the newly forming anomeric C-H bond o* 
because of their co-planar arrangement (Scheme 57).
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Scheme 57: Stereoselectivity of the Lewis acid-promoted silane reduction of lactol
144
The next step involved the oxidation of the bromoalkyne of 142 to an a- 
ketoacylbromide that would be quenched in situ with methanol, yielding the 
corresponding a-keto methylester. The experimental procedure was adapted from a
117similar reaction by Li and Wu, who carried out the transformation using potassium 
permanganate in a 1:1 mixture of methanol / water. However, substrate 142 was not 
soluble in this solvent system; it was not even soluble in a 99:1 mixture of methanol 
and water. Consequently, the reaction was performed in neat methanol (Scheme 58).
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Scheme 58: Synthesis of a-keto methylester 155
The reaction was particularly capricious, and tedious experimental 
optimisation had to be carried out to ensure a high-yielding, reproducible outcome. It 
was found that the potassium permanganate had to be added in small portions over 2 
h, after which time the reaction was immediately diluted with water. The optimum 
amount of potassium permanganate for the best yield of 155 (84 %) was 2.4 
equivalents even though the reaction was then not complete (4 % unreacted starting 
material recovered). Adding too much potassium permanganate resulted in 
decomposition to a complex mixture of non-identified degradation products. Ester 
154 was also obtained in 5 % yield and resulted from the nucleophilic attack of 
methanol on the ketone of intermediate a-ketoacylbromide 157 (Scheme 59). Attack 
of methanol at the acyl bromide carbonyl gives the desired product 155.
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Scheme 59: Mechanism for the formation of a-keto methylester 155 and ester 154
The !H NMR spectrum of a-keto ester 155 in deuterated chloroform (CDCI3) 
showed two different compounds in a 1:1 ratio, but TLC analysis only showed one 
clear spot. It appears that the ketone exists partially as its hydrate 156, confirmed by a 
13C NMR peak at 5 = 102.3 ppm, corresponding to C(OH)2. NMR spectroscopy in 
deuterated benzene showed a ratio of a-keto ester 155 to hydrated ketone 156 of 8:1, 
because the more polar hydrate is presumably more stable in more polar solvents.
The next step was to be the desilylation of the primary alcohol of 155 in order 
to introduce the necessary sulfur functionality to cyclise onto the electrophilic ketone. 
However, on treatment of silyl ether 155 with tetrabutylammonium fluoride solution 
in THF, the only isolable product was enol ether 158 (Scheme 60).
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Scheme 60: Attempted desilylation of a-keto methylester 158
Not only was the silyl protecting group cleaved, but in addition, the benzyl 
ether at C-2 had been eliminated. It can be reasoned that the hydrogen at C-l, a to a 
ketone, is sufficiently acidic that it is removed by the mildly basic fluoride ion, and 
loss of the benzyl ether follows in an ElcB reaction.
When a-keto ester 155 was treated with 5 equivalents of hydrogen fluoride- 
pyridine complex, acetal 159 was formed in 77 % yield (Scheme 61). In the course of 
the reaction, not only was the primary alcohol deprotected, so were the C-3 and C-4 
alcohols, and an acetal was formed between 0-3, 0-6 and the ketone. It is not known 
why the benzyl groups at C-3 and C-4 were cleaved selectively.
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Scheme 61: Mechanism for the formation of acetal 159
The amount of hydrogen fluoride pyridine complex was reduced to one 
equivalent in an attempt to prevent benzyl deprotection but even at -78 °C, the 
reaction proceeded cleanly to afford 159. Attempts to hydrolyse the acetal in aqueous 
acidic conditions were unsuccessful.
As removal of the TBDPS group in presence of the electrophilic a-keto ester 
was problematic, we decided to modify the route by installing the sulfur at C-6  prior 
to formation of the ketoester.
Both silyl protecting groups were cleaved from silylated alkyne 143 with 
tetrabutylammonium fluoride yielding 99 % of terminal alkyne 160 (Scheme 62). The 
primary alcohol was then activated as its mesylate (95 %) yielding 161, and 
displacement with potassium thioacetate gave thioester 162 in 99 % yield. 
Bromination of the terminal alkyne with A-bromosuccinimide proceeded in 98 %
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yield giving 163, and oxidation of 163 with potassium permanganate, according to the 
method developed previously, yielded a-keto ester 164 in 71 % yield along with 
methyl ester 165 in 10 % yield.
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Scheme 62: Synthetic route to a-keto ester 164
The final step in the sequence was then the deprotection of the thioacetate and 
the expected subsequent intramolecular cyclisation of the thiol moiety onto the 
electron-deficient ketone. This was accomplished using hydrazine monohydrate in 
methanol (Scheme 63) affording oxathiane 140 in 8 8  % yield. The free thiol 141 was 
not observed. The structure of 140 was confirmed by mass spectrometry and NMR
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spectroscopy; in particular, an HMBC correlation was observed between the 
hemithioacetal carbon at 5c = 71.9 ppm and one of the methylene protons adjacent to 
sulfur at 5h = 1.57 ppm, indicating a definite connectivity between the two. Vicinal 
coupling constants of 9.3 and 9.6 Hz between the pairs of CHOBn protons indicated a 
boat conformation for the tetrahydropyran ring, while the vicinal coupling constants 
between the CH2S protons and the adjacent methane proton indicated that the 
oxathiane ring adopted a chair conformation as depicted in Scheme 63. The 
hemithioacetal was obtained as a single stereoisomer. Although the configuration of 
this centre was not determined, we postulate that the hydroxyl group adopts an axial 
position on the 1,4-oxathiane ring.
The first step of this reaction is the cleavage of the acetyl group from thioester 
164 yielding free thiol 141. The tetrahydropyran ring must then flip to a boat 
conformation where both thiol and ketoester functionalities are pseudo-axial, allowing 
hemithioacetal formation to yield bicyclic 1,4-oxathiane 140. To our knowledge, this 
is the first synthesis of the bicyclic skeleton of tagetitoxin.
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Scheme 63: Mechanism for the formation of 1,4-oxathiane 140
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2.2.2.2 Towards a more complex substrate
2.2.2.2.1 Strategy and retrosynthesis
Having successfully synthesised the core ring system of tagetitoxin la , our 
next goal was the synthesis of a more functionalised compound, and we targeted the 
5-decarboxy analogue of tagetitoxin 166. We felt that this compound could be 
obtained fairly readily from a carbohydrate starting material, and that the late-stage 
protecting groups manipulations would give valuable information for a subsequent 
synthesis of the natural product.
1 a 166
tagetitoxin 5-decarboxy tagetitoxin
Figure 14: Tagetitoxin la  and its 5-decarboxy analogue 166
As can be seen in the retrosynthetic analysis Scheme 64, disconnection of the 
hemithioacetal bond in 5-decarboxy tagetitoxin 166 yields thiol 167, which has the D- 
altro configuration. A potential protected precursor to thiol 167 would be azide 168. 
Azide 168 could be derived from altronolactone 169 via TMS-acetylide addition and 
subsequent reduction, both reactions having been developed during the previous 
synthesis. The altro-configuration would be obtained through formation of a 0- 
configured epoxide from diol 170, followed by trans-diaxial ring opening with azide, 
and protection of the alcohol as a silyl ether to 171. Diol 170 can be obtained in two 
steps from D-glucose 55.
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Scheme 64: Retrosynthesis of 5-decarboxy tagetitoxin 166 from D-glucose 55
2.2.2.2.2 Results
The protection of the anomeric hydroxyl of D-glucose 55 as an allyl ether 
under acidic conditions yielded exclusively the thermodynamically more stable a-O- 
allyl D-glucopyranoside 172 as a single anomer in 85 % yield (Scheme 65).118 
Protection of the hydroxyls at C-4 and C-6  as a benzylidene acetal proceeded 
smoothly in 90 % yield giving 170. Upon treatment of diol 170 with 2.0 equivalents 
sodium hydride and 1.0 equivalents of N-tosylimidazole, as reported by Taylor et al., 
conversion to the desired epoxide 173 took place in only moderate yield with modest
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diastereoselectivity. Epoxide 173, which bears the desired configuration, isomer 174, 
with the opposite configuration and di-O-tosylate 175 were isolated in 52 %, 10 % 
and 24 % yield respectively.
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Scheme 65: Synthesis of epoxide 173
The p-epoxide 173 was opened with sodium azide in a trans-diaxial fashion, to
yield secondary alcohol 176 in high yield (92 %) (Scheme 6 6 ). This was protected as
a te/7-butyldimethylsilyl ether yielding 171 in 98 % yield. Removal of the anomeric
allyl protecting group with a stoichiometric amount of palladium(II) chloride, with
sodium acetate in a mixture of acetic acid and water gave lactol 177 in 91 % yield, 119
but this was too expensive to carry out on a large scale. More economically, exposure
of 171 to a catalytic amount of tetrakis(triphenylphosphine) palladium(O) with tri-«-
1
butyltin hydride and zinc chloride in THF, yielded the desired mixture of lactols 
177 in 90 % yield.
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Scheme 6 6 : Synthetic route to lactol 177
The oxidation of lactols 177 with Dess-Martin periodinane 127 cleanly 
afforded lactone 169 in 8 8  % yield (Scheme 67). However, when lactone 169 was 
subjected to the cerium-acetylide addition reaction, the desired 1,2 -addition product 
was not detected in the crude reaction mixture. Instead, after column chromatography, 
secondary alcohol 178 was isolated in 32 % yield.
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Scheme 67: Formation of secondary alcohol 178
It is thought that the desired cerium-acetylide addition to lactone 169 occurs as 
expected (Scheme 6 8 ), but does not stop at this stage. After coordination of the ring 
oxygen to a cerium Lewis acid, ring-opening occurs to form intermediate ketone 179. 
At this point, a second cerium acetylide could be added to the ketone to yield tertiary 
alcohol 180. The migration of the TBDMS group from the tertiary alcohol to the 
secondary one takes place; the reason of this migration is not understood but it 
completes the formation of alcohol 178.
The reasons for the difference in behaviour between lactone 169 and lactone 
145 are not understood. The differences between the two are the presence of a 
benzylidene conformational lock between hydroxyls at C-4 and C-6 , the presence of 
an azide at C-3 and a TBDMS ether at C-2. It is not known how these dissimilarities 
can account for such a different reactivity.
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Scheme 6 8 : Mechanism for the formation of alcohol 197
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We then decided to carry out the reaction with different organometallic 
species. Ytterbium triflate can be combined with organolithium reagents to form 
organoytterbium species, which have been shown to be more nucleophilic than
1 "71 • •organocerium compounds. Thus, in an analogous experiment to those discussed 
previously, cerium chloride was replaced with anhydrous ytterbium triflate. However, 
the desired addition product was again not detected but rather the JraHs-decalin 
compound 181 in 48 % yield (Scheme 69). In this sequence, the expected ytterbium 
acetylide addition occurs first yielding addition product 182. Again, the ring oxygen 
must be coordinated to some ytterbium species in solution and consequently triggers 
ring opening to yield ketone 183. Next, a transannular hydride shift from C-5 to the
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ketone yields secondary alcohol 184. Ring closing then occurs to secure trans-&Qca\in 
compound 181.
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Scheme 69: Synthesis of tertiary alcohol 181
The net result of this reaction is a selective p-addition of TMS-acetylide, 
accompanied by reduction of the anomeric carbon and oxidation at C-5. On 
comparison of the structure of 181 with that of tagetitoxin la , it was realised that if 
the tertiary OH of 181 could be replaced by a carbon nucleophile such as a cyanide, 
compound 185 could be the precursor of tagetitoxin la  itself, rather than of 5- 
decarboxy tagetitoxin 166 (Scheme 70).
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Scheme 70: From alcohol 201 to tagetitoxin la
However, attempts to reproduce the reaction all failed, even when rigorous 
purification procedures were applied to all the reagents and solvents immediately 
prior to the reaction. In all cases, starting lactone 169 was recovered. The 
concentration and ratio of reagents were also changed but all efforts remained 
unsuccessful. It is not known why this reaction was so capricious but compound 181 
could not be synthesised again, and so this approach was abandoned.
2.2.2.3 Revised approach
2.2.2.3.1 Strategy and retrosynthesis
The main problem encountered in the previous strategy was the introduction of 
a TMS-acetylene moiety at the anomeric position of an <a//ro-configured sugar. This 
reaction had not caused any problems with a g/wcoconfigured substrate (cf section 
2.2.1). Therefore, it was decided to incorporate the acetylene moiety into a gluco-
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configured lactone, prior to manipulating the stereochemistry at C-2 and C-3. 
Therefore, the end-game strategy would be the same as the one discussed in section 
2 .2 .2 .1 . IraHs-azidoalcohol 186 could be derived from the D-gluco configured 
compound 187 via epoxide formation and subsequent opening with sodium azide 
(Scheme 71). In turn, 187 could be derived from 2 ,4 -0 -di-Et3Si-protected compound 
188 via removal of the silyl protecting groups and formation of a benzylidene acetal 
between the hydroxyls at C-4 and C-6 . Diol 188 has been synthesised previously by 
Vasella et a l and is derived from the opening of 1,6-anhydro sugar 189 with a metal- 
coordinated acetylide. Bicycle 189 can be synthesised from D-glucose 55 in three
CONH
NH3+
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0 P 0 3 H~
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Et3SiO
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Scheme 71: Retrosynthesis of tagetitoxin la
One potential pitfall in this route is the selective sulfonylation of diol 187. 
While it is well established that O-glycosides such as 170 react selectively at the C-2 
hydroxyl, there is little precedent for the reaction of C-glycosides such as 187.
However, if it proved that reaction at the C-3 hydroxyl were preferred, we could 
modify the route by protecting initially at C-3 prior to sulfonylating the C-2 hydroxyl 
group.
2.2.2.3.2 Results
The initial task on this route was the synthesis of 1,6 -anhydro-D-glucose 190,
199which was accomplished by the method of Fraser-Reid. D-Glucose 55 was treated 
with tosyl chloride in pyridine at room temperature affording primary tosylate 191 as 
a mixture of anomers (Scheme 72). The crude mixture was treated with DBU in 
ethanol to initiate cyclisation to 1,6-anydro-D-glucose 190. The crude mixture was 
very impure because of the excess DBU used and the impurities carried from the first 
step, so peracetylation was carried out to obtain triacetate 192 which could be purified 
by crystallisation. The triacetate 192 was then treated with methanolic ammonia in 
order to remove the three acetyl protecting groups. Rapid filtration on SiCb afforded 
1,6 -anhydro-D-glucose 190 as a white solid. The hydroxyls at C-2 and C-4 were then
1 99protected as TES ethers in 8 6  % yield affording alcohol 189. A minor amount of 
the corresponding trisilylated compound 193 was also isolated (6  %). The next step 
was found to be more challenging than expected. The initial experiments used non­
purified aluminium chloride, and resulted in starting material being recovered 
quantitatively. Even when freshly sublimed aluminium chloride, weighed out under 
an inert atmosphere, was used, the reaction was unsuccessful. Under these conditions, 
when the lithium acetylide solution was added to the suspension of aluminium 
chloride in toluene, the reaction remained colourless with solid aluminium chloride 
clearly visible. Ultimately, it was found that sonication of the mixture was required.
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This gave a brown, cloudy suspension, and addition of the 1,6-anhydro sugar 189 to 
this led to the desired diol 188 in 84 % yield.
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D-glucose
OSiEt
TsCI
pyridine
Et3SiO OSiEt3  Et3SiO OSiEt3
193
6%
189
86%
AICI3
n-BuLi
TMS- E—H 
PhMe/THF
DBU
^OTs
HO
HO" ^ O H XOH EtOH 
191
TES-Cl
imidazole
DMF
0°C to rt
sonication 
2,4,6-collidine 
-18°C to reflux 
84%
NH4OH
MeOH
OH OH
17% over 4 step s 
190
OH OH 
190
AcoO AcOEt
OAc OAc
192
Et3SiO
HO
OSiEt3
•TMS
Scheme 72: Synthesis of diol 188
Removal of the silyl protecting groups under acidic conditions afforded tetra- 
ol 194 in 92 % yield (Scheme 73), but attempts to protect the hydroxyls at C-4 and C- 
6  as a benzylidene acetal were not satisfactory. When using benzaldehyde dimethyl 
acetal and an acid catalyst (either tosic acid or freshly fused zinc chloride) in either 
DMF or acetonitrile, the reaction proceeded very slowly even at reflux temperatures. 
After two days, a ratio of 1:2 of benzylidene acetal to starting material 194 was 
detected by NMR spectroscopy of the crude mixture (using tosic acid in 
acetonitrile at reflux). By contrast, reaction with /?-anisaldehyde dimethyl acetal and
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tosic acid afforded 80 % of the /?-methoxybenzylidene acetal 195. The next step 
involved the formation of an epoxide between C-2  and C-3 in order to invert the 
stereochemistry at both these centres and hence securing, after epoxide opening, an 
a/rro-configuration. However, when 195 was treated with sodium hydride followed by 
tosylimidazole, the two stereoisomeric allylic alcohols 196 and 197 were obtained in 
30 % and 31 % respectively.
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p-MeOC6 H4' x' ’^ O
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H20
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(i) NaH, DMF p-M e0C 6 H4^ ^ 0
_______________  O
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(ii) Ts-imidazole, DMF, 50°C
•TMS
196 195
TMS
OH197
Scheme 73: Synthesis of stereoisomeric allylic alcohols 196 and 197
The mechanism proposed for the formation of stereoisomers 196 and 197 is 
depicted in Scheme 74. It is speculated that unselective tosylation of hydroxyls at C-2 
and C-3 must happen first, leading to a mixture of the desired epoxide 198 and its 
stereoisomer 199. Loss of a proton at C-l then opens the epoxides, leading to a 
mixture of epimers at C-3.
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Scheme 74: Mechanism for the formation of allylic alcohols 196 and 197
The two problems in this reaction are the non-selective tosylation and the 
undesired elimination from epoxide 198 and 199 to allylic alcohol 196 and 197 
respectively. In an attempt to avoid one or both of these problems, a range of 
different sulfonylation conditions were investigated.
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First, the diol 195 was treated with tosyl chloride in pyridine: The reaction was 
carried out initially at 0 °C and warmed up every two hours to room temperature, then 
to 60 °C, then to reflux. After a further two hours, DMAP (2.0 equivalents) was added 
but even after 48 hours at reflux, starting material was recovered.
The corresponding reaction was next carried out with tosyl imidazole in 
pyridine, and then with tosic anhydride in pyridine: in both cases, starting material 
was recovered.
With mesyl chloride in pyridine, the reaction did not proceed at 60 °C and at 
reflux, the starting material decomposed to an unidentified mixture of degradation 
products.
It appears that, in contrast to the tosylation of 0-glycosides, the tosylation of 
C-glycoside 195 is unselective. For this reason, the synthetic approach to epoxide 198 
has to be revised, and we aim to utilise the protection which is present in diol 195. 
Selective protection of the primary alcohol with a triethylsilyl group, will be followed 
by acetylation of the C-3 alcohol yielding acetate 200 (Scheme 75). Cleavage of the 
silyl ethers will yield triol 201. Protection of the alcohols at C-4 and C-6  as an acetal 
will be followed by tosylation of the C-2 alcohol. Finally, solvolysis of the acetate at 
C-3 will be followed by formation of the C-2/C-3 P-epoxide 202 (Scheme 75).
While time constraints did not allow investigation of the route shown in 
Scheme 75, it has recently been brought to fruition by another PhD student in the 
group, Amandeep Sandhu.
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Scheme 75: Future work for the synthesis of epoxide 202
3 Conclusions and future work
The initial goal of this work was to achieve the total synthesis of tagetitoxin 1. 
The latter shows a unique biological activity as a specific inhibitor of RNA 
polymerase III. A synthetic way to access large quantities of tagetitoxin 1 would be 
invaluable to the biological community in order to study the mechanism of inhibition 
of RNA polymerase III. From a synthetic point of view, tagetitoxin 1 is an intriguing
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target because its structure is still somewhat ambiguous; however, the most probable 
structure consists of a 9-oxa-3-thiabicyclo[3.3.1]nonane ring system.
Our initial efforts focused on the synthesis of the core structure of tagetitoxin via 
a ring expansion reaction (Scheme 76). It was demonstrated that, using model systems 
derived from glucose or altrose, the favoured pathway was elimination instead of the 
desired ring expansion.
D-gluco configuration
It was thought that the instalment of a conformational lock as in 105 would 
prevent the elimination process, and that the intermediate oxonium ion would 
eventually cyclise to the ring expanded product (Scheme 77). However, these efforts 
proved to be unsuccessful and primary alcohol 108 was isolated.
Rh2 (OAc) 4  
PhH, reflux
Rh2 (OAc) 4  
PhH, reflux
OAc
 
ring expansion elimination AE t0 2C R
R=SiEt3: 203 
R =C 0 2 Et: 204 58
R=SiEt3: 62
R = C 0 2 Et: 65
l3-
D-a/fro configuration
Rh2 (OAc) 4  
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Rh2 (OAc) 4  
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ring expansion
OAc
R =C 0 2 Et: 205 76
E t0 2C R 
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Scheme 76: Unsuccessful attempts of ring expansion reactions
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Scheme 77: Synthesis of primary alcohol 108
The second approach to the core structure of tagetitoxin la  was based on the 
intramolecular cyclisation of a thiol onto an electron deficient ketone 141 to produce a 
bicyclic 1,4-oxathiane 140 (Scheme 78).
Scheme 78: Equilibrium between tri-benzyl ether 140 and a-keto ester 141
Spontaneous cyclisation to a single diastereomer occurred when thioester 164 
was deacetylated. Overall, bicycle 140 was synthesised in 32.5 % yield over 15 steps 
from D-glucose 55, providing the first synthesis of the tagetitoxin core structure.
Efforts were then concentrated on the synthesis of a more functionalised 
target, 5-decarboxytagetitoxin 166 (Scheme 79). Lactone 169 was synthesised in 28.4 
% yield over 7 steps from D-glucose 55.
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Scheme 79: Retrosynthesis of 5-decarboxytagetitoxin 166
However, this lactone did not yield the expected addition product with a 
cerium acetylide (Scheme 80). Instead, opening of the carbohydrate ring to form 
secondary alcohol 180 occurred in 32 % yield. Changing from cerium to ytterbium led 
to the formation of azide 181 in 48 % yield. However, this latter result was not 
reproducible
Scheme 80: Synthesis of secondary alcohol 180 and tertiary alcohol 181
An alternative strategy was therefore designed to introduce the acetylene 
moiety at an earlier stage, through reaction with 1,6 -anhydro-D-sugar 189 (Scheme
81).
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Scheme 81: Retrosynthesis of diol 195
Diol 195 was synthesised from D-glucose 55 in 8 steps in 9 % overall yield. 
However, the tosylation of this diol was not regioselective and a mixture of tosylates 
196 and 197 was obtained in 30 % and 31 % yield respectively (Scheme 82).
TMS
OH(i) NaH, DMF-TMS
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OH (ii) Ts-imidazole, DMF, 50°C TMS
195
OH
197
Scheme 82: Attempted epoxidation of diol 195
The future synthetic plan involves selective protection of the alcohol at C-3 
prior to tosylation at C-2, resulting in stereoselective epoxide formation. This plan is 
detailed in Scheme 75, and has recently been carried out within the group. Work is 
now focusing on the completion of the synthesis of 5-decarboxy tagetitoxin 166 and 
the natural product itself.
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4 Experimental
General experimental
All reactions under non-aqueous conditions were carried out in flame-dried glassware, 
which was allowed to cool in vacuo.
Temperatures
Reactions carried out at -78 °C were cooled by means of an acetone/dry ice bath, 
those at -10 °C by means of an ice/salt/water bath and those at 0 °C by means of an 
ice/water bath.
Solvents
THF, MeCN, Et2 0 , toluene and DCM used in reactions were collected from the UCL 
Chemistry anhydrous solvent system (dried by passage through alumina columns 
under nitrogen). MeOH and chloroform were analytical reagent grade and used as 
supplied. Benzene, pyridine and DMF were distilled from CaH2 prior to use. Acetone 
was distilled from and stored over 3 A molecular sieves. Where petrol is specified this 
refers to the fraction that boils in the range 40-60 °C.
Reagents
All starting materials were obtained commercially from Aldrich, Acros, Avocado, 
Fisher, Lancaster or BDH and were used without further purification unless otherwise 
stated. Benzaldehyde and 2,6-lutidine were distilled from CaH2 immediately prior to 
use. Triethylamine was distilled from potassium hydroxide. 4-Toluenesulfonyl 
chloride was recrystallised from chloroform/petrol prior to use. Acrolein was distilled 
twice before use. Ethyl (triethylsilanyl)diazoacetate was prepared according to the 
literature procedure described by Emde and Simchen. 124 Dess-Martin periodinane 127 
was prepared according to the literature procedure described by Liu and Ireland. 125
I l l
Penta-O-acetyl-p-D-glucopyranose 146 was prepared according to the literature 
procedure described by Wolffom and Wood. Tosyl imidazole was prepared 
according to the literature procedure by Hicks and Fraser-Reid. 127 1,6-Anhydro-D- 
glucose was prepared according to the literature procedure described by Fraser-Reid 
and Ratcliffe.128 
Chromatography
Column chromatography was carried out on BDH silica gel (Kieselgel 60), unless 
otherwise stated. TLC was carried out on Merck plates (aluminium coated with 0.2 
mm silica gel .60 F254). Plates were visualised either by UV light (254 nm), aq 
KMn0 4 , vanillin in ethanol, or iodine.
Spectroscopy/Spectrometry
IR spectra were recorded either as thin films or as KBr discs using a SHIMADZU FT- 
IR 8700 spectrometer. Peaks are labelled according to intensity: strong = s, medium = 
m, weak = w, broad = br.
Proton nuclear magnetic resonance spectra (JH NMR) were recorded at 500, 400 or 
300 MHz on Bruker AMX-500, AMX-400 or AMX-300 NMR spectrometers 
respectively. 13C NMR were recorded on the same instruments at 125, 100 or 75 
MHz. The spectra were referenced to the solvent peak (CHCI3 in CDCI3 at 7.24 ppm 
for !H NMR and 77.0 ppm for 13C NMR). 13C DEPT-45 was used to assist in the 
assignment of 13C NMR. HMQC and HMBC were used where necessary to assist in 
assignment and to determine structures. The signals are noted as s = singlet, 
d = doublet, dd = doublet of doublets, ddd = doublet of doublet of doublets, dddd = 
doublet of doublet of doublet of doublet, ddddd = doublet of doublet of doublet of 
doublet of doublet, t = triplet, td = trilplet of doublet, dt = doublet of triplets, 
m = multiplet and br s = broad singlet. Coupling constants (J) are reported in Hz.
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Nuclear Overhauser enhancement experiments were performed by Dr Abil Aliev of 
the Christopher Ingold Laboratories.
Mass measurements were recorded by Mr John Hill or Dr Lisa Harris of the 
Christopher Ingold Laboratories on a VG70-SE (CI+, El*, FAB+) or a Thermo MAT 
900 instrument (El*, ESP+). Major peaks are listed with intensities quoted as 
percentages of the base peak.
Melting points were recorded on an Electrothermal 9100 melting point apparatus.
The microwave oven used was a CEM Discover.
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l,2,3,4-Tetra-0-acetyl-6-0-(4-toluenesulfonyl)-a-D-mannopyranose 51
•T sO -“ v OAc
A c O " ^
AcO—
51 OAc
A solution ofp-toluenesulfonyl chloride (3.97 g, 20.8 mmol) in pyridine (20 mL) was 
added to a suspension of D-mannose 48 (2.50 g, 13.9 mmol) in pyridine (20 mL) over 
5 minutes with occasional ice-cooling to maintain the internal temperature below 20 
°C. The mixture was allowed to warm to RT and stirring was continued for 2 h. Acetic 
anhydride (6.3 mL, 67 mmol) was then added dropwise, again maintaining the 
temperature below 20 °C. Stirring was continued for 19 h. The mixture was 
concentrated in vacuo, and the residue redissolved in EtOAc (20 mL), washed with 
2M HC1 (20 mL), sat aq CUSO4 (20 mL), sat aq NaHCC>3 (20 mL), brine (20 mL), 
dried (MgSCU), and concentrated in vacuo affording the title compound 51 (5.93 g,
87%) as an off-white foam: mp 149-150 "C (Lit. 129 141-143 °C); [« ]“  = +78.3 (c 0.90
in DCM) (Lit. 129 [a ]“  = +81.9, c 0.80 in CHCL); vmax (CHC13 cast)/cm“' 3150s, 
2920s, 2856m, 1756s, 1650m, 1371s, 1220s; 8 H (500 MHz, CDC13) 7.70 (2H, d, 78.4, 
CH aromatic), 7.29 (2H, d, J  8 .4 , CH aromatic), 5.94 (1H, d, .72.1, H-l), 5.27 (1H, 
dd, J  10.1, 3.4, H-3), 5.21 (1H, ddd, J 11.8, 9.7, 3.8, H-5), 5.16 (1H, dd, 73.4, 2.1, H- 
2), 5.06 (1H, dd, J  10.1, 9.7, H-4), 4.06 (1H, dd, J  12.6, 11.8, H-6 ’), 3.99 (1H, dd, J
12.6, 3.8, H-6 ), 2.40 (3H, s, Ar-CH3), 2.10 (3H, s, C(0)CH3), 2.07 (3H, s, C(0)CH3), 
1.98 (3H, s, C(0)CH3), 1.95 (3H, s, C(0)CH3); 8C (125 MHz, CDC13) 169.7 (C=0),
169.6 (C=0), 169.4 (C=0), 169.0 (C=0), 145.1 (ipso C-CH3), 132.4 (ipso C-S02),
129.9 (2 x CH aromatic), 128.0 (2 x CH aromatic), 90.1 (C-l), 70.3 (C-4), 68.1 (C-3),
67.9 (C-2), 67.4 (C-6 ), 65.7 (C-5), 21.6 (Ar-CH3), 20.9 (C(0)CH3), 20.8 (C(0)CH3),
20.7 (C(0)CH3), 20.4 (C(0)CH3).
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2,3,4-Tri-0-acetyl-l-bromo-l-deoxy-6-0-(4-toluenesulfonyl)-a-D-mannopyranose
50
T sO — v OAc
AcO - V h K
A c O - ^ ^ |
_________50 Br
A solution of anomeric acetate 51 (1.50 g, 2.99 mmol) in acetic acid (5 mL) was 
cooled to 0 °C and then treated with 33% hydrogen bromide solution in acetic acid 
(8.9 mL, 13.4 mmol). The mixture was allowed to warm to RT and stirred for 18 h. It 
was then concentrated in vacuo; the residue was redissolved in Et20 (20 mL), washed 
with water (20 mL), sat aq NaHC03 (20 mL) and brine (20 mL), dried (MgSC^), and 
concentrated in vacuo. The off-white oil was dried under high vacuum, affording the 
title compound 50 (1.32 g, 87%) as a yellow foam which was used without further
purification: mp 92-94 °C; [«]“  = +32.6 (c 4.50 in DCM); 5H (500 MHz, CDC13) 7.67 
(2H, d, .78.4, CH aromatic), 7.26 (2H, d, J8 .4 , CH aromatic), 6.12 (1H, d, J  1.8, H-l), 
5.55 (1H, dd, J  10.1, 3.5, H-3), 5.30 (1H, dd, J  3.5, 1.8, H-2), 5.21 (1H, t, J  10.1, H- 
4), 4.12 (1H, dd, J  10.1, 3.4, H-6), 4.06 (1H, td, J  10.1, 3.4, H-5), 4.02 (1H, t, J  10.1, 
H-6'), 2.36 (3H, s, Ar-CH3), 2.07 (3H, s, C(0)CH3), 1.94 (3H, s, C(0)CH3), 1.92 (3H, 
s, C(0)CH3); 8c (125 MHz, CDC13) 169.6 (C=0), 169.5 (0=0), 169.3 (C=0), 145.1 
{ipso C-CH3), 132.4 {ipso C-SO2), 129.9 (2 x CH aromatic), 128.0 (2 x CH aromatic),
82.7 (C-l), 72.2 (C-3), 71.9 (C-2), 67.7 (C-6), 66.8 (C-5), 65.2 (C-4), 21.6 (Ar- CH3),
20.6 (C(0)CH3), 20.4 (C(0)CH3), 20.4 (C(0)CH3).
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2,3,4-T ri-O-acetyl-1,6-thioanhydro-D-mannopyranose 49
Anomeric bromide 50 (100 mg, 0.19 mmol) was dissolved in dry DMF (3 mL) and 
ethylxanthic acid potassium salt (92 mg, 0.57 mmol) was added at 0 °C. The mixture 
was then allowed to warm to RT and then heated to 85 °C for 17 h. It was then 
concentrated in vacuo and the residue was dissolved in water (5 mL). The organic 
material was extracted with diethyl ether (6 x 5 mL). Organic layers were combined 
and washed with brine (40 mL), dried (MgS0 4 ), and concentrated in vacuo. Column 
chromatography (EtOAc/ petrol 1:2) afforded the title compound 49 (33 mg, 57%) as
white crystals: mp 96-98 °C (Lit.130 98-99 °C); [a£° = -125.0 (c 1.20 in DCM)
(Lit.130 [ a £ 0 = -133.0, c 1.22 in CHC13); vmax (CHC13 cast)/cm_1 3059s, 2985m, 
2307m, 1755s, 1599s, 1425s, 1371s, 1267s; 6H (300 MHz, CDC13) 5.44 (1H, d, y  4.0, 
H-l), 5.28 (1H, dd, 75.6, 4.0, H-2), 5.17 (1H, d d ,/5 .6 , 2.1, H-3), 4.81 (1H, d t,/7 .5 ,
1.6, H-5), 4.75 (1H, dd, J 2.1, 1.6, H-4), 3.25 (1H, dd, J  10.2, 7.5, H-6'), 3.18 (1H, dd, 
J  10.2, 1.6, H-6), 2.14 (3H, s, C(0)CH3), 2.12 (3H, s, C(0)CH3), 2.03 (3H, s, 
C(0)CH3); 8c (75 MHz, CDC13) 169.7 (C=0), 169.6 (C=0), 169.5 (C=0), 81.6 (C-l),
77.9 (C-5), 72.8 (C-4), 67.0 (C-3), 66.4 (C-2), 32.7 (C-6), 20.9 (C(0)CH3), 20.8 
(C(0)CH3), 20.7 (C(0)CH3); m/z (FAB+) 327 (MNa+, 100%); HRMS (FAB+) 
expected MNa+ (Ci2Hi60 7SNa) 327.0514, found 327.0519.
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l,2,3,4-Tetra-0-acetyl-6-0-(4-toIuenesulfonyl)-D-glucopyranose 56
OTs
AcO OAc
A solution o f/7-toluenesulfonyl chloride (3.97 g, 20.8 mmol) in pyridine (20 mL) was 
added to a suspension of D-glucose 55 (2.50 g, 13.9 mmol) in pyridine (20 mL) over 5 
minutes with occasional ice-cooling to maintain the internal temperature below 20 °C. 
The mixture was then allowed to warm to RT and stirring was continued for 2 h. 
Acetic anhydride (6.3 mL, 67 mmol) was then added drop wise, again maintaining the 
temperature below 20 °C. Stirring was continued for 19 h. The mixture was 
concentrated in vacuo, then re-dissolved in EtOAc (20 mL), washed with 2M HC1 (20 
mL), sat aq Q 1SO4 (20 mL), sat aq NaHC03 (20 mL), brine (20 mL), dried (MgSCL), 
and concentrated in vacuo, affording the title compound 56 (5.61 g, 84%), as a 
mixture of anomers (a:p 2:8) as an off-white foam: mp 129-131 °C; vmax (CHCL 
cast)/cm_1 3155s, 2921s, 2856m, 1759s, 1651m, 1371s, 1217s; SH (CDC13, 500 MHz) 
a-anomer 7.75 (2H, d, J  8.2, CH aromatic), 7.35 (2H, d, J  7.9, CH aromatic), 6.20 
(1H, d, J  3.7, H-l), 5.40 (1H, t, J  9.7 H-3), 5.00 (1H, t, J  9.7, H-4), 4.90 (1H, dd, J
9.7, 3.7, H-2), 4.13-4.08 (2H, m, 2 x H-6 ), 4.13-4.05 (1H, m, H-5), 2.40 (3H, s, 
ArCH3), 2.10 (3H, s, C(0)CH3), 2.02 (3H, s, C(0)CH3), 2.00 (3H, s, C(0)CH3), 1.95 
(3H, s, C(0)CH3), P-anomer 7.75 (2H, d, J  8.2, CH aromatic), 7.35 (2H, d, J  7.9, CH 
aromatic), 5.63 (1H, d, J  8.0, H-l), 5.23 (1H, t, J  10.0, H-3), 5.04-5.00 (1H, m, H-2),
5.00 (1H, t, J  10.0, H-4), 4.15 (2H, m, 2 x H-6 ), 3.85 (1H, m, H-5), 2.43 (3H, s, 
ArCH3), 2.13 (3H, s, C(0)CH3), 2.05 (3H, s, C(0)CH3), 1.99 (3H, s, C(0)CH3), 1.97 
(3H, s, C(0)CH3); 5c (CDC13, 125 MHz) a-anomer 170.0 (C=0), 169.5 (C=0), 169.3 
(C=0), 169.2 (C=0), 129.9 (ipso C-S03), 129.8 (2 x CH aromatic), 128.1 (2 x CH 
aromatic), 128.0 (ipso C-CH3 aromatic), 88.5 (C-l), 70.4 (C-3), 69.9 (C-5), 69.6 (C-
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2), 69.4 (C-4), 67.9 (C-6 ), 27.8 (Ar-CH3) 20.8 (C(0)CH3), 20.6 (C(0)CH3), 20.5 
(C(0)CH3), 20.3 (C(0)CH3); P-anomer 170.0 (C=0), 169.5 (C=0), 169.3 (C O ),
169.2 (C O ), 129.9 {ipso C-S03), 129.8 (2 x CH aromatic), 128.1 (2 x CH aromatic),
128.0 {ipso C-CH3Ar), 91.5 (C-l), 72.5 (C-3), 70.0 (C-5), 69.6 (C-2), 69.1 (C-4), 66.9 
(C-6 ), 27.4 (Ar-CH3) 20.9 (C(0)CH3), 20.7 (C(0)CH3), 20.4 (C(0)CH3), 20.2 
(C(0)CH3); m/z (FAB+) 525 (MNa+, 30%), 415 (15), 338 (95), 203 (100); HRMS 
(FAB+) expected MNa+ (Ci9H2 3 0 ioSNa) 525.10426, found 525.10356.
2,3,4-Tri-0-acetyl-l-bromo-l-deoxy-6-0-(4-toluenesulfonyl)-a-D-glucopyranose
57
r —OTs
A c O - ^
57 A c 0 Br
Anomeric acetates 56 (1.50 g, 2.99 mmol) were cooled to 0 °C and treated with 
hydrogen bromide (33% in AcOH, 8.9 mL, 13.4 mmol) solution in acetic acid. 
Further acetic acid (3 mL) was added in order to completely dissolve the starting 
material. The mixture was allowed to warm to RT and stirred for 18 h. It was then 
concentrated in vacuo, and the residue re-dissolved in Et2 0  (20 mL), then washed 
with water (20 mL), sat aq NaHC03 (20 mL) and brine (20 mL), dried (MgSCL), and 
concentrated in vacuo affording the title compound 57 (1.32 g, 87%) as a yellow 
foam: mp 104-107 'C  (Lit. 131 110 °C); vmax (CHC13 cast)/cnf' 3160s, 2928s, 2856m, 
2255s, 1755s, 1634m, 1371s, 1223s, 1178s, 733s; 8 H (CDCI3, 400 MHz) 7.75 (2H, d, 
7  8.3, CH aromatic), 7.33 (2H, d, 7  8 .3 , CH aromatic), 6.45 (1H, d, 7  4.1, H-l), 5.47 
(1H, dd, 710.0,9.7, H-3), 5.06 (1H, dd, 710.0, 9.7, H-4), 4.69 (1H, dd, 710.0,4.1, H- 
2), 4.25 (1H, ddd, 7  10.4, 10.0, 3.3, H-5), 4.11-4.14 (2H, m, 2 x h - 6 ), 2.44 (3H, s, 
ArCH3), 2.06 (3H, s, C(0)CH3), 2.00 (3 H, s, C(0)CH3), 1.98 (3H, s, C(0)CH3); 8 C
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(CDC13, 100 MHz) 169.8 (C=0), 169.6 (C=0), 169.1 (C=0), 145.2 (ipso C), 132.4 
(ipso C), 129.8 (2 x CH aromatic), 128.1 (2 x CH aromatic), 86.0 (C-l), 71.6 (C-5),
70.3 (C-2), 70.0 (C-3), 67.1 (C-4), 66.2 (C-6 ), 29.6 (ArCH3), 21.6 (C(0)CH3), 20.5 
(C(0)CH3), 20.4 (C(0)CH3); m/z (FAB+) 545/547 (MNa+, 45/38%), 430 (48), 338 
(80), 226 (12), 203 (20), 165 (100); HRMS (FAB+) expected MNa+
(Ci9H23Oi0S79BrNa) 545.0093, found 545.0101.
2,3,4-Tri-0-acetyl-l,6-thioanhydro-D-glucopyranose 58
OAc
AcO
OAc
Anomeric bromide 57 (100 mg, 191 pmol) was dissolved in dry DMF (3 mL) and 
cooled to 0 °C, and ethylxanthic acid potassium salt (92 mg, 574 pmol) was then 
added. The mixture was allowed to warm to RT and then heated to 85 °C for 17 h. It 
was then concentrated in vacuo and the residue dissolved in water (5 mL). The 
organic material was extracted with EtOAc (6 x 5 mL), then the organic layers were 
combined and washed with brine (40 mL), dried (MgSCL), and concentrated in vacuo. 
Column chromatography (EtOAc/petrol 1:2) afforded the title compound 58 (33 mg,
57%) as white crystals: mp 92-95 °C (Lit. 132 93-94 °C); [«])"=-27.3 (c 1.25 in DCM)
(Lit. 131 [a]o = -50.0 (c 0.95 in CHC13); vm  (CHC13 cast)/cm“' 3055s, 2988s, 2307m, 
1742s, 1421m, 1371m, 1265s, 1229s; 5H (CDC13, 500 MHz) 5.44 (1H, d, 70.6, H-l), 
4.96 (1H, dd, 74.4, 3.2, H-3), 4.76 (1H, dt, 7  10.1, 1.7, H-5), 4.71 (1H, dd, 73.2, 0.6, 
H-2), 4.62 (1H, dd, 7  4.4, 1.7, H-4), 3.19 (1H, t, 7  10.1, H-6 '), 3.08 (1H, dd, 7  10.1,
1.7, H-6 ), 2.15 (3H, s, C(0)CH3), 2.11 (3H, s, C(0)CH3), 2.05 (3H, s, C(0)CH3); 8C 
(CDC13, 125 MHz) 170.2 (C=0), 170.0 (C=0), 169.4 (C=0), 81.7 (C-l), 79.5 (C-5),
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74.1 (C-2), 72.1 (C-4), 69.1 (C-3), 34.4 (C-6 ), 22.4 (C(0)CH3), 21.6 (C(0)CH3), 20.9 
(C(0)CH3); m/z (FAB+) 305 (MH+, 25%), 203 (100); HRMS (FAB+) expected MH+ 
(C12H17O7S) 305.0695, found 305.0697.
Ethyl (2*iS, 3 'S, 4’iS')-2-(3,4,5-triacetoxy-3,4-dihydro-2//-pyran-2-
ylmethylsuIfanyl)-2-triethylsilanylacetate 62
OAc
>OAc
SiEt-
Tri-acetate 58 (100 mg, 330 pmol) and rhodium acetate dimer (16 mg, 33 pmol) were 
placed and dissolved in dry benzene (2 mL). The mixture was heated to reflux and a 
solution of ethyl diazo(triethylsilanyl)acetate (98 mg, 430 pmol) in dry benzene (1 
mL) was added dropwise over 10 min. The mixture was refluxed for a further 23 h, 
allowed to cool to RT and concentrated in vacuo. Column chromatography (Florisil® 
petrol/EtOAc 10:1) afforded the title compound 62 (56 mg, 34%) as a yellow oil:
[a]“  = -56.5 (c 2.05 in DCM); vmax (CHC13 cast)/cm~' 3055s, 2986s, 2961s, 2877m, 
2684m, 2411m, 2305m, 1746s, 1721s, 1421m, 1371s, 1265m, 1223s, 1151s; 5H 
(CDC13, 500 MHz) 6.60 (1H, s, H-6 ’), 5.44 (1H, ddd, 74.0, 1.2, 0.8, H-4’), 5.34 (1H, 
dd, 7  4.0, 3.2, H-3'), 4.35 (1H, ddd, 7  7.1, 3.2, 1.2, H-2'), 4.18 (2H, q, 7  7.2, C 02- 
CHjCH3), 3.30 (1H, s, SCHC02Et), 2.86 (1H, d, 7  7.3, CIL.SCHCCt-Et), 2.84 (1H, 
dd, 77.3, 7.1, CH2SCHC0 2Et), 2.08 (3H, s, C(0)CH3), 2.07 (3H, s, C(0)CH3), 2.04 
(3H, s, C(0)CH3), 1.26 (3H, t, 7  7.2, C 0 2CH2CH3), 0.96 (9H, t, 77.7, (Si(CH2CH3)3), 
0.69 (6 H, q, 77.7, (Si(CH2CH3)3); 8 C (CDC13, 125 MHz) 172.6 (C=0), 170.1 (C=Q),
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169.6 (C=0), 169.5 (C=0), 139.0 (C=CH), 127.1 (O C H ), 75.2 (C-2’), 68.9 (C-3’),
65.7 (C-4’), 61.0 (CH2CH3), 35.4 (CHSi(CH2CH3)3), 32.3 (CH2-S), 20.9 (C(0)CH3),
20.8 (C(0)CH3), 20.5 (C(0)CH3), 14.3 (C02CH2CH3), 7.1 (Si(CH2CH3)3), 2.7 
(Si(CH2CH3)3); m/z (FAB+) 527 (MNa+, 100%), 343 (12), 145 (22); HRMS (FAB+) 
expected MNa+ (C22H360 9SSiNa) 527.1747, found 527.1735.
Diethyl^'S1, 3’S, 4'5)-2-(3,4,5-triacetoxy-3,4-dihydro-2//-pyran-2-
ylmethylsulfanyl)malonate 65
OAc
tOAc
COoEt
65
Tri-acetate 58 (100 mg, 330 pmol) and rhodium acetate dimer (16 mg, 33 pmol) were 
placed and dissolved in dry benzene (2 mL). The mixture was heated to reflux and a 
solution of diethyl diazomalonate (80 mg, 430 pmol) in dry benzene (1 mL) was 
added dropwise over 10 min. The mixture was refluxed for a further 23 h, allowed to 
cool to RT and concentrated in vacuo. Column chromatography (Florisil® 
petrol/EtOAc 7:1) afforded the title compound 65 (56 mg, 44%) as a colourless oil:
[a]o = -32.7 (c 0.25 in DCM); vmax (CHCI3 cast)/cm_l 2986m, 2939m, 2856m, 1732s, 
1682m, 1634m, 1372m, 1223m, 1151m; 8 H (CDC13, 500 MHz) 6.61 (1H, s, C=CH),
5.51 (1H, d, J3 .8 , H-4'), 5.28 (1H, dd, J 5.1, 3.8, H-3'), 4.40 (1H, ddd, /7 .6 , 6.0, 5.1, 
H-2’), 4.28 (1H, s, SCH(C02Et)2), 4.24 (2H, q, J  7.1, CO2CH2CH3), 4.23 (2H, q, J
7.1, CO2CH2CH3), 3.15 (1H, dd, J  14.4, 7.6, C^SCHCOzEt), 3.06 (1H, dd, J  14.4,
6.0, CHjSCHCOzEt), 2.11 (3H, s, C(Q)CH3), 2.10 (3H, s, C(0)CH3), 2.08 (3H, s,
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C(0)CH3), 1.29 (3H, t, J  7.1, CO2-CH2CH3), 1.28 (3H, t, J  7.1, CO2-CH2CH3); 8C 
(CDCI3, 125 MHz) 170.5 (C=0), 170.0 (C=0), 169.9 (C=0), 167.1 (C=0), 167.0 
(C=0), 139.4 (C=CH), 127.8 (C=CH), 75.8 (C-2'), 69.6 (C-3’), 66.4 (C-4'), 62.9 (2 x 
CH2CH3), 51.2 (CH(C02Et)2), 30.9 (CH2S), 21.2 (C(0)CH3), 20.9 (C(0)CH3), 14.4 (2 
x CH2CH3); m/z (FAB+) 485 (MNa+, 15%), 413 (33), 349 (10), 326 (14), 217 (16), 
199 (26), 165 (100); HRMS (FAB+) expected MNa+ (Ci9H260nSNa) 485.1096, 
found 485.1101.
Methyl 4,6-0-benzylidene-a-D-glucopyranoside 203
P h ^ ° ^ 0
HOl 
203 OMe
V_____________________________J
A mixture of benzaldehyde (136 g, 1.29 mol), methyl-a-D-glucopyranoside 6 8  (50 g, 
257 mmol) and freshly fused and powdered zinc chloride (38.5 g, 283 mmol) was 
stirred vigorously for 10 h. The reaction mixture was allowed to stand at RT for 24 h 
then poured onto crushed ice (700 mL). The mixture was stirred and the solid filtered 
off and washed with petrol (1.5 L). The solid was then shaken with a solution of 
sodium metabisulfite (20 g) in water (200 mL), filtered off and dried in a vacuum 
desicator ( P 2 O 5 )  for 18 h, then recrystallised (CHCl3/Et2 0 ) affording the title
compound 203 (48.9 g, 6 8 %) as a white solid: mp 164-166 °C (Lit.72 165 °C); [ccf^ =
+90.5 (c 1.28 in DCM) (Lit.72 [a fD2 = + 1 12, c 0.5 in CHCh); vmax (CHC13 cast)/cm_1 
3445s, 3053m, 2986m, 1421m, 1385m, 1265s; 5H (CDCI3, 500 MHz) 8.02-7.91 (2H, 
m, CH aromatic), 7.60-7.54 (1H, m, CH aromatic), 7.46-7.37 (2H, m, CH aromatic),
5.52 (1H, s, PhCH), 4.74 (1H, d, J 3.9, H-l), 4.28 (1H, dd, J 9.5, 3.6, H-6 ), 3.92 (1H, 
t, 7  9.2, H-3), 3.81-3.77 (1H, m, H-5), 3.71 (1H, t, ^  9.5, H-6 ’), 3.61 (1H, dd, J9 .2 ,
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3.9, H-2), 3.48 (1H, t, J9 .2 , H-4), 3.45 (3H, s, OCH3), 2.67 (1H, broad s, 2-OH), 2.56 
(1H, broad s, 3 -OH); 8 C (CDC13, 125 MHz) 130.2 (CH aromatic), 129.0 (2 x CH 
aromatic), 128.1 (ipso C), 127.6 (2 x CH aromatic), 101.4 (PhCH) 99.8 (C-l), 81.0 
(C-4), 72.4 (C-2), 70.4 (C-3), 6 8 .6  (C-6 ), 62.0 (C-5), 54.9 (OCH3); m/z (EI+) 282 
(M+, 20%), 193 (100), 179 (30), 162 (18), 133 (34); HRMS (EI+) expected M+ 
(Ci4Hi80 6) 282.1103, found 282.1107.
Methyl-4,6-0-benzyIidene-2,3-di-0-(4-toIuenesulfonyl)-a-D-glucopyranoside 69
4-Toluenesulfonyl chloride (82.00 g, 0.430 mol) was dissolved in pyridine (200 mL) 
with occasional ice-cooling to maintain the internal temperature below 20 °C. The 
solution was stirred for 30 min before diol 203 (43.5 g, 0.155 mol) was added. The 
reaction mixture was stirred for 5 days then concentrated in vacuo. The residue was 
dissolved in EtOAc (300 mL), washed with 2M HC1 (300 mL), H2O (300 mL), sat aq 
CuSCU (300 mL), sat aq NaHC03 (300 mL) and brine (300 mL), dried (MgS04) and 
concentrated in vacuo. The resulting crude oil was crystallised from CHC13/Et2 0  
affording the title compound 69 (87.5 g, 96%) as a white solid: mp 151-153 °C (Lit.72
152-154 °C); [« ]“  = +1.0 (c 1.40 in DCM) (Lit.72 [a ]„  = +11.8, c 1.00 in CHC13); 
Vmax (CHCh cast)/cm_l 3055s, 2986m, 2939m, 1599m, 1421s, 1371m, 1265s; 5H 
(CDCI3, 500 MHz) 7.84-7.99 (2H, m, CH aromatic), 7.62-7.58 (2H, m, CH aromatic), 
7.31-7.23 (7H, m, CH aromatic), 6.91-6.88 (2H, m, CH aromatic), 5.30 (1H, s, 
OCHO), 5.08 (1H, t, J 9.3, H-3), 5.03 (1H, d, J  3.6, H-l), 4.41 (1H, dd, J9 .3 , 3.6, H- 
2), 4.24 (1H, dd, J  10.3,4.8, H-6 ), 3.84 (1H, ddd, J 9.8, 9.6,4.6, H-5), 3.65 (1H, dd, J
10.3, 10.1, H-6 ’), 3.50 (1H, dd, J  9.6, 9.3, H-4), 3.40 (3H, s, OCH3), 2.45 (3H, s,
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ArCH3), 2.25 (3H, s, ArCH3); 5C (CDC13, 125 MHz) 145.4 (ipso C), 144.2 (ipso C),
133.8 (ipso C), 132.4 (ipso C), 129.9 (2 x CH aromatic), 129.7 (2 x CH aromatic),
129.5 (CH aromatic), 128.4 (2 x CH aromatic), 128.0 (2 x CH aromatic), 126.6 (ipso 
C), 126.4 (2 x CH aromatic), 126.3 (2 x CH aromatic), 101.9 (C-l), 101.3 (PhCH),
98.5 (C-4), 78.9 (C-2), 75.8 (C-3), 6 8 .6  (C-6 ), 62.3 (C-5), 55.7 (OCH3), 21.8 
(ArCH3), 21.7 (ArCH3); m/z (EI+) 590 (M+, 25%), 435 (52), 375 (100), 269 (50), 203 
(37); HRMS (EI+) expected M+ (C28H3oOioS2) 590.1280, found 590.1283.
Methyl 2,3-anhydro-4,6-0-benzylidene-a-D-allopyranoside 70
In a 2-necked round bottom flask equipped with a pressure-equalizing funnel and 
CaCE guard tube was placed a solution of ditosylate 69 (2.90 g, 5.94 mmol) in dry 
DCM (40 mL). The solution was cooled to 0 °C and a solution of sodium methoxide 
in dry methanol (prepared from sodium (680 mg) and methanol (12 mL) was added 
dropwise. When the addition was complete, the flask was stoppered and left in the 
fridge for 48 h and then at RT for 24 h. The organic solution was repeatedly washed 
with H2O until the aqueous washings were neutral. The organic solution was dried 
(MgSC>4) and concentrated in vacuo affording the title compound 70 (1.30 g, 1 0 0 %)
as a white solid: mp 195-197 °C (Lit.72 195-199 °C); [a]2J  = +152.8 (c 1.18 in DCM)
(Lit.72 [a]o = +140, c 2.00 in CHC13); vmax (CHCI3 cast)/cm_1 3055s, 2986m, 2930m, 
1467m, 1450m 1421s, 1390m, 1265s; 8 H (CDC13, 500 MHz) 7.48-7.45 (2H, m, CH 
aromatic), 7.37-7.33 (3H, m, CH aromatic), 5.55 (1H, s, OCHO), 4.87 (1H, d, 72.8,
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H-l), 4.22 (1H, dd, J  10.3, 5.0, H-6 ), 4.06 (1H, ddd, J9 .7 , 9.2, 5.0, H-5), 3.93 (1H, 
dd, J  9.2, 1.1, H-4), 3.66 (1H, dd, J  10.3, 9.7, H-6 ’), 3.50 (1H, dd, J  4.3, 1.0, H-3), 
3.48 (1H, dd, J 43, 2.8, H-2), 3.46 (3H, s, OCH3); 5C (CDC13, 125 MHz) 137.2 (ipso 
C), 129.3 (CH aromatic), 128.3 (2 x CH aromatic), 126.3 (2 x CH aromatic), 102.8 
(OCHO), 95.3 (C-l), 77.9 (C-5), 68.9 (C-6 ), 60.1 (C-4), 55.9 (C-2), 53.2 (C-3), 50.7 
(O-CHs); m/z (EI+) 264 (M+, 80%), 221 (38), 162 (100), 149 (20), 127 (54); HRMS 
(EI+) expected M+ (CuHnOs) 264.0998, found 264.0993.
Methyl 4,6-0-benzylidene-a-D-altropyranoside 72
OH
OH OMe
Epoxide 70 (1.30 g, 4.92 mmol) was triturated in a mortar with a solution of 
potassium hydroxide (1.66 g, 29.5 mmol) and water (50 mL). The suspension was 
transferred to a round bottom flask and heated to reflux until all of the solid had 
dissolved (22 h). The solution was then allowed to cool and neutralised with solid 
carbon dioxide. The organic material was extracted with DCM (5 x 20 mL). The 
combined organic extracts were washed with water (20 mL), dried (MgSCL) and 
concentrated in vacuo. The resulting syrup was crystallised by scratching a small 
portion on a watch glass with Et2 0 . The bulk syrup and seed crystals were stirred with 
Et2 0  (30 mL) and the resulting crystals were filetered off; these were then 
recrystallised from methanol to afford the title compound 72 (1.23 g, 89%) as white
prisms: mp 173-175 "C (Lit. 107-108 °C); [« ]“  = +107.6 (c 1.30 in DCM) (Lit.72
[afg = +126, c 3.0 in CHC13); vrn»  (CHC13 cast)/cm"' 3423br, 3055s, 2986m, 2930m, 
1452s, 1421s, 1375s, 1265s; 8 H (CD3OD, 300 MHz) 7.48-7.45 (2H, m, CH aromatic),
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7.35-7.32 (3H, m, CH aromatic), 5.62 (1H, s, OCHO), 4.59 (1H, d, J  1.1, H-l), 4.24 
(1H, dd, J 9.6, 5.1, H-6 ), 4.22 (1H, d d ,/9 .6 , 5.1, H-4), 4.02 (1H, dd, J5 .2 , 3.1, H-3),
4.00 (1H, td, J  9.6, 5.1, H-5), 3.84 (1H, dd, J3 .2 , 1.1, H-2), 3.81 (1H, t, J9 .6 , H-6 ’), 
3.37 (1H, s, OCH3); 5c (CD3OD, 75 MHz) 139.3 {ipso C), 129.9 (CH aromatic),
129.1 (2 x CH aromatic), 127.6 (2 x CH aromatic), 103.5 (OCHO), 103.4 (C-l), 77.9 
(C-5), 72.1 (C-2), 70.3 (C-6 ), 70.2 (C-4), 59.5 (C-3), 55.7 (OCH3); m/z (EI+) 283 
(M+, 6 %), 221 (100), 179 (87), 162 (73), 145 (24), 133 (92), 107 (90); HRMS (EI+) 
expected M+ (Ci4H,806) 282.1103, found 282.1091.
Methyl 4-0-benzoyl-6-bromo-6-deoxy-a-D-altropyranoside 204
OH
J-Q
BzO'
OH OMe 
204
Diol 72 (100 mg, 0.36 mmol), was dissolved in CHC13 (2 mL), and barium carbonate 
(14 mg, 0.07 mmol) followed by 7V-bromosuccinimide (76 mg, 0.43 mmol) were 
added. The reaction mixture was heated to reflux (1 h). The resulting mixture was 
then concentrated in vacuo, re-dissolved in Et2<3 (5 mL) and washed with H2O (3 x 5 
mL). The organic solution was dried (MgS04) and concentrated in vacuo. Column 
chromatography (petrol/EtOAc 3:2) afforded the title compound 204 (96 mg, 74%) as
a brown solid: mp 165-168 °C; = -54.9 (c 0.65 in DCM); vmax (CHC13 cast)/cm~
1 3430br, 3053s, 2988m, 1745s, 1421s, 1265s, 743s; 5H (CDC13, 400 MHz) 8.04-8.00 
(2H, m, CH aromatic), 7.60-7.54 (1H, m, CH aromatic), 7.47-7.42 (2H, m, CH 
aromatic), 5.26 (1H, dd, J 9.8, 3.3, H-4), 4.77 (1H, d, J  1.7, H-l), 4.34 (1H, ddd, /9 .8 ,
7.8, 2.7, H-5), 4.23 (1H, dd, J4 .3 , 3.3, H-3), 3.98 (1H, dd, J4.3 , 1.7, H-2), 3.61 (1H, 
dd, J  11.1, 2.7, H-6 ), 3.55 (1H, dd, J  11.1, 7.8, H-6 '), 3.49 (3H, s, OCH3); 6 C (CDC13,
126
100 MHz) 165.6 (C=0), 133.5 (ipso C), 130.0 (CH aromatic), 129.9 (2 x CH 
aromatic), 129.8 (2 x CH aromatic), 101.5 (C-l), 69.7 (C-2), 69.5 (C-4), 68.9 (C-5),
66.4 (C-3), 55.9 (OCH3), 32.4 (C-6 ); m/z (EI+) 361/363 (M+, 7/5%), 295 (12), 223 
(43), 162 (100), 199 (56); HRMS (EI+) expected M+ (C,4Hl779Br06) 360.0209, found 
360.0213.
Methyl 2,3-di-0-acetyI-4-0-benzoyI-6-bromo-6-deoxy-a-D-aItropyranoside 73
BzO'
OAc OMe
Acetic anhydride (63 pL, 0.67 mmol) was added to a solution of diol 204 (100 mg, 
0.28 mmol) in dry pyridine (2 mL). The reaction mixture was stirred at RT (18 h) and 
then concentrated in vacuo. The residue was re-dissolved in EtOAc (5 mL), washed 
with 2M HC1 solution (5 mL), H2O (5 mL) sat aq CuSCL (5 mL), sat aq NaHCC>3 (5 
mL) and brine (5 mL), dried (MgSCL) and concentrated in vacuo. Column 
chromatography (petrol/EtOAc 5:1) afforded the title compound 73 (110 mg, 89%) as
a light brown solid: mp 145-147 "C; [a]o = +55.5 (c 1.99 in DCM); vrax (CHC13 
cast)/cm_l 3057s, 2968m, 1747s, 1732s, 1421s, 1371s, 1265s, 738s; 5H (CDC13, 300 
MHz) 7.96-7.90 (2H, m, CH aromatic), 7.58-7.54 (1H, m, CH aromatic), 7.44-7.41 
(2H, m, CH aromatic), 5.35 (1H, dd, 7  3.8, 3.2, H-3), 5.32 (1H, dd, 7  9.3, 3.8, H-4),
5.01 (1H, dd, 73.2, 1.2, H-2), 4.72 (1H, d, 7  1.2, H-l), 4.48 (1H, ddd, 79.3, 7.8, 2.7, 
H-5), 3.61 (1H, dd, 7  11.1, 2.7, H-6 ), 3.52 (1H, dd, 7  11.1, 7.6, H-6 ’), 3.49 (3H, s, 
OCH3), 2.14 (3H, s, C(0)CH3), 2.08 (3H, s, C(0)CH3); 8 C (CDC13, 75 MHz) 169.8 
(C=0), 169.4 (C=0), 165.1 (PhC=0), 133.7 (CH aromatic), 129.7 (2 x CH aromatic),
129.0 (ipso C), 128.6 (2 x CH aromatic), 99.9 (C-l), 69.4 (C-5), 68.1 (C-2), 67.4 (C-
127
4), 66.2 (C-3), 55.9 (OCH3), 32.2 (C-6 ), 20.9 (C(0)CH3), 20.8 (C(0)CH3); m/z (CI+) 
445/447 (MH+, 5/3%), 417 (80), 415 (78), 355 (43), 353 (50), 219 (60), 183 (28), 163 
(22), 141 (72), 133 (100); HRMS (CI+) expected MH+ (QsffeBrOg) 445.0498, found 
445.0486.
Methyl 2,3-di-(9-acetyl-6-iS'-acetyl-4-61-benzoyl-6-thio-a-D-altropyranoside 74
AcS
BzO‘
OAc OMe
Potassium thioacetate (128 mg, 1.11 mmol) was added to a solution of di-acetate 73 
(100 mg, 0.23 mmol) in dry DMF (2 mL) and heated to 80 °C for 18 h. It was then 
allowed to cool to RT and partitioned between EtOAc (10 mL) and H20  (60 mL). The 
aqueous phase was extracted with EtOAc (6  x 10 mL) and the organic extracts were 
combined, washed with brine (60 mL), dried (MgSO^ and concentrated in vacuo. 
Column chromatography (petrol/EtOAc 6:1) afforded the title compound 74 (82 mg,
83%) as a viscous colourless oil; = +21.7 (c 0.35 in DCM); Vmax (CHCI3
cast)/cm-1 3055s, 2986m, 2929, 1751s, 1697s, 1452m, 1421s, 1371s, 1265s; 5H 
(CDCI3, 300 MHz); 8.03-8.00 (2H, m, CH aromatic), 7.57-7.55 (1H, m, CH 
aromatic), 7.46-7.42 (2H, m, CH aromatic), 5.32 (1H, dd, J  3.7, 3.5, H-3), 5.27 (1H, 
dd, J 9.4, 3.5, H-4), 4.98 (1H, dd, J3 .7 , 1.2, H-2), 4.63 (1H, d, J  1.2, H-l), 4.34 (1H, 
ddd, J  9.7, 9.4, 3.1, H-5), 3.44 (1H, dd, J  13.7, 3.1, H-6 ), 3.42 (3H, s, OCH3), 3.01 
(1H, dd, J  13.7, 9.7, H-6 ’), 2.35 (3H, s, SC(0)CH3), 2.15 (3H, s, C(0)CH3), 2.04 (3H, 
s, C(0)CH3); 5c (CDCI3, 75 MHz) 194.8 (SC=0), 169.9 (C O ), 169.4 (C O ), 165.3 
(PhCO ), 133.5 (CH aromatic), 129.8 (2 x CH aromatic), 129.3 (ipso C), 128.6 (2 x 
CH aromatic), 98.7 (C-l), 69.4 (C-5), 68.4 (C-2), 67.3 (C-4), 65.9 (C-3), 55.7
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(OCH3), 30.5 (C-6 ), 20.9 (C(0)CH3), 20.84 (C(0)CH3), 20.81 (C(0)CH3); m/z (EI+) 
440 (M+, 13%), 389 (18), 345 (11), 254 (18), 199 (45), 183 (100); HRMS (EI+) 
expected M+ (C20H24O9S) 440.1141, found 440.1149.
l,2,3-Tri-0-acetyI-6-5-acetyl-4-0-benzoyl-6-thio-D-altropyranoside 75 and 2,3-di- 
O-acetyI-4-O-benzoyI-l ,6-thioanhydro-D-aItropyranose 76
OAc
OBz
OAcBzO‘
AcS
OAc OAc
Thioacetate 74 (70 mg, 0.16 mmol) was dissolved in acetic anhydride (4 mL) and 
glacial acetic acid (4 mL) with occasional ice-cooling to maintain the internal 
temperature below 5 °C. Concentrated sulfuric acid (70 pL) was then added drop wise 
over 10 min. The reaction mixture was stirred at RT for 24 h and was then poured 
onto ice (30 mL). The organic material was extracted with DCM (5 * 10 mL). The 
organic extracts were washed with water (20 mL) and sat aq NaHC03 (20 mL), dried 
(MgSCL) and concentrated in vacuo. Column chromatography (petrol/EtOAc 6:1) 
afforded triacetate 75 (48 mg, 65%), as a mixture of anomers (a:p 4:6) as a colourless 
oil: vmax (CHC13 cast)/cm_1 3055s, 2986m, 2929m, 1751s, 1697m, 1421s, 1265s; 8 H 
(CDCI3, 500 MHz) a-anomer 8.00-7.96 (2H, m, CH aromatic), 7.57-7.55 (1H, m, CH 
aromatic), 7.45-7.41 (2H, m, CH aromatic), 5.95 (1H, d, J  1.6, H-l), 5.40 (1H, dd, J
4.0, 3.5, H-3), 5.31 (1H, dd, J9 .5 , 3.5, H-4), 5.03 (1H, dd, /  4.0, 1.6, dd, H-2), 4.41 
(1H, ddd, J  9.5, 7.7, 3.5, H-5), 3.36 (1H, dd, J  14.1, 3.5, H-6 ), 3.08 (1H, dd, J  14.1,
7.7, H-6 ’), 2.30 (3H, s, SC(0)CH3), 2.16 (3H, s, C(0)CH3), 2 .1 2  (3H, s, C(0)CH3),
2.07 (3H, s, C(0)CH3); irradiation of the signal at 5.95 ppm produced the following 
nuclear Overhauser enhancements: 5.40 (0.2%), 5.03 (1.5%), 2.07 (0.1%), 2.12
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(0.2%), 2.16 (0.2%); fi-anomer 8.00-7.95 (2H, m, CH aromatic), 7.57-7.51 (1H, m, 
CH aromatic), 7.43-7.33 (2H, m, CH aromatic), 6.19 (1H, d, J  1.6, H-l), 5.56 (1H, dd, 
J 6.0, 3.3, H-3), 5.36 (1H, dd, J 7.6, 3.3, H-4), 5.24 (1H, dd, J 6.0, 2.1, dd, H-2), 4.20 
(1H, ddd, J  8.3, 7.6, 4.3 , H-5), 3.43 (1H, dd, J  14.2, 4.3, H-6 ), 3.06 (1H, dd, J  14.2,
8.3, H-6 '), 2.32 (3H, s, SC(0)CH3), 2.15 (3H, s, C(0)CH3), 2.11 (3H, s, C(0)CH3),
2.05 (3H, s, C(0)CH3); irradiation of the signal at 6.19 ppm produced the following 
nuclear Overhauser enhancements: 5.24 (2.2%), 4.20 (2.0%), 2.15 (0.1%), 2.11 
(0.2%), 2.05 (0.2%); m/z (FAB+) 469 (MH+, 70%), 193 (100); HRMS (FAB+) 
expected MH+ (C21H25O10S) 469.1168, found 469.1166.
Further elution with petrol/EtOAc (3:1) afforded bicycle 76 (9 mg, 15%) as a 
colourless oil: [oc\2^  = -160.2 (c 3.15 in DCM); vmax (CHC13 cast)/cm_1 3055s, 
2988m, 2930m, 1748s, 1600br, 1421s, 1265s; 5H (CDC13, 500 MHz) 8.00-7.95 (2H, 
m, CH aromatic), 7.58-7.52 (1H, m, H aromatic), 7.45-7.35 (2H, m, CH aromatic), 
5.68 (1H, d, J 3.5, H-l), 5.46 (1H, dd, J  9.5, 4.2, H-3), 5.41 (1H, dd, J 4.2, 2.1, H-4),
5.32 (1H, dd, J  9.5, 3.5, H-2), 4.98 (1H, ddd, J  7.3, 2.1, 0.7, H-5), 3.28 (1H, dd, J  
10.7, 7.3, H-6 '), 3.08 (1H, dd, J  10.7, 0.7, H-6 ), 2.04 (3H, s, C(0)CH3), 1.92 (3H, s, 
C(0)CH3); 5c (CDC13, 125 MHz) 170.2 (C=0), 170.0 (C=0), 165.6 (PhC=0), 133.5 
(CH aromatic), 129.9 (2 x CH aromatic), 129.2 {ipso C), 128.5 (2 x CH aromatic), 
82.9 (C-l), 79.4 (C-5), 71.0 (C-2), 69.9 (C-4), 67.4 (C-3), 33.0 (C-6 ), 20.9 
(C(0)CH3), 20.6 (C(0)CH3); m/z (FAB+) 367 (MH+, 27%), 163 (100); HRMS 
(FAB+) expected MH+(Ci7Hi90 7S) 367.0852, found 367.0852.
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Diethyl (2’S, VS,  4'R)-2-(4,5-Diacetoxy-3-benzoyloxy-3,4-dihydro-2//-pyran-2- 
ylmethyIsuIfan\i)maIonate 78
OAc
AcO.
COoEt
Rhodium heptafluorobutyrate dimer (8  mg, 7.5 pmol) was weighed under Ar in a 
glovebag and added to diacetate 76 (28 mg, 76 pmol). The mixture was suspended in 
dry toluene (0.5 mL) and heated to reflux. A solution of diethyl diazomalonate (18 
mg, 98 pmol) in dry toluene (1 mL) was added dropwise and the resulting mixture 
was heated to reflux for 18 h. The reaction mixture was allowed to cool to RT and 
concentrated in vacuo. Column chromatography (Florisil®; petrol/EtOAc 10:1)
afforded the title compound 78 (3 mg, 8 %) as a colourless oil: [ocf^ = +7.0 (c 0.20 in 
DCM); Vmax (CHC13 cast)/cm-1 3053s, 2988, 1742s, 1421s, 1265s; 5H (CDCI3, 500 
MHz) 7.97-7.94 (2H, m, CH aromatic), 7.57-7.53 (1H, m, CH aromatic), 7.43-7.39 
(2H, m, CH aromatic), 6.74 (1H, s, C=CH), 5.87 (1H, d, J  4.1, H-4'), 5.41 (1H, dd, J
10.6, 4.1, H-3'), 4.44 (1H, ddd, J  10.6, 7.6, 2.9, H-2'), 4.31 (1H, s, CH(C02Et)2), 4.19- 
4.15 (4H, m, C 02CH2CH3), 3.21 (1H, dd, J  14.4, 2.9, CH2S), 3.02 (1H, dd, J  14.4,
7.6, CH2S), 2 .1 1  (3H, s, C(0)CH3), 2.00 (3H, s, C(0)CH3), 1.28-1.19 (6 H, m, 
C0 2CH2CH3); 5c (CDC13, 125 MHz) 170.2 (C=0), 170.1 (C O ), 167.3 (C O ), 167.2 
(C O ), 165.2 (PhC O ), 131.7 (C=CH), 133.4 (CH aromatic), 129.4 (2 x CH 
aromatic), 128.9 {ipso C), 128.6 (2 x CH aromatic), 127.0 (C O H ), 73.7 (C-2’), 68.4 
(C-3’), 64.8 (C-4’), 63.1 (C02CH2CH3), 51.9 (CH(C02Et)2), 32.6 (CH2S), 21.8 
(C(0)CH3), 21.0 (C(0)CH3), 14.5 (C 02CH2CH3); m/z (CI+) 547 (MH+, 43%), 301
131
(26), 193 (12), 161 (23), 133 (100); HRMS (CI+) expected MH+ (C24H2<,Ou S) 
525.1431, found 525.1437.
1,6 -Thioanhydro-D-glucopyranose 82
OH
HO
OH
Concentrated NH4OH solution (d = 0.88, 0.5 mL) was added to a solution of tri­
acetate 58 (100 mg, 330 pmol) in MeOH (1 mL). The reaction mixture was stirred at 
RT for 15 h, then concentrated in vacuo and rendered anhydrous by co-evaporation 
several times with absolute EtOH. Column chromatography (EtOAc/petrol 95:5) 
afforded the title compound 82 (45 mg, 77%) as white needles: mp 180-182 °C (Lit. 132
180 °C); [a ]“  = -13.7 (c 1.50 in EtOH) (Lit. 131 [a ]“  = -52 (c 0.75 in H20); v „  
(KBr disc)/cm_1 3340br, 3053s, 2987m, 1420s, 1265s; 5H (CD3OD, 500 MHz) 5.30 
(1H, t, 7  1.1, H-l), 4.65 (1H, dt, 76.2, 0.9, H-5), 3.52 (1H, dd, 71.1, 1.0, H-2), 3.49 
(1H, dd, 7  1.9, 0.9, H-4), 3.40 (1H, dd, 7  1.9, 1.0, H-3), 3.07 (1H, dd, 79.7, 0.9, H-6 ), 
2.98 (1H, dd, 79.7,6.2, H-6 '); 5C (CD3OD, 125 MHz) 84.3 (C-l), 81.2 (C-5), 71.5 (C- 
2), 69.2 (C-3), 68.4 (C-4), 34.5 (C-6 ); m/z (FAB+) 201 (MNa+, 57%), 161 (100); 
HRMS (FAB+) expected MNa+ (C6Hi0NaO4S) 201.01975, found 201.01927.
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1,2:5,6-Di-0-isopropyIidene-a-D-gIucofurariose 84
HO
D-Glucose 55 (5.00 g, 28 mmol) was sonicated with 100 mL of acetone in a 
sonication bath. Concentrated sulfuric acid (5.2 mL, 10.4 mmol) was added dropwise. 
The resulting mixture was left sonicating for 2 h, then ammonia gas was passed 
through the mixture until neutral. Ammonium sulfate salts were removed by filtration 
and the filtrate was concentrated to a syrup. The residue was extracted with 
chloroform and the organic layer concentrated in vacuo. It was then recrystallised 
from high-boiling petrol (60-80) to afford the title compound 84 (3.76 g, 52%) as
white needles: mp 110-112 °C (Lit.133 110 °C); [a£ ° = -11.5  (c 1.35 in DCM) (Lit. 134
[a f£  = -18.5, c 5 in H20); vmax (CHC13 cast)/cm_1 3448br, 3055s, 2988m, 2937m, 
1421s, 1256s; 5H (CDC13, 300 MHz) 5.91 (1H, d, /3 .8 , H-l), 4.49 (1H, br d, J 3.8, H- 
2), 4.30 (1H, ddd, J  8.0, 6.2, 5.4, H-5), 4.27 (1H, dd, /8 .0 , 7.8, H-4), 4.12 (1H, dd, J
8 .8 , 6.2, H-6 '), 4.01 (1H, dd, J 7.8, 2.7, H-3), 3.96 (1H, dd, J  8 .8 , 5.4, H-6 ), 2.91 (1H, 
br s, OH), 1.47 (3H, s, CH3), 1.42 (3H, s, CH3), 1.36 (3H, s, CH3), 1.31 (3H, s, CH3); 
5C (CDC13, 75 MHz) 111.8 (CH2OCO), 109.6 (CHOCO), 105.2 (C-l), 85.1 (C-2),
81.2 (C-3), 75.0 (C-4), 73.2 (C-5), 67.6 (C-6 ), 26.8 (CH3), 26.7 (CH3), 26.2 (CH3),
25.2 (CH3); m/z (FAB+) 283 (MNa+, 62%), 245 (13), 199 (17), 176 (100); HRMS 
(FAB+) expected MNa+ (Ci2H20NaO6) 283.1158, found 283.1152.
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l,2:5,6-Di-O-isopropylidene-3-0-methyl-D-glucofuranose 85
MeO
To a stirred solution of diacetonide 84 (1.50 g, 5.8 mmol) in 10 mL of dry acetone 
was added finely crushed potassium hydroxide (0.87 g, 15.5 mmol) and n- 
tetrabutylammonium iodide (106 mg, 290 pmol). The mixture was then cooled to 0 
°C, and iodomethane (0.8 mL, 12.9 mmol) was added dropwise. The mixture was 
allowed to warm to RT and stirred for 1 h. The acetone was removed in vacuo and 
water (5 mL) was added; the organic material was then extracted with DCM (4 x 30 
mL). The combined organic phases were washed with sat aq NH4C1 (10 mL), water 
(10 mL) and brine (10 mL), dried (MgS04) and concentrated in vacuo to give the title
compound 85 (1.54 g, 97%) as a yellow oil: \ocfp = -58.8 (c 4.75 in DCM) (Lit. 135
[a f*  = -38.0, c 1 in CHC13); vmax (CHC13 cast)/cnf1 3055s, 2988m, 2937s, 2902m, 
1456m, 1421m, 1265s; 5H (CDC13, 300 MHz) 5.75 (1H, d, J  3.8, H-l), 4.47 (1H, 
apparent d, y  3.8, H-2), 4.20 (1H, ddd, J  7.8, 6.2, 5.6, H-5), 4.02 (1H, dd, 7  7.8, 3.0, 
H-4), 4.00 (1H, dd, J  8 .6 , 6.2, H-6 '), 3.90 (1H, dd, y  8 .6 , 5.6, H-6 ), 3.67 (1H, apparent 
d, 7  3.2, H-3), 3.36 (3H, s, OCH3), 1.47 (3H, s, CH3), 1.42 (3H, s, CH3), 1.36 (3H, s, 
CH3), 1.31 (3H, s, CH3); 6 c (CDC13, 75 MHz) 111.1 (CH2OCO), 108.9 (CHOCO),
105.1 (C-l), 83.6 (C-3), 81.8 (C-2), 81.0 (C-4), 72.3 (C-5), 67.1 (C-6 ), 58.1 (OCH3),
26.8 (CH3), 26.7 (CH3), 26.1 (CH3), 25.4 (CH3); m/z (FAB+) 297 (MNa+, 48%), 259 
(15), 242 (100), 199 (10), 176 (72), 154 (10); HRMS (FAB+) expected MNa+ 
(Ci3H22N a06) 297.1314, found 297.1306.
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3-0-Methyl-D-glucose 86
OH
HO OH
Dowex® 50x8 resin (1.00 g) was washed with 2M HC1 solution and then rinsed 5 
times with H2O until the filtrate was neutral. The resin was then added to a solution of 
methyl ether 85 (5.00 g, 18.2 mmol) in H2O (20 mL), and the mixture was heated to 
reflux for 4 h. The resin was then filtered off and the solution clarified with charcoal. 
The solution was then concentrated in vacuo and co-evaporated several times with 
absolute EtOH to afford the title compound 8 6  (3.50 g, 99%), a mixture of anomers 
(a:P: 1:1) as white crystals: mp 166-168 °C (Lit.136 165-166 °C); vmax (KBr disc)/cm_1 
3485br, 3053s, 2988m, 2936s, 2831s, 1633m, 1456s, 1371s; SH (500 MHz, D20 ) a- 
anomer 4.52 (1H, d, 77.3, H-l), 3.72 (1H, m, H-4), 3.66 (1H, ddd, J  12.6, 9.8, 5.5, H-
5), 3.61 (1H, dd, J  12.6, 5.5, H-6 ), 3.49 (3H, s, O-CH3), 3.39-3.35 (1H, m, H-3), 3.35-
3.33 (1H, m, H-6 '), 3.18 (1H, dd, J  9.1, 7.3, H-2); P-anomer 5.09 (1H, d, J  3.6, H-l),
3.78 (1H, dd, J  12.5, 1.7, H-6 ), 3.60 (1H, dd, J  12.6, 10.0, H-6 ’), 3.49 (3H, s, OCH3), 
3.47 (1H, dd, J  4.2, 3.6, H-2), 3.42-3.40 (1H, m, H-3), 3.41-3.37 (1H, m, H-5), 3.22- 
3.17 (1H, m, H-4); 5C (125 MHz, D20 ) a-anomer 95.8 (C-l), 82.7 (C-5), 73.4 (C-2),
71.4 (C-4), 69.0 (C-3), 60.6 (C-6 ), 60.0 (OCH3); P-anomer 92.0 (C-l), 85.3 (C-5),
75.7 (C-4), 70.9 (C-2), 68.9 (C-3), 60.4 (C-6 ), 59.7 (O-CH3); m/z (FAB+) 217 (MNa+, 
22%), 154 (100); HRMS (FAB+) expected MNa+ (C7Hi40 6Na) 217.0688, found 
217.0693.
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2,4-Di-0-acetyl-3-0-methyl-l ,6-thioanhydro-D-glucopyranose 206
OMe
AcO
OAc
206
3-O-Methyl-D-glucose 86 was converted to bromide 205 using identical experimental 
procedures to the conversion of D-glucose 55 to bromide 57. Bromide 205 (6.47 g,
13.1 mmol) was dissolved in dry acetone (150 mL) and cooled to 0 °C. Ethylxanthic 
acid potassium salt (6.28 g, 39.2 mmol) was added. The mixture was then allowed to 
warm to RT and then heated at 85 °C for 17 h, concentrated in vacuo, and the residue 
dissolved in water (250 mL). The organic material was extracted with diethyl ether (6 
x 50 mL). The combined organic extracts were washed with brine (100 mL), dried 
(MgS0 4 ), and concentrated in vacuo. Column chromatography (EtOAc/petrol 1:3)
afforded the title compound 206 (1.80 g, 50%) as white needles: mp 83-85 °C; =
-21.6 (c 1.75 in DCM); vmax (KBr disc)/cm'1 2988m, 2955s, 2831s, 1745s, 1630m, 
1450s, 1373s; 5H (CDC13, 300 MHz) 5.44 (1H, d, J  1.1, H-l), 4.78 (1H, ddd, J  7.2, 
3.5, 0.8, H-5), 4.75 (1H, dd, 72.7, 1.1, H-2), 4.65 (1H, dd, y  3.5, 1.6, H-4), 3.47 (3H, 
s, OCH3), 3.42 (1H, dd, J 2.7, 1.6, H-3), 3.38 (1H, dd, J 9.9, 0.8, H-6), 3.33 (1H, dd, J
9.9, 7.2, H-6’), 2.16 (C(0)CH3), 2.14 (C(0)CH3); 5C (CDC13, 300 MHz) 170.2 (C=0),
170.1 (C=0), 85.1 (C-l), 80.8 (C-5), 77.8 (C-2), 75.4 (C-4), 69.0 (C-3), 55.2 (OCH3),
32.6 (C-6), 18.6 (C(0)CH3), 18.4 (C(0)CH3); m/z (FAB+) 276 (MNa+, 85%), 133 
(100), 84 (40), 69 (44), 59 (38); HRMS (FAB+) expected MNa+ (CnH160 6NaS) 
276.0668, found 276.0674.
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3-0-Methyl-l ,6-thioanhydro-D-glucopyranose 87
OMe
HO
OH
Concentrated NH4OH solution (d = 0.88, 18 mL) was added to a solution of di-acetate 
206 (3.34 g, 11.6 mmol) in MeOH (50 mL). The reaction mixture was stirred at RT 
for 12  h, concentrated in vacuo and rendered anhydrous by co-evaporation several 
times with absolute EtOH. Column chromatography (EtOAc/petrol 8:3) afforded the
title compound 87 (1.76 g, 79% yield) as white crystals: mp 174-176 °C; [ocf^ = _
89.7 (c 3.30 in DCM); vmax (KBr disc)/cm_1 3455br, 2989m, 2950s, 2830s, 1628m, 
1450s, 1375s; 5H (CDC13, 400 MHz) 5.41 (1H, d, J  1.7, H-l), 4.75 (1H, ddd, J  8.5,
5.0, 2.0, H-5), 3.73 (1H, dd, J  1.8, 1.7, H-2), 3.59 (1H, dd, J2 .0 , 1.9, H-4), 3.40 (3H, 
s, OCH3), 3.33 (1H, dd, J  1.9, 1.8, H-3), 3.09 (1H, dd, 10.1, 8.5, H-6 '), 3.07 (1H, dd, J
10.1, 5.0, H-6 ); 5C (CDC13, 100 MHz) 83.4 (C-l), 81.0 (C-3), 80.1 (C-5), 69.9 (C-2),
69.5 (C-4), 58.1 (OCH3), 32.4 (C-6 ); m/z (FAB+) 215 (MNa+, 30%), 84 (100); HRMS 
(FAB+) expected MNa+ (C7H120 4NaS) 215.0354, found 215.0359.
(VS, 45)-4-(l-Hydroxy-2-mercaptoethyl)-l,5-dioxa-spiro[5.5]undec-2-ene-2- 
carbaldehyde 88
SH
OHC
'OH
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Activated 4 A molecular sieves (25 mg) were added to a solution of diol 87 (50 mg, 
0.29 mmol) in dry EtOAc followed by cyclohexanone (0.18 mL, 2.92 mmol) and p- 
toluenesulfonic acid (5 mg, 0.03 mmol). The resulting mixture was heated to reflux 
for 12 h. 2% NaHCOs solution (15 mL) was added and the organic material was then 
extracted with Et2 0  (4 x 20 mL). The organic extracts were combined, and washed 
with brine (20 mL), dried (MgS0 4 ) and concentrated in vacuo. Column 
chromatography (EtOAc/petrol 1:9) afforded the title compound 8 8  (33 mg, 45%) as a
colourless oil: [«]“  = +8.5 (c 0.15 in DCM); 5H (CDC13, 400 MHz) 9.47 (1H, s, 
CHO), 6.95 (1H, d, J3 .9 , C=CH), 4.66 (1H, dd, J5 .9 , 3.9, CHCH=C), 4.32 (1H, ddd, 
J  10.6, 5.9, 4.4, CHOH), 2.91 (1H, dd, J  12.7, 4.4, CHjSH), 2.51 (1H, dd, J  12.7,
10.6, CH?SH), 1.67-1.43 (10H, m, cyclohexylidene); 5c (CDCI3, 100 MHz) 189.2 
(CHO), 143.1 (C=CH), 109.1 (C=CH), 94.2 (OCO), 72.9 (CHOH), 69.7 (CHCHOH),
38.0 (CH2CCH2), 34.8 (CH2SH), 28.6 (CH2CH2CH2C), 24.9 (CH2CH2CH2CH2CH2).
(35, 4R,  55)-4,5-(9-Cyclohexylidene-2-ethylsulfanylmethylene-3-
methoxytetrahydrothiophene-4,5-diol 91
iOMe
A solution of diol 87 (100 mg, 0.58 mmol) in dry DCM was treated with activated 4 
A molecular sieves, cyclohexanone (0.36 mL, 5.8 mmol) and /?-toluenesulfonic acid 
(10 mg, 0.06 mmol), and refluxed for 12 h. 2% Aq NaHC0 3  (15 mL) was added and
138
the organic material was extracted with Et2 0  (4 x 20 mL) then washed with water (20 
mL) and brine (20 mL), dried (MgS0 4 ) and concentrated in vacuo. The crude product 
was subjected to column chromatography (EtOAc/petrol 5:95) affording the title
compound 91 (51 mg, 28%) as a colourless oil; [#]^° = -12.6 (c 0.90 in DCM); vmax 
(thin film)/cm-1 2984m, 2945s, 2830s, 1628m, 1444s, 1370s; 5H (CDC13, 500 MHz)
6.06 (1H, s, CHSEt), 4.52 (1H, ddd, J7.6, 5.8, 3.0, CHCH2S), 4.23 (1H, dd, J1.6, 4.8, 
CHCHOMe), 3.90 (1H, d, 74.8, CHOMe), 3.36 (3H, s, OCH3), 3.27 (1H, dd, J  13.5,
3.0, CH2S), 2.81 (1H, dd, J  13.5, 5.8, CH2S), 2.74 (2H, q, J  7.9, CH2CH3), 1.68-1.43 
(10H, m, cyclohexylidene), 1.30 (3H, t, J7 .9 , CH2CH3); 6 C (CDC13, 125 MHz) 127.0 
(C=CSEt), 119.5 (C=CSEt), 110.1 (OCO), 81.9 (OCHCHOMe), 75.7 (SCH2CHO),
72.0 (CHOMe), 57.0 (OCH3), 36.2 (2 x CH2CO), 34.2 (SCH2CHO), 28.3 
(OCCH2CH2CH2), 27.6 (SCH2CH3), 23.6 (2  x OCCH2CH2CH2), 15.5 (SCH2CH3); 
m/z (FAB+) 339 (MNa+, 25%); HRMS (FAB+) expected MNa+ (Ci5H240 3NaS2) 
339.1065, found 339.1069.
(15, 55, 6i?)-4-Ethylsulfanylmethylene-5-methoxy-7,9-dioxa-4-
thiabicyclo[4.3.0]nonan-8-one 96
,OMe
Dry pyridine (256 pL, 3.17 mmol) was added dropwise at 0 °C to a solution of diol 87 
(100 mg, 0.53 mmol) in dry DCM (1 mL). The reaction mixture was allowed to warm 
to RT and stirred for 30 min, then cooled to -78 °C. A solution of triphosgene (156
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mg, 0.58 mmol) in dry DCM (2 mL) was added dropwise, the mixture was allowed to 
warm to RT and stirred for 10 h. The solution was then carefully poured onto ice (20 
g); the organic material was extracted with DCM (3 x 20 mL), the organic extracts 
were combined, washed with sat aq NaHCC>3 (20 mL), sat aq NH4CI (20 mL) and 
brine (20 mL), dried (MgS04), and concentrated in vacuo. Pyridine traces were 
removed by co-evaporation three times with toluene. Column chromatography 
(petrol/EtOAc 2:1) afforded the title compound 96 (59 mg, 43%) as a colourless oil:
M d  = —51.4 (c 0.25 in DCM); vmax (thin film)/cm-1 2985m, 2950s, 2833s, 1705s, 
1630m, 1443s, .1372s; 5H (CDC13, 500 MHz) 6.19 (1H, s, CHSEt), 5.07 (1H, ddd, J
8 .8 , 3.8, 2.4, CHCH2S), 4.80 (1H, dd, J  8 .8 , 4.2, CHCHOMe), 4.06 (1H, d, J  4.2, 
CHOMe), 3.54 (1H, dd, J  14.3, 2.4, CH2S), 3.33 (3H, s, OCH3), 2.91 (1H, dd, J  14.3,
3.8, CH2S), 2.72 (2H, q, J 7.4, CH2CH3), 1.26 (3H, t, J 7.4, CH2CH3); 6 C (CDC13, 125 
MHz): 153.6 (C=0), 125.1 (C=CSEt), 122.4 (C=CSEt), 78.9 (OCHCHOMe), 74.1 
(SCH2CHO), 72.4 (CHOMe), 56.4 (OCH3), 28.5 (SCH2CHO), 26.8 (SQfcOHb), 15.4 
(SCH2CH3); m/z (EI+) 262 (M+, 100%), 233 (11), 201 (72), 147 (16), 133 (21); 
HRMS (EI+) expected M+ (Ci0Hi4O4S2) 262.0334, found 262.0337.
2,4-Di-0-(methoxycarbonyl)-3-0-methyl-l,6-thioanhydro-D-glucopyranose 104, 
2-0-methoxycarbonyl-3-0-methyl-l,6-thioanhydro-D-glucopyranose 103 and 4- 
0-methoxycarbonyl-3-0-methyl-l ,6-thioanhydro-D-glucopyranose 101
OMe OMe
HOM e02C O ' . .  z O C 02Me
101104
M e02CO
Diol 87 (0.70 g, 3.7 mmol) was dissolved in dry DCM (3 mL). The solution was 
cooled to -78 °C and triethylamine (0.65 mL, 4.4 mmol) was added dropwise. Stirring
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was continued for 30 min before a solution of methyl chloroformate (0.29 mL, 3.70 
mmol) in dry DCM (3 mL) was added over 20 min at -78 °C. The reaction mixture 
was allowed to warm to RT and stirred for 1 h. Water (5 mL) was added to the 
mixture. The organic material was then extracted with DCM (4 x 5 mL). The organic 
layers were combined, washed with sat aq NH4CI (25 mL), water (25 mL) and brine 
(25 mL), dried (MgS0 4 ) and concentrated in vacuo. Column chromatography
(EtOAc/petrol 1:3) afforded dicarbonate 104 (92 mg, 9%) as a colourless o i l : [ccf^ = 
-37.6 (c 0.13 in DCM); vmax (CHC13 cast)/cm_1 3053s, 2986m, 1736s, 1606w, 1421s, 
1256s; 5h (CDCI3, 300 MHz) 5.50 (1H, d, J  1.2, H-l), 4.81 (1H, ddd, J  10.1, 6.4, 2.0, 
H-5), 4.60 (1H, d, J  2.3, 1.2, H-2), 4.48-4.40 (1H, dd, J2 .8 , 2.0, H-4), 3.81 (3H, s, 
CO2CH3), 3.80 (3H, s, CO2CH3), 3.46 (1H, d d ,/2 .8 , 2.3, H-3), 3.19 (1H, t, ^  10.1, H- 
6'),3.07 (1H, dd, J  10.1, 6.4, H-6 ); 5C (CDC13, 75 MHz) 155.1 (C=0), 155.0 (C=0),
81.5 (C-l), 79.3 (C-5), 77.7 (C-2), 77.6 (C-4), 76.1 (C-3), 59.1 (CO2CH3), 59.0 
(CO2CH3), 55.1 (OCH3), 34.4 (C-6 ); m/z (FAB+) 331 (MNa+, 6 %), 59 (100); HRMS 
(FAB+) expected MNa+ (Cn Hi60 8SNa) 331.0464, found 331.0456.
Further elution with EtO Ac/petrol (3:1) afforded carbonate 101 (301 mg, 35%) as a
colourless oil: [d\ ^  = -98.1 (c 0.75 in DCM); vmax (CHCI3 cast)/cm-1 3440br, 3053s, 
2988m, 1740s, 1600w, 1421s, 1256s; 5H (CDC13, 300 MHz) 5.41 (1H, d, J  1.3, H-l),
4.81 (1H, ddd, J  9.9, 6.1, 2.0, H-5), 4.52 (1H, dd, J  2.4, 2.0, H-4), 3.81 (3H, s, 
CO2CH3), 3.70 (1H, dd, J2 .0 , 1.3, H-2), 3.45 (3H, s, OCH3), 3.39 (1H, dd, J 2 A ,  2.0, 
H-3), 3.16 (1H, dd, J  10.0, 9.9, H-6 '), 3.14 (1H, dd, J  10.0, 6.4, H-6 ); 6 C (CDC13, 75 
MHz) 155.0 (C=0), 83.5 (C-l), 79.3 (C-5), 77.8 (C-2), 74.6 (C-3), 70.5 (C-4), 58.6 
(CO2CH3), 55.2 (OCH3), 32.9 (C-6 ); m/z (FAB+) 273 (MNa+, 56%), 133 (100); 
HRMS (FAB+) expected MNa+ (C9H 140 6SNa) 273.0409, found 273.0418.
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Further elution with EtO Ac/petrol (3:1) afforded carbonate 103 (279 mg, 32%) as a 
colourless oil: [ccf^ = -33.2 (c 2.7 in DCM); vmax (CHCI3 cast)/cm-1 3449br, 3052s, 
2988m, 1742s, 1606w, 1421s, 1256s; 5H (CDC13, 300 MHz) 5.50 (1H, d, J  1.1, H-l),
4.81 (1H, ddd, J  9.8, 6.2, 2.6, H-5), 4.67 (1H, dd, J  2.0, 1.1, H-2), 3.84 (3H, s, 
CO2CH3), 3.55 (1H, dd, J2 .6 , 2 .1 , H-4), 3.46 (3H, s, OCH3), 3.39 (1H, d, J  2.1, 2.0, 
H-3), 3.13 (1H, dd, J  10.0, 9.8, H-6 ’), 3.09 (1H, dd, J  10.0, 6.2, H-6 ); 5C (CDC13, 75 
MHz) 154.6 (C=0), 81.1 (C-l), 80.6 (C-5), 79.3 (C-4), 74.8 (C-3), 69.7 (C-2), 58.3 
(CO2CH3), 55.2 (OCH3), 32.7 (C-6 ); m/z (FAB+) 273 (MNa+, 19%), 69 (100); HRMS 
(FAB+) expected MNa+ (C9Hi40 6SNa) 273.0409, found 273.0401.
2,4-0-(Di-terf-biitylsilyleiie)-3-0-methyl-l ,6-thioanhydro-D-glucopyranose 105
OMe
f-Bu f-Bu
105
Freshly distilled 2,6-lutidine (92 pL, 0.80 mmol) was added to a solution of diol 87 
(50 mg, 0.27 mmol) in dry DCM (1 mL) and di-te/Y-butylsilyl ditriflate (145 pL, 0.40 
mmol) was added in one portion. The mixture was stirred at RT for 1.5 h, then 
partitioned between DCM (10 mL) and sat aq NaHC0 3  (10 mL). The organic material 
was extracted with DCM (5 x 10 mL); the combined organic extracts were washed 
with water (10 mL) and brine (10 mL), dried (MgS04) and concentrated in vacuo. 
Column chromatography (SiC>2 previously treated with Et3N, EtOAc/petrol/Et3N 
1:20:0.2) afforded the title compound 105 (76 mg, 8 6 %) as white crystals: mp 107-
110 °C; [a ]“  = -11.4 (c 1.0 in DCM); vmax (CHCI3 cast)/cm~' 2988m, 2950m, 
1600m, 1420m, 1253s; 8 H (CDCI3, 500 MHz) 5.43 (1H, d, J2 .2 , H-l), 4.73 (1H, ddd,
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77.8, 2.8,1.8, H-5), 4.00 (1H, dd, 72.7,2.2, H-2), 3.87 (1H, dd,72.7, 1.9, H-3), 3.85 
(1H, dd, 72.8,1.9, H-4), 3.37 (3H, s, OCH3), 3.21 (1H, dd, 79.3, 1.8, H-6 ), 3.08 (1H, 
dd, 7  9.3, 7.8, H-6 '), 1.11 (9H, s, C(CH3)3), 1.03 (9H, s, C(CH3)3); 8C (CDC13, 125 
MHz) 81.9 (C-l), 78.5 (C-5), 77.6 (C-3), 70.9 (C-4), 70.1 (C-2), 57.7 (OCH3), 32.6 
(C-6 ), 29.7 (C(CH3)3), 28.4 (C(CH3)3), 22.3 (C(CH3)3), 21.3 (C(CH3)3); m/z (FAB+) 
355 (MNa+, 65%), 193 (100); HRMS (FAB+) expected MNa+ (Ci5H2804SSiNa) 
355.1375, found 355.1364.
4-0-Di-tert-butylfluorosilaiiyl-3-0-methyl-2-{Mriethylsilaiiyl-l,6-thioanhydro-D- 
glucopyranose 106 and 2-0-di-teF,7-butylfluorosilanyl-3-0-methyl-4-0- 
triethylsilanyl-l ,6-thioanhydro-D-glucopyranose 107
Sv OMe
W EtaSiO^
>iF 
f-Bu "f-Bu
106
Tetrakis(acetonitrile)copper(I) hexafluorophosphate (16 mg, 15 pmol) was weighed 
under Ar in a glovebag and added to silylene bisether 105 (100 mg, 150 pmol). The 
mixture was suspended in dry benzene (1 mL) and heated to reflux. A solution of 
ethyl diazo(triethylsilanyl)acetate (92 mg, 400 pmol) in dry benzene (1 mL) was then 
added dropwise to the refluxing mixture and reflux was continued for 14 h. The 
reaction mixture was cooled to RT and concentrated in vacuo. Column 
chromatography (Florisil®; petrol/EtOAc 100:1) afforded silyl fluoride 106 (18 mg, 
13%) as a colourless oil: vmax (CHCI3 cast)/cm_1 3053s, 2988m, 2856m, 2252s, 
1472m, 1385m, 1261m, 1096m, 902s, 652s; 5H (CDC13, 500 MHz) 5.26 (1H, d, J 0.7, 
H-l), 4.73 (1H, dt, J6 .3 , 0.7, H-5), 3.85 (1H, dd, J 4.5, 0.7, H-4), 3.61 (1H, dd, 73.2,
o
OMe
/ S i  
f-Bu 'f-
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0.7, H-2), 3.46 (1H, s, OCH3), 3.20 (1H, dd, J4 .5 , 3.2, H-3), 3.01 (1H, dd, J  10.0, 6.5, 
H-6 '), 2.98 (1H, dd, J  10.0, 0.7, H-6 ), 1.04 (9H, s, C(CH3)3), 1.01 (9H, s, C(CH3)3), 
0.93 (9H, t, y  7.9, Si(CH2CH3)3), 0.59 (6 H, q, J7 .9 , Si(CH2CH3)3); 5C (CDC13, 125 
MHz) 84.8 (C-l), 82.9 (C-5), 77.1 (C-2), 76.9 (C-4), 72.9 (C-3), 59.8 (OCH3), 34.9 
(C-6 ), 26.9 (C(CH3)3), 27.1 (C(CH3)3), 6 .8  (Si(CH2CH3)3), 4.81 (Si(CH2CH3)3), 1.1 
(C(CH3)3), 1.0 (C(CH3)3); 5f (CDC13, 282 MHz): -161.2 (s); m/z (EI+) 466 (M+, 7%), 
437 (56), 409 (13), 275 (23), 249 (100); HRMS (EI+) expected M+ (C2iH430 4SSi2F)
466.2405, found 466.2408.
Further elution with petrol/EtOAc 100:1 afforded silyl fluoride 107 (20 mg, 15%) as a 
colourless oil: vmax (CHC13 cast)/cm-1 3053s, 2988m, 2856m, 2252s, 1472m, 1385m, 
1096m, 902s, 652s; 5H (CDC13, 500 MHz) 5.42 (1H, d, J0 .7 , H-l), 4.60 (1H, dt, J 6.0, 
0.7, H-5), 3.98 (1H, dd, J4 .0 , 0.7, H-4), 3.49 (1H, dd, J3 .5 , 0.7, H-2), 3.47 (1H, s, 
OCH3), 3.20 (1H, dd, /4 .0 , 3.5, H-3), 2.98 (1H, dd, J  10.6, 6.0, H-6 '), 2.95 (1H, dd, J
10.6, 0.7, H-6 ), 1.04 (9H, s, C(CH3)3), 1.02 (9H, s, C(CH3)3), 0.93 (9H, t, J  7.9, 
Si(CH2CH3)3), 0.59 (6 H, q, J  7.9, Si(CH2CH3)3); 6 C (CDC13, 125 MHz) 84.2 (C-l),
82.4 (C-5), 77.2 (C-2), 76.9 (C-4), 73.8 (C-3), 59.6 (OCH3), 29.7 (C-6 ), 26.9 
(C(CH3)3), 26.8 (C(CH3)3), 6 .8  (Si(CH2CH3)3), 4.81 (Si(CH2CH3)3), 1.0 (C(CH3)3), 
0.9 (C(CH3)3); 8 f (CDC13, 282 MHz) -161.4 (s); m/z (EI+) 466 (M+, 5%), 437 (70), 
409 (100), 377 (17), 275 (12), 249 (72); HRMS (EI+) expected M+ (C2iH430 4SSi2F)
466.2405, found 466.2413.
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Di(ethoxycarbonyl)methyl 2,4-0-di-tert-butylsilylene-l-deoxy-3-0-methyl-l-thio-
p-D-glucopyranoside 108
f-B u -S i
f-Bu
108
Rhodium heptafluorobutyrate dimer (8  mg, 7.5 pmol) was weighed under Ar in a 
glovebag, added to silylene bisether 105 (25 mg, 75 prnol), suspended in dry benzene 
(1 mL) and heated to reflux. A solution of diethyl diazomalonate (18 mg, 98 pmol) in 
dry benzene (1 mL) was then added dropwise to the refluxing mixture, and reflux was 
continued for 14 h. The reaction mixture was cooled to RT and concentrated in vacuo. 
Column chromatography (Florisil®; petrol/EtOAc 9:1) afforded the title compound
108 (8  mg, 21%) as a colourless oil: [ccfp = -8.0 (c 0.25 in DCM); vmax (CHCI3 
cast)/cm_1 3420br, 3053s, 2982m, 1745s, 1695s, 1421s, 1265s; 5h (C6D6, 500 MHz)
5.78 (1H, d, J  1.1, H-l), 4.85 (1H, dd, J  12.1, 10.4, H-6 ’), 4.46 (1H, dd, /1 .7 , 1.1, H- 
2), 4.35 (1H, ddd, J  10.4, 4.3, 2.7, H-5), 4.26 (1H, s, CH(C02CH2CH3)2), 4.23 (1H, s, 
OH), 3.94-3.86 (4H, m, 2 x C O ^ f ^ C ^ ) ,  3.78 (1H, dd, J  1.7, 1.5, H-3), 3.71 (1H, 
dd, J  2.7, 1.5, H-4), 3.53 (1H, dd, J  12.1, 4.3, H-6 ), 2.89 (3H, s, O-Me), 1.20 (9H, s, 
C(CH3)3), 1.08 (9H, s, C(CH3)3), 0.89-0.83 (6 H, m, 2  x C 0 2CH2CH3); 5C (C6D6, 125 
MHz) 168.4(C=0), 167.2 (C=0), 82.7 (C-l), 81.6 (C-5), 74.0 (C-3), 70.3 (C-2), 67.3 
(C-4), 62.6 (C-6 ), 62.4 (C 02CH2CH3), 62.3 (C 02CH2CH3), 57.7 (OCH3), 52.8 
(CH(C02CH2CH3)2), 28.4 (C(CH3)3), 28.3 (C(CH3)3), 2 1 .6  (C(CH3)3), 2 1 .2  
(C(CH3)3), 13.7 (C02CH2CH3); m/z (FAB+) 531 (MNa+, 6 %), 329 (23), 217 (90), 176 
(100); HRMS (FAB+) expected MNa+ (C22H40NaO9SSi) 531.2060, found 531.2068.
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Ethoxycarbonylmethyl 6-bromo-6-deoxy-2,4-<?-di-teFY-butylsilylene-3-0-methyl-
1-thio-p-D-glucopyranoside 112
f-Bu—Si
f-Bu
112
Ethyl bromoacetate (16 pL, 150 pmol) was added in one portion to a solution of 
silylene bisether 105 (50 mg, 150 pmol) in dry MeCN (0.3 mL). The mixture was 
stirred for a further 10 h at RT. The resulting black precipitate was removed by 
filtration through Celite® and the filtrate was concentrated in vacuo. Column 
chromatography (Florisil®; EtO Ac/petrol 5:95) afforded the title compound 112 (54
mg, 72%) as a colourless oil: \ccf£ = -59.5 (c 1.50 in DCM); vmax (CHCI3 cast)/cm-1 
3050s, 2980m, 1747s, 1691s, 1421s, 1265s; 6 H (CDC13, 500 MHz) 5.37 (1H, t, /1 .0 , 
H-l), 4.38 (1H, dd, J  3.8, 2.4, H-4), 4.34 (1H, ddd, J  3.7, 2.5, 1.0, H-3), 4.23 (1H, 
ddd, J  9.0, 6.7, 3.8, H-5), 4.17 (2H, q, y  7.1, CO2CH2CH3), 4.09 (1H, dd, J  10.3, 9.0, 
H-6 '), 3.96 (1H, dd, J  10.3, 6.7, H-6 ), 3.95 (1H, dd, J3 .7 , 1.0, H-2), 3.52 (1H, d, J
14.7, SCH2), 3.48 (3H, s, OCH3), 3.28 (1H, d, J  14.7, SCH2), 1.26 (3H, t, J  7.1, 
C0 2CH2CH3), 1.04 (9H, s, C(CH3)3), 1 .0 2  (9H, s, C(CH3)3); 5C (CDC13, 125 MHz)
170.6 (C=0), 82.7 (C-l), 78.6 (C-5), 74.1 (C-2), 69.0 (C-3), 66.5 (C-4), 61.4 
(C02CH2CH3), 58.4 (OCH3), 34.3 (SCH2), 33.3 (C-6 ), 28.1 (C(CH3)3), 28.0 
(C(CH3)3), 21.5 (C(CH3)3), 2 1 .2  (C(CH3)3), 14.1 (C02CH2CH3). m/z (FAB+) 521/523 
(MNa+, 85/43%), 498/500 (31/19), 443 (21), 411 (35), 321 (100), 275 (35); HRMS 
(FAB+) expected MNa+(Ci9H3579BrNa0 6 SSi) 521.1005, found 521.1010.
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3,4-Dihydro-2/7-pyran-2-carbaldehyde 121
121
A solution of redistilled acrolein 122 (2.50 g, 44.6 mmol) and hydroquinone (100 mg, 
0.9 mmol) in dry benzene (2.5 mL) was subjected to microwave irradiation (200 W) 
at 160 °C for 3 h in a pyrex tube (5 mm thickness). The volatile material was removed 
on a rotary evaporator and the residual crude mixture was subjected to fractional 
distillation under reduced pressure affording affording the title compound 121 (2.40 g, 
48%) as a colourless oil: (bp 30 mm Hg, 58-60 °C) (Lit. 137 760 mm Hg, 146 °C); vmax 
(CHCI3 film)/cm_1 3055s, 2988m, 2958m, 1713s, 1634m, 1421m; 5H (CDC13, 300 
MHz) 9.63 (1H, d, J  0.6, CHO), 6.36 (1H, d, J6 .5 , CH=CHO), 4.81 (1H, ddd, J6 .5 ,
4.0, 2.1, CH=CHO), 4.13 (1H, dd, J5 .6 , 2.4, CH2CH), 1.86-2.03 (4H, m, 2 x CH2); 5C 
(CDCI3, 75 MHz) 202.0 (C=0), 142.8 (CH=CHO), 101.9 (CH=CHO), 78.7 (CH),
22.3 (CH2), 17.8 (CH2); m/z (EI+) 112 (M+, 100%), 99 (26), 83 (46); HRMS (EI+) 
expected M+(C6H80 2) 112.0524, found 112.0526.
3,4-Dihydro-2//-pyran-2-methanol 120
-OH
120
A solution of aldehyde 121 (1.00 g, 8.91 mmol) in dry ethanol (10 mL) was added 
dropwise to a solution of sodium borohydride (337 mg, 8.91 mmol) in dry ethanol (10 
mL) at 0 °C. The resulting solution was allowed to warm to RT and stirred for 18 h. It 
was then concentrated in vacuo and diluted with water (20 mL). The organic material
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was extracted with Et2 0  (5 x 20 mL) and the combined organic extracts were dried 
(MgSCLO and concentrated in vacuo. Column chromatography (petrol/EtOAc 5:1) 
afforded the title compound 120 (0.99 g, 97%) as a colourless liquid: vmax (CHCI3 
film)/cm_1 3418br, 2941s, 2870m, 1640w, 1456m; 5H (CDC13, 400 MHz) 6.39 (1H, 
ddd, J  6.2, 3.8, 1.9 CH=CHO), 4.71 (1H, ddd, J  6.2, 2.4, 1.3 CH=CHO), 3.92 (1H, 
ddt, J  10.1, 6 .6 , 3.4, CH2CHCH2), 3.72 (1H, ddd, J  11.7, 7.2, 3.4, CH20), 3.66 (1H, 
ddd, J  11.7, 6 .6 , 5.4, CH20), 2.07-2.12 (1H, m, CH2), 1.92-2.03 (1H, m, CH2), 1.86 
(1H, dd, J 6 .8 , 6.5, OH), 1.73-1.77 (1H, m, CH2), 1.69-1.72 (1H, m, CH2); 5C (CDC13, 
100 MHz) 143.3 (CH=CHO), 100.8 (CH=CHO), 75.5 (CH2CHCH2), 65.5 (CH20),
23.9 (CH2), 19.4 (CH2); m/z (EI+) 114 (M+, 100%), 97 (50), 79 (27); HRMS (EI+) 
expected M+(C6Hio02) 114.0681, found 114.0677.
2-(te/Y-ButyldiphenylsiIanyloxymethyl)-3,4-dihydro-2//-pyran 123
OTBDPS
123
To a stirred solution of alcohol 120 (500 mg, 4.38 mmol) and imidazole (596 mg, 
8.76 mmol) in dry DMF (12 mL), was added tert-butyldiphenylsilylchloride (1.14 
mL, 4.38 mmol) dropwise at RT. The solution was stirred at RT for 3 h, then poured 
onto an ice/water mixture (20 mL) and the organic material extracted with Et20  (5 x 
20 mL). The organic extracts were combined and washed with cold 2M HC1 (40 mL), 
water (40 mL), sat aq NaHCC>3 (40 mL) and brine (40 mL), then dried (Na2SC>4) and 
concentrated in vacuo. Column chromatography (petrol/EtOAc 100:1) afforded the 
title compound 123 (1.53 g, 99%) as a colourless liquid: vmax (CHCI3 cast)/cm_1 
3053s, 2932m, 2858m, 1651m, 1470m, 1427m; 5H (CDC13, 400 MHz) 7.25-7.46 (6 H, 
m, CH aromatic), 7.67-7.94 (4H, m, CH aromatic), 6.34 (1H, dt, J  6.4, 3.4,
CH=CHO), 4.64 (1H, ddd, 76.4, 2.7, 1.4, CH=CHO), 3.92 (1H, dddd, 78.3, 5.7, 5.4,
2.4, CH2CHCH2), 3.78 (1H, dd, 710.4, 5.2, CH20), 3.67 (1H, dd, 710.4, 5.7, CH20), 
2.02-2.12 (1H, m, CH2), 1.91-1.97 (2H, m, CH2), 1.67-1.74 (1H, m, CH2), 1.08 (9H, s, 
(C(CH3)3)); 6 c (CDC13, 100 MHz) 143.6 (CH=CHO), 135.7 (4 x CH aromatic), 133.6 
(2 x ipso C), 129.7 (4 x CH aromatic), 127.7 (2 x CH aromatic), 100.4 (CH=CHO),
75.3 (CH2CHCH2), 66.0 (CH20), 26.8 (C(CH3)3)), 24.4 (CH2), 19.3 (C(CH3)3)), 19.2 
(CH2); m/z (CI+) 353 (MH+, 30%), 295 (100), 275 (61), 239 (20); HRMS (CI+) 
expected MH+(C22H2 9 0 2Si) 353.1937, found 353.1934.
6-(terf-Butyldipheiiylsilaiiyloxymethyl)tetrahydropy ran-2-ol 124
OTBDPS
HO
124
0.5M Hydrochloric acid (100 mL, 50 mmol) was added to a solution of enol ether 123 
(10.0 g, 28.4 mmol) in THF (300 mL). The reaction mixture was stirred at 40 °C for 
14 h. THF was then removed in vacuo and the organic material was extracted with 
DCM (5 x 100 mL). The combined organic extracts were washed with sat aq 
NaHC03 (200 mL) and brine (200 mL), dried (Na2S0 4 ) and concentrated in vacuo. 
Column chromatography (petrol/EtOAc 95:5) afforded the title compound 124 (9.95 
g, 95%), as a mixture of anomers (a:(3 1:1) as a white solid: vmax (CHC13 cast)/cm_1 
3406br, 3053m, 2933m, 2858m, 1471w, 1427m; 6H (CDC13, 400 MHz) a-anomer 
7.66-7.78 (4H, m, CH aromatic), 7.39-7.48 (6 H, m, CH aromatic), 5.25 (1H, d, 72.0, 
OCHO), 4.03 (1H, ddt, 7  11.7, 5.4, 5.3, CH2CHCH2), 3.65 (1H, dd, 7  10.3, 5.3, 
CH20), 3.53 (1H, dd, 7  10.3, 5.4, CH20), 2.28 (1H, dd, 7  2.8, 2.0, OH), 1.82-1.89 
(2H, m, CH2), 1.60-1.67 (2H, m, CH2), 1.17-1.29 (2H, m, CH2), 1.04 (9H, s, 
(C(CH3)3)); j6-anomer 7.66-7.78 (4H, m, CH aromatic), 7.39-7.48 (6 H, m, CH
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aromatic), 4.64 (1H, dt, J  7.2, 6.1, 2.1, OCHO), 3.73 (1H, ddt, J  11.7, 7.6, 3.0 
CH2CHCH2), 3.61 (1H, dd, J  10.3, 5.3, CH20), 3.55 (1H, dd, J  10.3, 5.4, CH20), 2.68 
(1H, d, 7  6.1, OH), 1.82-1.89 (2H, m, CH2), 1.60-1.67 (2H, m, CH2), 1.17-1.29 (2H, 
m, CH2), 1.04 (9H, s, (C(CH3)3)); 5C (CDC13, 100 MHz) a-anomer 135.6 (4 x CH 
aromatic) 133.2 (2 x ipso C), 129.7 (4 x CH aromatic), 127.7 (2 x CH aromatic), 91.7 
(OCHOH), 76.8 (CH2CHCH2), 67.5 (CH20), 30.0 (CH2), 27.9 (CH2), 27.0 
(C(CH3)3)), 17.0 (CH2), 14.3 (C(CH3)3)); fi-anomer 135.7 (4 x CH aromatic), 133.6 (2 
x C ipso), 129.9 (4 x CH aromatic), 127.9 (2 x CH aromatic), 96.4 (OCHO), 69.4 
(CH2CHCH2), 67.0 (CH2O), 32.7 (CH2), 27.3 (CH2), 27.0 (C(CH3)3)), 21.7 (CH2),
19.3 (C(CH3)3)); m/z (ESP+) 393 (MNa+, 100%), 388 (13) 352 (10), 283 (11), 274 
(33); HRMS (ESP+) expected MNa+ (C22H30O3SiNa) 393.1856, found 393.1855.
2- Acetoxy-6-(terf-butyldiphenylsilanyloxymethyl)tetrahydropyran 126
.OTBDPS
AcO
126
To a solution of freshly prepared Dess-Martin periodinane 127 (137 mg, 0.32 mmol) 
in DCM (3 mL) at 0 °C was added dropwise a solution of lactol 124 (100 mg, 0.27 
mmol) in DCM (3 mL). The reaction mixture was allowed to warm to RT and stirred 
for 2 h. It was then quenched with sat aq NaHC03 (15 mL) and the organic material 
extracted with DCM (5 x 15 mL). The combined organic extracts were washed with 
water (20 mL), dried (Na2S0 4 ) and concentrated in vacuo. Column chromatography 
(petrol/EtOAc 95:5) afforded the title compound 126 (100 mg, 89%), as a mixture of 
anomers (a:p 95:5) as a white solid: vmax (CHC13 cast)/cm_1 3053m, 2932m, 2858m, 
1744s, 1427m; 5h (CDC13, 400 MHz) a-anomer 7.56-7.66 (4H, m, CH aromatic), 
7.34-7.58 (6 H, m, CH aromatic), 6.10 (1H, d, 72.4, OCHO), 3.90 (1H, ddt, 76.0, 4.8,
2.2, CH2CHCH2), 3.70 (1H, dd, J  10.3, 4.8, CH20), 3.55 (1H, dd, J  10.3, 6.0, CH20),
2.07 (3H, s, C(0)CH3), 1.72-1.82 (1H, m, CH2), 1.65-1.71 (2H, m, CH2), 1.38-1.45 
(2H, m, CH2), 1.22-1.30 (1H, m, CH2), 1.05 (9H, s, (C(CH3)3)); fi-anomer 7.60-7.66 
(4H, m, CH aromatic), 7.32-7.50 (6 H, m, CH aromatic), 5.67 (1H, dd, J  9.2, 2.2, 
OCHO), 3.92 (1H, ddt, J  6.2, 5.0, 2.2, CH2CHCH2), 3.76 (1H, dd, J9 .6 , 5.0, CH20),
3.59 (1H, dd, J9 .6 , 6.2, CH20), 2.06 (3H, s, C(0)CH3), 1.80-1.85 (2H, m, CH2), 
1.52-1.60 (2H, m, CH2), 1.32-1.40 (2H, m, CH2), 1.05 (9H, s, (C(CH3)3)); 6 C (CDC13, 
100 MHz) a-anomer 169.8 (C=0), 135.6 (4 x CH aromatic), 133.6 (2 x ipso C), 129.6 
(4 x CH aromatic), 127.6 (2 x CH aromatic), 92.4 (O-CH-CO), 71.7 (CH2CHCH2),
67.0 (CH20), 28.6 (CH2), 27.4 (CH2), 27.0 (C(CH3)3)), 21.2 (CH2), 19.3 (C(CH3)3)),
17.3 (C(0)CH3); fi-anomer 169.4 (C=0), 135.6 (4 x CH aromatic), 133.6 (2 x ipso 
C), 129.6 (4 x CH aromatic), 127.6 (2 x CH aromatic), 94.6 (OCHCO), 76.3 
(CH2CHCH2), 66.5 (CH20), 30.0 (CH2), 29.7 (CH2), 26.8 (C(CH3)3)), 20.9 (CH2),
19.3 (C(CH3)3)), 17.1 (C(0)CH3); m/z (FAB+) 435 (MNa+, 100%), 375 (28), 175 
(51); HRMS (FAB+) expected MNa+ (Cj-dfaCUSiNa) 435.1968, found 435.1958.
6-(te/*f-ButyldiphenyIsilaiiyloxymethyl)tetrahydropyraii-2-one 125
Ja .OTBDPScr o ^ ✓
125
4
To a solution of freshly prepared Dess-Martin periodinane 127 (480 mg, 1.13 mmol) 
and pyridine (0.62 mL, 7.56 mmol) in DCM (5 mL) at 0 °C was added dropwise a 
solution of lactol 124 (140 mg, 0.38 mmol) in DCM (3 mL). The reaction mixture was 
allowed to warm to RT and stirred for 4 h. It was then quenched with water (15 mL) 
and the organic material extracted with DCM (5 x 15 mL). The combined organic 
extracts were washed successively with 2M HC1 (20 mL), sat aq CuS04 (20 mL), sat
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aq NaHC0 3  (20 mL) and water ( 2 0  mL), then dried (Na2SC>4) and concentrated in 
vacuo. Column chromatography (petrol/EtOAc 7:1) afforded the title compound 125 
(135 mg, 97%) which was recrystallised from Et2 0 :hexane (120 mg, 8 6 %) as white 
prisms: vmax (CHCI3 cast)/cm_1 3053s, 2932s, 2858s, 1732s, 1464m, 1427m; 5h 
(CDCI3, 400 MHz) 7.66-7.69 (4H, m, CH aromatic), 7.37-7.45 (6 H, m, CH aromatic), 
4.39 (1H, ddt, J  9.6, 5.2, 4.3, CH2CHCH2), 3.73 (1H, dd, J  10.9, 4.3, CH20), 3.70 
(1H, dd, J  10.9, 5.2, CH20), 2.55-2.61 (1H, ddd, 7  6.1, 5.0, 1.1, CH2C=0), 2.40-2.48 
(1H, m, CH2C=0), 1.93-1.99 (2H, m, CH2), 1.78-1.83 (2H, m, CH2), 1.04 (9H, s, CH3 
(C(CH3)3)); 5c (CDCI3, 100 MHz): 171.2 (C=0), 135.6 (CH aromatic), 135.5 (CH 
aromatic), 133.1 (2 x C aromatic), 129.8 (4 x CH aromatic), 127.8 (2 x CH aromatic),
132.9 (2 x ipso C), 80.2 (CH2CHCH2), 65.6 (CH20), 29.9 (CH2), 26.8 (C(CH3)3)),
24.5 (CH2), 19.3 (C(CH3)3)), 18.3 (CH2); m/z (CI+) 369 (MH+, 7%), 311 (8 8 ), 291 
(100), 267 (24), 233 (72), 213 (60), 199 (31), 135 (25); HRMS (CI+) expected MH+ 
(C22H290 3Si) 369.1886, found 369.1892.
6-(tert-ButyIdipheiiylsilaiiyIoxy)-5-Iiydroxyhexanoic acid 130
h o 2c ^ v ' / ^ r ^ ^ O T B D P S
OH
130
Cerium chloride heptahydrate (202 mg, 0.54 mmol) was made anhydrous by heating 
at 140 °C for 3 h under high vacuum (2 mmHg) and then allowed to cool to RT before 
it was suspended in THF (2 mL) and the resulting mixture was stirred for 2 h. To a 
solution of trimethysilylacetylene (94 pL, 0.68 mmol) in THF (2 mL) at -78 °C was 
added «-BuLi (2.25 M in hexane, 455 pL, 1.02 mmol) dropwise and the resulting 
mixture was stirred for 45 min. This solution was added dropwise to the cerium 
chloride suspension at -78 °C and stirred for 1 h before a solution of lactone 125 (150
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mg, 0.47 mmol) in THF (2 mL) was added dropwise. The mixture was stirred for 30 
min at -78 °C then allowed to warm to RT and stirred for 14 h. The precipitate was 
removed by filtration through Celite® and rinsed with THF (40 mL). The combined 
filtrate and washings were concentrated in vacuo and the residue was subjected to 
column chromatography (petrol/EtOAc 7:1 to 3:1) affording recovered starting 
material 125 (65 mg, 43%) then the title compound 148 (71 mg, 39%) as a colourless 
liquid: 5H (CDC13, 400 MHz) 7.67-7.76 (4H, m, CH aromatic), 7.34-7.42 (6 H, m, CH 
aromatic), 3.70 (1H, ddddd, J9 .5 , 7.4, 7.3, 4.3, 3.4, CHOH), 3.62 (1H, J  10.1, 3.4, 
CH2OTBDPS), 3.47 (1H, J  10.1, 7.4, CH2OTBDPS), 2.35 (2H, t, /  7.4, CH2CHOH), 
2.35 (2 H, t, J7 .4 , C(0)CH2), 1.75-1.78 (2H, m, CH2), 1.63-1.73 (2H, m, CH2), 1.06 
(9H, s, (C(CH3)3)); 5c (CDC13, 100 MHz) 178.6 (C=0), 135.5 (4 x CH aromatic),
133.0 (2 x ipso C), 129.8 (2 x CH aromatic), 127.8 (4 x CH aromatic), 71.5 (CHOH),
68.2 (CH2OTBDPS), 31.8 (CH2), 26.8 (C(CH3)3)), 20.7 (CH2), 19.8 (CH2), 19.2 
(C(CH3)3)); m/z (FAB+) 409 (MNa+, 90%), 161 (100); HRMS (FAB+) expected 
MNa+ (C22H30O4SiNa) 409.1811, found 409.1819.
2-(te#*f-ButyldiphenylsiIanyloxymethyI)-6-(trimethylsilanylethynyI)-3,4-diIiydro- 
2//-pyran 131 and 8-(terf-butyldiphenylsi]anyloxy)-7-hydroxy-l-trimethyIsilanyl- 
oct-l-yn-3-one 132
TMS
OTBDPSOTBDPS
OH
TMS 132131
Cerium chloride heptahydrate (405 mg, 1.09 mmol) was made anhydrous by heating 
at 140 °C for 3 h under high vacuum (2 mmHg) and then allowed to cool to RT before 
it was suspended in THF (4 mL) and the resulting mixture was stirred for 2 h. To a
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solution of trimethysilylacetylene (190 pL, 0.68 mmol) in THF (3 mL) at -78 °C was 
added /-BuLi (1.50 M in hexane, 901 jjL, 1.36 mmol) dropwise and the resulting 
mixture was stirred for 45 min. This solution was added dropwise to the cerium 
chloride suspension at -78 °C and stirred for 1 h before a solution of lactone 125 (2 0 0  
mg, 0.53 mmol) in THF (3 mL) was added dropwise. The mixture was stirred for 30 
min at -78 °C and then allowed to warm to RT and stirred for 14 h. The precipitate 
was removed by filtration through Celite® and rinsed with THF (40 mL). The 
combined filtrate and washings were concentrated in vacuo and the residue was 
subjected to column chromatography (petrol/EtOAc 7:1) afforded recovered lactone 
125 (40 mg, 20%), and enyne 131 (96 mg, 47%) as a colourless oil: vmax (CHCI3 
cast)/cm_1 3053m, 2930m, 2858m, 2305m, 1480w, 1427m; 8 H (CDCI3, 500 MHz) 
7.64-7.67 (4H, m, CH aromatic), 7.35-7.42 (6 H, m, CH aromatic), 4.01 (1H, dddd, J
6.7, 6.3, 4.9, 3.2, CH2CHCH2), 3.86 (1H, dt, J4 .9 , 3.3, CH=C), 3.76 (1H, dd, J  10.4, 
4.9, CH20), 3.64 (1H, dd, J  10.4, 6.7, CH20), 2.08-2.12 (1H, m, CH2), 1.92-2.03 (1H, 
m, CH2), 1.63-1.72 (1H, m, CH2), 1.07-1.26 (1H, m, CH2), 1.07 (9H, s, (C(CH3)3)), 
0.04 (9H, s, Si(CH3)3); 8 C (CDC13, 125 MHz) 135.5 (4 x CH aromatic), 133.4 (2 x 
ipso C), 129.6 (2 x CH aromatic), 127.6 (4 x CH aromatic), 127.4 (CH=C) 109.3 
(CH=C), 100.0 (C=CSi(CH3)3), 92.1 (CSi(CH3)3), 75.8 (CHO), 65.4 (CH20), 26.8 
(C(CH3)3)), 20.3 (CH2), 19.2 (C(CH3)3)), 19.1 (CH2), -0.3 (Si(CH3)3); m/z (CI+) 449 
(MH+, 14%), 433 (32), 391 (85), 371 (52), 357 (18), 321 (24), 299 (17), 279 (95), 239 
(42), 221 (17), 164 (100); HRMS (FAB+) expected MH+ (C27H370 2Si2) 449.2332, 
found 449.2347.
Further elution with petrol/EtOAc (3:1) afforded ynone 132 (15 mg, 7%) as a 
colourless oil; vmax (CHCI3 cast)/cm_1 3440br, 3055m, 2930m, 2855m, 2304m, 1745s, 
1480w, 1428m; 5H (CDC13, 500 MHz) 7.64-7.67 (4H, m, CH aromatic), 7.35-7.42
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(6 H, m, CH aromatic), 3.69 (1H, ddddd, J  9.0, 7.5, 5.9, 5.1, 3.5, CH-OH), 3.62 (1H, 
dd, J  10.2, 3.5, CH20), 3.46 (1H, dd, J  10.2, 7.5, CH20), 2.55 (1H, dt, J  7.6, 7.1, 
CH2CO), 2.54 (1H, dt, J  1.6, 7.1, CH2CO), 2.50 (1H, br s, OH), 1.74-1.81 (1H, m, 
CH2), 1.64-1.70 (1H, m, CH2), 1.38-1.41 (2H, m, CH2), 1.06 (9H, s, (C(CH3)3)), 0.20 
(9H, s, Si(CH3)3) 6C (CDC13, 125 MHz) 187.5 (C=0), 135.5 (4 * CH aromatic), 133.0 
(2 x ipso C), 129.8 (4 x CH aromatic), 127.7 (2 x CH aromatic), 101.9 
(C=CSi(CH3)3), 97.7 (CSi(CH3)3), 71.5 (CHOH), 67.8 (CH20), 45.0 (CH2), 31.8 
(CH2), 27.6 (C(CH3)3)), 20.4 (CH2), 19.5 (C(CH3)3)), -0.8 (Si(CH3)3); m/z (CI+) 467 
(MH+, 22%), 319 (11), 297 (15), 277 (40), 239 (23), 199 (100), 179 (28), 147 (63), 91 
(41); HRMS (CI+) expected MH+ (C27H39O3S12) 467.2438, found 467.2415.
6-(te#*-Butyldiphenylsilaiiyloxymethyl)-2- 
(trimethylsiIanylethynyl)tetrahydropyran-2-ol 134
OTBDPS
OH
TMS'
134
Cerium chloride heptahydrate (1.21 g, 3.26 mmol) was made anhydrous by heating at 
140 °C for 3 h under high vacuum (2 mmHg) and then allowed to cool to RT before it 
was suspended in THF (6  mL) and the resulting mixture was stirred for 2 h before it 
was treated with /-BuLi (1.50 M in hexane, 1.10 mL, 1.09 mmol). To a solution of 
trimethysilylacetylene (0.56 mL, 4.1 mmol) in THF (6  mL) at -78 °C was added t- 
BuLi (1.50 M in hexane, 2.70 mL, 4.08 mmol) dropwise and the resulting mixture 
was stirred for 45 min. This solution was added dropwise to the cerium chloride 
suspension at -78 °C and stirred for 1 h before a solution of lactone 125 (600 mg, 1.63 
mmol) in THF (3 mL) was added dropwise. The mixture was stirred for 30 min at -78
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°C and then allowed to warm to RT and stirred for 14 h. The precipitate was removed 
by filtration through Celite® and rinsed with THF (40 mL). The combined filtrate and 
washings were concentrated in vacuo and the residue was subjected to column 
chromatography (petrol/EtOAc 7:1) affording the title compound 134 (450 mg, 61%) 
as a colourless oil: Vmax (CHCI3 cast)/cm_1 3406br, 3053s, 2960s, 2931s, 2858s, 
2305m, 1472m, 1428m; 5H (CDC13, 500 MHz) 7.63-7.69 (4H, m, CH aromatic), 7.35- 
7.41 (6 H, m, CH aromatic), 3.72 (1H, dddd, J  7.6, 6.1, 4.9, 3.4, CH-O), 3.64 (1H, dd, 
J  10.1, 3.4, CH20), 3.47 (1H, dd, J  10.1, 7.6, CH20), 2.51 (1H, br. s, OH), 1.60-1.64 
(2H, m, CH2), 1.49-1.56 (2H, m, CH2), 1.39-1.46 (2H, m, CH2), 1.04 (9H, s, 
(C(CH3)3)), 0.12 (9H, s, Si(CH3)3); 5C (CDC13, 125 MHz) 135.5 (4 x CH aromatic),
133.0 (2 x ipSo C), 129.8 (4 x CH aromatic), 127.7 (2 x CH aromatic), 105.0 
(C=CSi(CH3)3), 88.1 (COH), 71.5 (CHO), 68.0 (CH20), 63.9 (CSi(CH3)3), 43.4 
(CH2), 32.3 (CH2), 26.7 (C(CH3)3)), 20.3 (CH2), 19.2 (C(CH3)3)), -0.3 (Si(CH3)3); m/z 
(CI+) 467 (MH+, 21%), 319 (10) 297 (15), 277 (38), 239 (22), 199 (100), 179 (27), 
147 (61), 91 (41); HRMS (CI+) expected MH+ (C27H3 9 0 3Si2) 467.2438, found 
467.2415.
Further elution with petrol/EtOAc (7:1) afforded enyne 131 (120 mg, 16%) as a 
colourless oil.
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6,6-Bis(trimethylsilanylethynyl)tetrahydropyran-2-methanol 137, 6-ethynyI-2- 
trimethylsiIanyloxymethyl-3,4-dihydro-2//-pyran 135, 6-
ethynyltetrahydropyran-2-methanol 136
.OH
TMS'
.OTMS
TMS
135137
■OH
136
To a solution of hemiacetal 134 (133 mg, 0.29 mmol) and triethylsilane (182 pL, 1.14 
mmol) in acetonitrile (2.8 mL) at -10 °C was added dropwise freshly distilled boron 
trifluoride diethyl etherate (145 pL, 1.14 mmol). The mixture was maintained at -10 
°C for 1 h then allowed to warm to RT and stirred for 14 h. Triethylamine (0.2 mL, 
1.90 mmol) was then added, and the mixture was concentrated in vacuo. The residue 
was partitioned between water (5 mL) and DCM (10 mL), and the organic material 
extracted with further DCM (4><10 mL). The combined organic extracts were washed 
with brine (30 mL), dried (MgSCU) and concentrated in vacuo. Column 
chromatography (petrol/EtOAc 7:1) afforded dialkyne 137 (22 mg, 23%) as a 
colourless oil: Vmax (CHCI3 cast)/cm_I 3410br, 2925m, 2870m, 2253s, 1470m, 1385m; 
5h (CDCI3, 400 MHz) 3.95 (1H, dddd, /9 .2 , 5.9, 4.8, 2.5, CHO), 3.56 (1H, dd, J  10.6,
4.4, CH20), 3.53 (1H, dd, J  1 0 .6 , 5.9, CH20), 1.95-1.98 (1H, m, CH2), 1.83-1.87 (2H, 
m, CH2), 1.66-1.71 (1H, m, CH2), 1.17-1.44 (2H, m, CH2), 0.18 (9H, s, Si(CH3)3), 
0.17 (9H, s, Si(CH3)3); 5C (CDC13, 1 0 0  MHz) 104.3 (C=CSi(CH3)3), 1 0 1 .5  
(C=CSi(CH3)3), 91.6 (CSi(CH3)3), 87.6 (CSi(CH3)3), 73.4 (CHO), 66.7 (CO), 65.8 
(CH20), 38.2 (CH2), 25.9 (CH2), 19.4 (CH2), -0.2 (Si(CH3)3), -0.3 (Si(CH3)3); m/z 
(FAB+) 331 (MNa+, 100%), 176 (15); HRMS (FAB+) expected MNa+ 
(Ci6H280 2NaSi2) 331.1525, found 331.1519.
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Further elution with petrol/EtOAc (5:1) afforded enyne 135 (12 mg, 30%) as a 
colourless oil: vmax (CHCI3 cast)/cm-1 2925m, 2870m, 2253s, 1476m, 1396m; 5h 
(CDCI3, 500 MHz) 6.41 (1H, t, J  7.1, C=CH), 3.69 (1H, dddd, J  7.5, 6.5, 4.9, 3.4, 
CHO), 3.63 (1H, dd, J  10.9, 3.4, CH20), 3.45 (1H, dd, J  10.9, 7.5, CH20), 2.83 (1H, 
s, C=CH), 2.55-2.40 (2H, m, 0 ^ -0 1 = ) ,  1.52-1.60 (2H, m, CHs-CH), 0.20 (9H, s, 
Si(CH3)3); 6 c (CDC13, 125 MHz) 150.7 (CH=C), 105.6 (CH=C), 84.1 (C=CH), 75.3 
(C=CH), 71.1 (CHO), 66.5 (CH20), 31.4 (CH2), 26.7 (CH2), -0.2 (Si(CH3)3); m/z 
(FAB+) 233 (MNa+, 13%), 176 (100); HRMS (FAB+) expected MNa+ 
(CnH180 2SiNa) 233.0974, found 233.0978.
Further elution with petrol/EtOAc (3:1) afforded alcohol 136 (10 mg, 16%) as a 
colourless oil; Vmax (CHCI3 cast)/cm_1 3400br, 2927m, 2870m, 2253s, 1473m, 1390m; 
6h (CDCI3, 500 MHz) 4.14 (1H, dt, J  11.4, 2.2, C=CCH), 3.58 (1H, dd, J  11.9, 3.4, 
CH20), 3.55 (1H, dd, J  11.9, 2.4, CH20), 3.46 (1H, dddd, J  3.6, 3.4, 2.4, 2.0, CHO), 
2.46 (1H, d, J2 .2 , C=CH), 2.05 (1H, br s, OH), 1.82-1.89 (2H, m, CH2), 1.63-1.66 
(1H, m, CH2), 1.45-1.56 (3H, m, CH2), 1.30-1.33 (1H, m, CH2); 6 C (CDC13, 125 
MHz) 83.0 (C=CH), 78.7 (C=CCHO), 72.5 (C=CH), 67.7 (CCHO), 66.0 (CH20),
32.3 (CH2), 26.2 (CH2), 22.6 (CH2); m/z (FAB+) 233 (MNa+, 13%), 147 (100); 
HRMS (FAB+) expected MNa+ (C8Hi20 2Na) 163.0735, found 163.0731.
Phenyl 2,3,4,6-tetra-O-acetyl-l-thio-p-D-glucopyranoside 147
OAc
SPh
OAc
147
To a solution of penta-O-acetyl-p-D-glucopyranose 146 (56.0 g, 143 mmol) in DCM 
(1.3 L) at 0 °C were added dropwise thiophenol (19.1 mL, 186 mmol) and BF3.Et20
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(54.5 mL, 431 mmol). The reaction mixture was allowed to warm to RT and stirred 
for 12  h. Sat aq NaHCC>3 (1 L) was added and the organic material was extracted with 
DCM (5 x 250 mL). The organic extracts were combined, dried (MgS0 4 ) and 
concentrated in vacuo. Recrystallisation from EtOAc/petrol yielded the title
compound 147 (55.0 g, 8 8 %), as white flakes: mp 117-118 °C; [oc\2^  = -36.0 (c 1.75 
in DCM); vmax (CHCI3 cast)/cm-1 3055s, 2988m, 1757s, 1601w, 1583w, 1504w; 5h 
(CDCI3, 300 MHz) 7.50-7.44 (2H, m, CH aromatic), 7.33-7.22 (3H, m, CH aromatic), 
5.20 (1H, dd, J9 .7 , 9.4, H-3), 5.02 (1H, dd, J  9.7, 9.4, H-4), 4.98 (1H, dd, J  10.2, 9.4, 
H-2), 4.68 (1H, d, J  10.2, H-l), 4.22 (1H, dd, J  12.3, 4.8, H-6 '), 4.18 (1H, dd, J  12.3,
3.5, H-6 ), 3.71 (1H, ddd, J  9.9, 4.8, 3.5, H-5), 2.06 (3H, s, CH3), 2.05 (3H, s, CH3),
1.99 (3H, s, CH3), 1.95 (3H, s, CH3); 5C (CDC13, 75 MHz) 170.5 (C=0), 170.1 (C=0),
169.4 (C=0), 169.2 (C=0), 133.1 (2 x CH aromatic), 131.6 (1ipso C), 128.9 (CH 
aromatic), 128.4 (2 x CH aromatic), 85.7 (C-l), 75.8 (C-3), 74.0 (C-2), 69.9 (C-4), 
68.2(C-5), 62.1 (C-6 ), 21.0 (CH3), 20.7 (CH3), 20.7 (CH3), 20.6 (CH3); m/z (FAB+) 
463 (MNa+, 58%), 329 (21), 245 (100) 199 (14), 154 (13), 91 (100); HRMS (FAB+) 
expected MNa+ (C2oH2 4 0 9SNa) 463.1039, found 463.1043.
Phenyl 1-thio-P-D-glucopyranoside 148
OH
HO SPh
HO
OH
148
To a solution of thioglycoside 147 (2.10 g, 4.77 mmol) in MeOH (15 mL) was added 
sodium methoxide powder (1.24 g, 22.9 mmol) at RT. The reaction was stirred for 30 
min. Dowex® 50x8 resin (10 g) was added until neutralisation; the suspension was 
filtered and the filtrate was concentrated in vacuo. The crude title compound 148
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(1.29 g, 100%) was used in the next step without further purification: mp 130-132 °C; 
[ o f f  = -67.8 (c 3.25 in EtOH); vmax (neat)/cm-1 3055br, 2988m, 2958m, 1634m, 
1421m; 5H (DMSO-<4, 300 MHz) 7.44 (2H, d, /8 .1 , CH aromatic), 7.29 (2H, t, J 8.1, 
CH aromatic), 7.20 (1H, t, J 8.1, CH aromatic), 4.59 (1H, d, J9 .7 , H-l), 3.67 (1H, dd, 
J  11.9, 1.7, H-6), 3.42 (1H, dd, J  11.9, 5.9, H-6'), 3.21 (1H, dd, J9 .4 , 8.9, H-3), 3.16 
(1H, dd, /9 .6 , 9.4, H-4), 3.07 (1H, ddd, J 9.6, 5.9, 1.7, H-5), 3.03 (1H, dd, J9 .7 , 8.9, 
H-2); 5C (d6-DMSO, 75 MHz) 135.7 {ipso C), 129.5 (2 x CH aromatic), 128.8 (CH 
aromatic), 126.2 (2 x CH aromatic), 87.1 (C-l), 80.9 (C-5), 78.1 (C-3), 72.3 (C-2),
69.7 (C-4), 60.9 (C-6); m/z (FAB+) 295 (MNa+, 29%), 199 (100); HRMS (FAB+) 
expected MNa+ (CnH^OsSNa) 295.0616, found 295.0621.
Phenyl 6-0-terf-butyldiphenyIsilanyl-l-thio-P-D-glucopyranosise 149
OTBDPS
HO SPh
HO
OH
149
To solution of tetraol 148 (2.50 g, 9.19 mmol) in dry DMF (90 mL) at 0 °C was added 
imidazole (1.14 g, 18.4 mmol) followed by tert-butyldiphenylsilyl chloride (2.63 mL,
10.1 mmol) dropwise. The reaction mixture was stirred for 6 h. Sat aq NH4C1 (30 mL) 
was added and the organic material was extracted with EtOAc (5 x 15 mL). The 
organic extracts were combined, dried (MgS04) and concentrated in vacuo. Column 
chromatography (EtOAc/petrol 3:1) afforded the title compound 149 (4.60 g, 99%) as
a colourless liquid: [cc]2^  = -45.0 (c 1.25 in DCM); vmax (CHCI3 cast)/cm_1 3385br, 
3053s, 2986m, 1601w, 1585w, 1504w; 5H (CDC13, 400 MHz) 7.78-7.76 (4H, m, CH 
aromatic), 7.56-7.54 (2H, m, CH aromatic), 7.42-7.35 (6H, m, CH aromatic), 7.17-
7.16 (3H, m, CH aromatic), 4.59 (1H, d, J9 .8 , H-l), 4.00 (1H, dd, J  11.2, 2.9, H-6),
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3.88 (1H, d d , / 11.2, 5.5, H-6 '), 3.60 (1H, d d ,/9 .0 , 8.9, H-3), 3.53 (1H, d d ,/9 .2 , 9.0, 
H-4), 3.47 (1H, ddd, J  9.2, 5.5, 2.9, H-5), 3.43 (1H, dd, /9 .8 ,  8.9, H-2), 1.10 (9H, s, 
C(CH3)3); 5 c  (CDC13, 100 MHz) 135.7 (4 x CH aromatic), 135.6 (4 x  CH aromatic),
133.2 {ipso C), 133.1 {ipso C), 133.0 {ipso C), 131.7 (2 x CH aromatic), 129.7 (CH 
aromatic), 128.9 (CH aromatic), 127.5 (2 x CH aromatic), 87.7 (C-l), 79.7 (C-3), 77.9 
(C-2), 71.9 (C-4), 70.5 (C-5), 64.0 (C-6 ), 26.8 (C(CH3)3), 19.2 (C(CH3)3); m/z (FAB+) 
533 (MNa+, 50%), 326 (14), 301 (100); HRMS (FAB+) expected MNa+ 
(C28H340 5SSiNa) 533.1794, found 533.1796.
Phenyl 2,3,4-Tri-0-benzyl-6-0-tert-butyldiphenylsilanyl-l-thio-p-D-
glucopyranoside 150
OTBDPS
SPh
OBn
150
Sodium hydride (60% in mineral oil, 5.90 g, 154 mmol) was washed twice with petrol 
to remove mineral oil, then suspended in dry DMF (250 mL) and cooled to 0 °C. Silyl 
ether 149 (15.7 g, 30.7 mmol) was added and the mixture stirred for 1 h, then a 
solution of benzyl bromide (18.4 mL, 154 mmol) in DMF (50 mL) was added 
dropwise. The reaction mixture was stirred for 2 h at RT. Methanol (6  mL) was added 
and the mixture was partitioned between EtOAc (300 mL) and water (50 mL). The 
organic material was fiither extracted from the aqueous phase with EtOAc (5 x 50 
mL) and the organic extracts were then combined, dried (MgS04) and concentrated in 
vacuo. Column chromatography (EtOAc/petrol 1:10) afforded the title compound 150
(23.8 g, 97%) as a colourless oil: [ccfp = -11.5 (c 0.82 in DCM); vmax (CHC13 
cast)/cm_1 2988m, 1601w, 1583w, 1504w; 5H (CDC13, 400 MHz) 7.78 (2H, d, /8 .0 ,
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CH aromatic), 7.72 (2H, d, J  7.9, CH aromatic), 7.55-7.50 (2H, m, CH aromatic), 
7.42-7.00 (24H, m, CH aromatic), 4.92-4.86 (5H, m, PhCH2), 4.74 (1H, d, J9.1, H-l), 
4.70 (1H, d, J  11.0, PhCH2), 3.99 (1H, dd, J  11.4, 1.9, H-6 ), 3.96 (1H, dd, J  11.4, 3.8, 
H-6 '), 3.82 (1H, dd, J9 .3 , 8.7, H-4), 3.74 (1H, d d , J 8 .8 , 8.7, H-3), 3.56 (1H, dd, J9 .7 ,
8 .8 , H-2), 3.41 (1H, ddd, J  9.3, 3.8, 1.9, H-5), 1.10 (9H, s, C(CH3)3); 6 C (CDC13, 100 
MHz) 138.4 {ipso C), 138.2 {ipso C), 138.1 {ipso C), 135.9 (4 x CH aromatic), 135.7 
(2 x CH aromatic), 134.2 {ipso C), 133.5 {ipso C), 132.9 (CH aromatic), 131.7 (CH 
aromatic), 129.7 (CH aromatic), 128.9 (2 x CH aromatic), 128.5 (4 x CH aromatic),
128.4 (CH aromatic), 128.2 (2 x CH aromatic), 128.0 (2 x CH aromatic), 127.9 (2 x 
CH aromatic), 127.9 (2 x CH aromatic), 127.8 (2 x CH aromatic), 127.7 (2 x CH 
aromatic), 127.3 (2 x CH aromatic), 87.5 (C-l), 86.9 (C-3), 80.8 (C-2), 78.0 (C-4),
77.4 (C-5), 76.0 (PhCH2), 75.4 (PhCH2), 75.2 (PhCH2), 62.7 (C-6 ) 26.9 (C(CH3)3),
19.3 (C(CH3)3)); m/z (FAB+) 803 (MNa+, 65%), 711 (27), 487 (12), 349 (100), 326 
(11); HRMS (FAB+) expected MNa+ (CisHszOsSSiNa) 803.3202, found 803.331.
2,3,4-Tri-0-benzyl-6-0-te#*-biityldipheiiylsilaiiyl-D-glucopyraiiose 151
OTBDPS
OH
OBn
151
A mixture of tribenzyl ether 145 (1.05 g, 1.32 mmol) and A-bromosuccinimide (0.29 
g, 1.65 mmol) in acetone/water (9:1, 5 mL) was stirred at 0 °C for 3 h. NaHC03 (100 
mg) was added and the resulting mixture was concentrated in vacuo. It was then 
partitioned between EtOAc/H20  (5:1, 100 mL). The organic material was further 
extracted from the aqueous layer with EtOAc ( 4 x 1 0  mL). The organic extracts were 
combined, washed with brine (25 mL), dried (MgSO^ and concentrated in vacuo.
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Column chromatography (EtOAc/petrol 1:10 to 1:5 to 1:3) afforded the title 
compound 151 (0.85 g, 94%), as a mixture of anomers (1:1) as a white solid: vmax 
(CHC13 cast)/cm“‘ 3423br, 2988m, 1600w, 1581w, 1502w; 8 H (CDCI3, 500 MHz) a- 
anomer 7.77-7.70 (6 H, m, CH aromatic), 7.40-7.12 (19H, m, CH aromatic), 5.29 (1H, 
dd, J3 .6 , 1.5, H-l), 4.99-4.68 (6 H, m, 3 x PhCH2), 4.12 (1H, dd, J9 .5 , 9.3, H-3), 4.05 
(1H, dd, J  11.5, 9.6, H-6 '), 4.01 (1H, dd, /  11.5, 4.9, H-6 ), 3.92 (1H, ddd, J  9.6, 9.5,
4.9, H-5), 3.81 (1H, dd, J9 .5 , 9.3, H-4), 3.60 (1H, dd, 79.5, 3.6, H-2), 2.90 (1H, d, J
1.5, OH), 1.08 (9H, s, C(CHs)3); p-anomer 7.89-7.72 (6 H, m, CH aromatic), 7.40-7.12 
(19H, m, CH aromatic), 4.99-4.68 (6 H, m, 3 x PhCH2),4.63 (1H, dd, 79.0, 5.2, H-l),
3.96 (1H, dd, 7  11.9, 9.5, H-6 ’), 3.93 (1H, dd, 7  11.9, 4.2, H-6 ), 3.88 (1H, ddd, 79.5,
9.4, 4.2, H-5), 3.75 (1H, dd, 79.5, 9.2, H-4), 3.67 (1H, dd, 79.2, 9.1, H-3), 3.39 (1H, 
dd, 7  9.1, 9.0, H-2 ), 2.97 (1H, d, 7  5.2, OH), 1.09 (9H, s, C(CH3)3); 5C (CDC13, 125 
MHz) a-anomer 138.6 (4 x CH aromatic), 138.5 {ipso C), 138.2 {ipso C), 137.9 (CH 
aromatic), 135.8 (2 x CH aromatic), 135.6 (CH aromatic), 133.8 {ipso C), 133.2 (4 x 
CH aromatic), 129.6 {ipso C), 128. 5{ipso C), 128.4 (2 x CH aromatic), 128.4 (CH 
aromatic), 128.1 (CH aromatic), 128.0 (2 x CH aromatic), 127.9 (CH aromatic), 127.8 
(2 x CH aromatic), 127.7 (2 x CH aromatic), 127.7 (CH aromatic), 127.5 (2 x CH 
aromatic), 127.4 (2 x CH aromatic), 91.2 (C-l), 81.8 (C-3), 80.5 (C-2), 77.5 (PhCH2),
76.7 (PhCH2), 75.8 (PhCH2), 75.9 (C-4), 73.3 (C-5), 62.6 (C-6 ), 26.9 (C(CH3)3), 19.3 
(C(CH3)3); p-anomer 138.5 {ipso C), 138.4 (4 x CH aromatic), 138.1 {ipso C), 136.0 
(2 x CH aromatic), 135.6 (2 x CH aromatic), 135.0 (CH aromatic), 133.7 {ipso C),
133.2 (CH aromatic), 129.6 (4 x CH aromatic), 129. 5 {ipso C), 129.4 {ipso C), 128.4 
(CH aromatic), 128.3 (4 x CH aromatic), 128.0 (2 x CH aromatic), 127.8 (2 x CH 
aromatic), 97.4 (C-l), 84.6 (C-3), 83.6 (C-2), 77.4 (PhCH2), 77.2 (C-4), 75.9 
(PhCH2), 75.0 (C-5), 74.7 (PhCH2), 62.9 (C-6 ), 26.9 (C(CH3)3), 19.3 (C(CH3)3); m/z
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(FAB+) 711 (MNa+, 27%), 413 (13), 326 (18), 301 (100); HRMS (FAB+) expected 
MNa+ (C43H4 8 0 6SiNa) 711.3118, found 711.3102.
2,3,4-Tri-0-benzyl-6-0-te/T-butyldiphenylsilanyl-D-glucono-l,5-lactone 145
OTBDPS
OBn
145
To a solution of Dess-Martin periodinane 127 (9.24 g, 21.8 mmol) and pyridine (11.8 
mL, 145 mmol) in DCM (75 mL) at 0 °C was added dropwise a solution of lactol 151 
(5.00 g, 7.3 mmol) in DCM (30 mL). The reaction mixture was allowed to warm to 
RT and stirred for 14 h. H2O (40 mL) was added and the two phases separated; the 
organic material was further extracted from the aqueous layer with DCM (5 x 50 mL). 
The organic extracts were combined and washed with 2M HC1 (100 mL), H2O (100 
mL), sat aq CUSO4 (100 mL), sat aq NaHCC>3 (100 mL) and brine (100 mL), dried 
(MgSC>4) and concentrated in vacuo. Column chromatography (EtOAc/petrol 1:10)
afforded the title compound 145 (4.49 g, 90%) as a white solid: mp 120-123 °C; [oc\^ 
= +18.9 (c 2.80 in DCM); vmax (CHC13 cast)/cm-1 3444s, 2986m, 1755s, 1600w, 
1580w, 1502w; 8 H (CDC13, 300 MHz) 7.79-7.68 (6 H, m, CH aromatic), 7.48-7.22 
(19H, m, CH aromatic), 5.10 (1H, d, 711.2, PhCH2, 4.86 (1H, d, J  11.2, PhCH2), 4.84 
(1H, d, / 1 1.2, PhCH2), 4.73 (1H, d, J 1 1 .2 , PhCH2), 4.70 (1H, d, J 11.2, PhCH2), 4.64 
(1H, d, J  11.2, PhCH2), 4.56 (1H, ddd, J  9.1, 8 .6 , 2.4, H-5), 4.21 (1H, d ,J7 .0 , H-2),
4.17 (1H, dd, J  8 .6 , 7.2, H-4), 4.03 (1H, dd, J7.2, 7.0, H-3), 4.01 (1H, dd, J 11.8, 9.1, 
H-6 ’), 3.94 (1H, dd, J  11.8, 2.9, H-6 ), 1.14 (9H, s, C(CH3)3); 6C (CDC13, 75 MHz)
169.5 (C=0), 137.7 (ipso C), 137.6 (ipso C), 137.1 (ipso C), 135.9 (4 x CH aromatic),
135.7 (2 x CH aromatic), 133.1 (ipso C), 132.5 (ipso C), 130.0 (CH aromatic), 129.9
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(CH aromatic), 128.6 (CH aromatic), 128.5 (2 x CH aromatic), 128.4 (4 x CH 
aromatic), 128.2 (CH aromatic), 128.1 (CH aromatic), 128.0 (2 x CH aromatic),
127.96 (2 x CH aromatic), 127.93 (2 x CH aromatic), 127.91 (2 x CH aromatic),
127.8 (CH aromatic), 127.7 (CH aromatic), 81.1 (C-3), 79.3 (C-2), 77.8 (C-4), 75.9 
(C-5), 74.2 (PhCH2), 74.0 (PhCH2), 73.9 (PhCH2), 62.3 (C-6 ), 27.0 (C(CH3)3), 19.4 
(C(CH3)3); m/z (FAB+) 709 (MNa+, 37%), 199 (100); HRMS (FAB+) expected MNa+ 
(C43H4 6 0 6SiNa) 709.2961, found 109.291 A.
2,3,4-Tri-0-benzyl-l-C-terf-butyI-6-0-tert-butyldiphenylsilanyl-a-D-
glucopyranose 207
^ O T B D P S
BnO ^
BnO—
BnO q H
207
Cerium chloride heptahydrate (402 mg, 1.08 mmol) was made anhydrous by heating 
at 140 °C for 3 h under high vacuum (2 mmHg) and then allowed to cool to RT before 
it was suspended in THF (2 mL) and the resulting mixture was stirred for 2 h. To a 
solution of trimethysilylacetylene (187 pL, 1.35 mmol) in THF (2 mL) at -78 °C was 
added /-BuLi (1.5 M in hexane, 0.90 mL, 1.35 mmol) dropwise and the resulting 
mixture was stirred for 45 min. This solution was added dropwise to the cerium 
chloride suspension at -78 °C and stirred for 1 h before a solution of lactone 145 (370 
mg, 0.54 mmol) in THF (2 mL) was added dropwise. The mixture was stirred for 30 
min at -78 °C then allowed to warm to RT and stirred for 14 h. The precipitate was 
removed by filtration through Celite® and rinsed with THF (40 mL). The combined 
filtrate and washings were concentrated in vacuo and the residue was subjected to 
column chromatography (EtOAc/petrol 25:1) affording the title compound 207 (180
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mg, 48%) as a colourless oil: [a = +34.0 (c 2.25 in DCM); vmax (CHCI3 cast)/cm 1 
3408s, 2985m, 1601w, 1583w, 1504w; 5H (CDC13, 500 MHz) 7.76-7.66 (4H, m, CH 
aromatic), 7.36-7.24 (21H, m, CH aromatic), 5.12 (1H, d, J  11.0, PhCH2), 4.99 (1H, 
d, J  10.8, PhCH2), 4.92 (1H, d, J  10.8, PhCH2), 4.81 (1H, d, J  10.8, PhCH2), 4.79 (1H, 
d, J  10.8, PhCH2), 4.75 (1H, d, /  11.0, PhCH2), 4.03 (1H, dd, J9 .4 , 8.7, H-3), 4.01 
(1H, dd, J  11.3, 2.5, H-6 ’), 3.91 (1H, dd, J9 .7 , 9.4, H-4), 3.90 (1H, dd, J  11.3, 1.7, H- 
6 ), 3.83 (1H, ddd, J 9.7, 2.5, 1.7, H-5), 3.82 (1H, d, J8 .7 , H-2), 2.88 (1H, s, OH), 1.09 
(9H, s, SiC(CH3)3), 1.06 (9H, s, C(CH3)3); 6C (CDC13, 125 MHz) 138.3 (ipso C),
138.0 (ipso C), 135.8 (4 x CH aromatic), 135.5 (ipso C), 135.4 (2 x CH aromatic),
133.6 (ipso C), 132.8 (ipso C), 129.6 (2 x CH aromatic), 129.5 (CH aromatic), 128.5 
(CH aromatic), 128.4 (CH aromatic), 128.3 (4 x CH aromatic), 127.8 (2 x CH 
aromatic), 127.7 (2 x CH aromatic), 127.7 (CH aromatic), 127.7 (CH aromatic), 127.6 
(2 x CH aromatic), 127.5 (2 x CH aromatic), 127.4 (2 x CH aromatic), 100.7 (C-l),
85.8 (C-3), 79.4 (C-2), 77.8 (C-4), 75.9 (PhCH2), 75.8 (PhCH2), 73.9 (PhCH2), 71.8 
(C-5), 62.1 (C-6 ), 39.5 (C(CH3)3), 26.8 (SiC(CH3)3), 25.6 (C(CH3)3)), 19.3 
(SiC(CH3)3)); m/z (FAB+) 767 (MNa+, 83%), 349 (100); HRMS (FAB+) expected 
MNa+ (C47H56 0 6SiNa) 767.3744, found 767.3745.
293,4-Tri-0-benzyl-6-0-tert-butyldiphenyIsilanyl-l-C-trimethylsilanylethynyl-D- 
glucopyranose 144
OTBDPS
Cerium chloride heptahydrate (650 mg, 1.75 mmol) was made anhydrous by heating 
at 140 °C for 3 h under high vacuum (2 mmHg) and then allowed to cool to RT before
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it was suspended in THF (2 mL) and the resulting mixture was stirred for 2 h. To a 
solution of trimethysilylacetylene (240 pL, 1.75 mmol) in THF (2 mL) at -78 °C was 
added «-BuLi (1.5 M in hexane, 0.90 mL, 1.35 mmol) dropwise and the resulting 
mixture was stirred for 45 min. This solution was added dropwise to the cerium 
chloride suspension at -78 °C and stirred for 1 h before a solution of lactone 145 (200 
mg, 0.29 mmol) in THF (2 mL) was added dropwise. The mixture was stirred for 30 
min at -78 °C and then allowed to warm to RT and stirred for 14 h. The precipitate 
was removed by filtration through Celite® and rinsed with THF (40 mL). The 
combined filtrate and washings were concentrated in vacuo. The title compound 144 
appeared to be very unstable and was used in the next step without further 
purification.
l-(2,3,4-Tri-0-benzyl-6-{?-te/*/-butyldiphenylsilanyl-p-D-glucopyranosyl)-2-
trimethylsilanylethyne 143
OTBDPS TM S
OBn
143
To a solution of hemiacetal 144 (100 mg, 126 pmol) in DCM (2 mL) at -78 °C was 
added dropwise triethylsilane (23 pL, 140 pmol), followed by trimethylsilyl triflate 
(26 pL, 140 pmol). The resulting mixture was stirred at -78 °C for 30 min then 
triethylamine (50 pL) was added and the mixture was allowed to warm to RT. The 
material was partitioned between sat aq NaHCCh (5 mL) and EtOAc (10 mL) and the 
organic material extracted further with EtOAc ( 4 x 1 0  mL). The organic extracts were 
combined, dried (MgS0 4 ) and concentrated in vacuo. Column chromatography 
(EtOAc/petrol 50:1) afforded the title compound 143 (81 mg, 83%) as a yellow oil:
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M z? = +9.3 (c 0.75 in DCM); vmax (CHC13 cast)/cm_1 2988m, 2304m, 2181m, 
1605w, 1589w, 1504w; 5H (C6D6, 400 MHz) 8.06-8.04 (2H, m, CH aromatic), 7.90-
7.88 (2H, m, CH aromatic), 7.49-7.14 (21H, m, CH aromatic), 5.21 (1H, d, J  10.9, 
PI1CH2), 5.02 (1H, d, J 1 1.3, PhCH2), 4.95 (1H, d, J 11.4, PhCH2), 4.90 (1H, d, J  10.9, 
PhCH2), 4.88 (1H, d, J  11.3, PhCH2), 4.82 (1H, d, J  11.4, PhCH2), 4.07 (1H, d, J  9.7, 
H-l), 4.02 (1H, dd, J  11.6, 2.2, H-6 ), 4.00 (1H, dd, J  11.6, 3.3, H-6 '), 3.89 (1H, dd, J
9.6, 9.3, H-4), 3.75 (1H, dd, J9 .7 , 9.0, H-2), 3.55 (1H, dd, J9 .3 , 9.0, H-3), 3.13 (1H, 
ddd, J 9.6, 3.3, 2 .2 , H-5), 1.24 (9H, s, SiC(CH3)3), 0.23 (9H, s, Si(CH3)3); 5C (CDC13, 
100 MHz) 139.1 (ipso C), 138.9 (ipso C), 138.7 (ipso C), 136.2 (4 x CH aromatic),
135.7 (CH aromatic), 133.8 (ipso C), 133.3 (ipso C), 129.6 (CH aromatic), 128.2 (CH 
aromatic), 127.9 (2 x CH aromatic), 127.8 (2 x CH aromatic), 127.7 (2 x CH 
aromatic), 127.6 (4 x CH aromatic), 127.5 (2 x CH aromatic), 127.5 (2 x CH 
aromatic), 127.4 (2 x CH aromatic), 127.3 (2 x CH aromatic), 104.0 (C=CSi(CH3)3),
89.9 (C=CSi(CH3)3), 85.9 (C-l), 82.8 (C-3), 79.8 (C-2), 77.6 (C-4), 75.3 (PhCH2),
75.1 (PhCH2), 74.8 (PhCH2), 70.1 (C-5), 63.0 (C-6 ), 26.8 (SiC(CH3)3), 19.3 
(SiC(CH3)3), -0.5 (Si(CH3)3); m/z (FAB+) 791 (MNa+, 80%), 628 (11), 479 (23), 413 
(19), 326 (39), 301 (100), 199 (21); HRMS (FAB+) expected MNa+ (C48H4 6 0 5Si2Na) 
791.3564, found 791.3570.
168
(2,394-Tri-(7-benzyl-6-0-/^-butyldiphenylsilanyl"p-D-glucopyranosyl)ethyne
152
OTBDPS
BnO
152
To a solution of tribenzyl ether 143 (67 mg, 87 pmol) in MeOH/DCM (5:1, 3 mL) 
was added 1M NaOH (450 pL) and the resulting mixture was stirred for 2 h. It was 
then neutralised with 1M aq HC1 and the organic material extracted with EtOAc (6  x 
10 mL). The organic extracts were combined, dried (MgS0 4 ) and concentrated in 
vacuo. Column chromatography (EtOAc/petrol 50:1) afforded the title compound 152
(60 mg, 100%) as a white solid: mp 125-127 °C; [oc]2^  = +8.4 (c 0.28 in DCM); vmax 
(CHCI3 cast)/cm-1 2986m, 2305m, 1604w, 1589w, 1496w; 5h (C6D6, 500 MHz) 8.08- 
8.06 (2H, m, CH aromatic), 7.92-7.89 (2H, m, CH aromatic), 7.45-7.16 (21H, m, CH 
aromatic), 5.08 (1H, d, J  10.9, PhCH2), 5.05 (1H, d, J  11.4, PhCH2), 4.96 (1H, d, J
11.4, PhCH2), 4.87 (1H, d, J 11.4, PhCH2), 4.85 (1H, d, J 11.4, PhCH2), 4.83 (1H, d, J
10.9, PhCH2), 4.02 (1H, dd ,79.1 , 2.1, H-l), 4.01 (1H, dd,79.8 , 3.4, H-6 '), 4.00 (1H, 
dd, J 9.8, 2.1, H-6 ), 3.91 (1H, dd, J  9.6, 9.3, H-4), 3.73 (1H, dd, J  9.5, 9.1, H-2), 3.56 
(1H, dd, J  9.5, 9.3, H-3), 3.13 (1H, J  9.6, 3.4, 2.1, H-5), 2.12 (1H, d J  2.1, CH), 1.24 
(9H, s, C(CH3)3), 0.23 (9H, s, Si(CH3)3); 5C (CDC13, 125 MHz) 139.1 (ipso C), 138.9 
{ipso C), 138.7 {ipso C), 136.2 (4 x CH aromatic), 135.7 (CH aromatic), 133.8 {ipso 
C), 133.3 (ipso C), 129.6 (CH aromatic), 128.2 (4 x CH aromatic), 127.9 (CH 
aromatic), 127.8 (2 x CH aromatic), 127.7 (2 x CH aromatic), 127.6 (CH aromatic),
127,5 (2 x CH aromatic), 127.5 (2 x CH aromatic), 127.4 (2 x CH aromatic), 127.3 (2 
x CH aromatic), 86.1 (C-3), 82.6 (C-2), 81.6 (C=C-H), 79.9 (C-5), 77.6 (C-4), 75.4 
(PhCH2), 75.2 (PhCH2), 74.9 (PhCH2), 73.5 (C=C-H), 69.6 (C-l), 63.0 (C-6 ), 26.7
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(C(CH3)3), 19.4 (C(CH3)3); m/z (FAB+) 719 (MNa+, 100%), 326 (33), 199 (37); 
HRMS (FAB+) expected MNa+ (CisftusOsSiNa) 719.3169, found 719.3154.
l-(2,3,4-Tri-0-beiizyl-6-0-terf-biityldiphenylsilaiiyl-p-D-glucopyranosyl)-2-
bromoethyne 142
OTBDPS
OBn
142
To a solution of terminal alkyne 152 (120 mg, 0.17 mmol) in acetone (0.70 mL) was 
added AgN0 3  (12 mg, 0.07 mmol) and A-bromosuccinimide (45 mg, 0.26 mmol). 
After stirring at RT for 14 h, the reaction mixture was diluted with Et2 0  (5 mL), and 
filtered through a pad of Celite®. The filtrate was concentrated under reduced 
pressure; the residue was dissolved in Et2 0  (10 mL), then washed with H2O (4 mL) 
and brine (4 mL), dried (MgS0 4 ) and concentrated in vacuo. Column chromatography 
(EtOAc/petrol 20:1) afforded the title compound 142 (130 mg, 98%) as colourless
needles: mp 97-99 *C; [a ]“  = -5.2 (c 0.25 in DCM); vmax (CHC13 cast)/cm 1 3053s, 
2986m, 2305m, 1601w, 1583w, 1504w, 897s; 5H (C6D6) 400 MHz) 8.04-8.00 (2H, m, 
CH aromatic), 7.90-7.85 (2H, m, CH aromatic), 7.40-7.14 (21H, m, CH aromatic),
5.00 (1H, d, J  10.5, PhCH2), 4.94 (1H, d, J  10.9, PhCH2), 4.92 (1H, d, J  10.8, PhCH2),
4.85 (1H, d, J  10.9, PhCH2), 4.81 ( 1H, d, J  10.5, PhCH2), 4.78 (1H, d, J  1 0 .8 , PhCH2), 
3.98 (1H, dd, J  11.0, 5.2, H-6 '), 3.97 (1H, dd, J  11.0, 2.9, H-6 ), 3.93 (1H, d, J9 .6 , H-
1), 3.85 (1H, dd, J  9.5, 9.2, H-4), 3.64 (1H, dd, J9 .6 , 9.0, H-2), 3.51 (1H, dd, J  9.2,
9.0, H-3), 3.08 (1H, ddd, J  9.5, 5.2, 2.9, H-5), 1.25 (9H, s, C(CH3)3); 5C (CDC13, 100 
MHz) 138.3 (ipso C), 138.1 (ipso C), 137.8 (ipso C), 136.0 (4 x CH aromatic), 135.6 
(CH aromatic), 133.6 (ipso C), 133.0 (ipso C), 129.6 (CH aromatic), 129.3 (CH
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aromatic), 128.4 (2 x CH aromatic), 128.3 (4 x CH aromatic), 128.14 (CH aromatic), 
128.11 (2 x CH aromatic), 128.0 (CH aromatic), 127.98 (CH aromatic), 127.95 (2 x 
CH aromatic), 127.8 (2 x CH aromatic), 127.7 (2 x CH aromatic), 127.6 (2 x CH 
aromatic), 127.5 (2 x CH aromatic), 85.9 (C-l), 82.2 (C-3), 79.7 (C-2), 77.5 (C-4),
77.3 (C=C-Br), 75.8 (PhCH2), 75.5 (PhCH2), 75.2 (PhCH2), 70.2 (C-5), 62.7 (C-6 ), 
45.8(C=C-Br), 26.8 (C(CH3)3), 19.3 (C(CH3)3); m/z (FAB+) 797/799 (MNa+, 
37/43%), 326/328 (17/17), 245 (100); HRMS (FAB+) expected MNa+ 
(C45H5o0 7Si79BrNa) 797.2274, found 797.2287.
Methyl (2,3,4-tri-0-benzyl-6-0-tef*-butyldiphenylsilanyl-p-D-
glucopyranosyl)acetate 154 and Methyl 2-(2,3,4-tri-0-benzyl-6-0-terf- 
butyldiphenylsilanyl-P-D-glucopyranosyl)glyoxylate 155
OTBDPS,OTBDPS
O M eBnO-"
BnO OMe OBn
OBn
154 155
To a vigorously stirred solution of bromoalkyne 142 (38 mg, 49 pmol) in MeOH/H20  
(1:1 4 mL) at 0 °C were added NaHC03 (2 mg, 25 pmol), MgSCL (12 mg, 98 pmol) 
and KMnCL (16 mg, 98 pmol). The reaction mixture was stirred at 0  °C for 14 h then 
quenched with ice/water (10 mL) and the organic material was extracted with EtOAc 
(5 x 10  mL). The combined organic phases were washed with H20  (10 mL) and brine 
(10 mL), dried (MgS0 4 ) and concentrated in vacuo. Column chromatography 
(EtOAc/petrol 20:1) afforded recovered terminal bromoalkyne 142 (5 mg, 14%) and
ester 154 (12 mg, 32%) as a white powder: mp 137-139 °C; = +7.8 (c 0.45 in
DCM); vmax (CHC13 cast)/cm-1 3444br, 3053s, 2988m, 2304m, 1749s, 1606w, 1421s, 
1256s; 5h (CDC13, 400 MHz) 7.75-7.67 (4H, m, CH aromatic), 7.36-7.23 (21H, m,
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CH aromatic), 4.93-4.89 (3H, m, PhCH2), 4.83 (1H, d, J  10.9, PhCH2), 4.77 (1H, d, J  
10.7, PhCH2), 4.65 (1H, d, J  10.9, PhCH2), 3.95 (1H, dd, J  11.7, 3.5, H-6), 3.91 (1H, 
d, J 9.6, H-l), 3.89 (1H, dd, J 11.7, 7.0, H-6'), 3.86 (1H, dd, J 9.6, 9.0, H-4), 3.83 (1H, 
dd, J 9.6, 8.7, H-2), 3.76 (3H, s, OCH3), 3.72 (1H, dd, J 9.0, 8.7, H-3), 3.37 (1H, ddd, 
J 9.6, 7.0, 3.5, H-5), 1.06 (9H, s, C(CH3)3); 6C (CDC13, 100 MHz) 169.4 (C=0), 138.3 
(ipso C), 138.1 (ipso C), 137.9 (ipso C), 136.0 (4 x CH aromatic), 135.6 (2 x CH 
aromatic), 133.7 (ipso C), 133.0 (ipso C), 129.6 (CH aromatic), 128.5 (CH aromatic),
128.4 (4 x CH aromatic), 128.3 (CH aromatic), 128.0 (2 x CH aromatic), 127.93 (CH 
aromatic), 127.91 (CH aromatic), 127.8 (2 x CH aromatic), 127.7 (2 x CH aromatic),
127.6 (2 x CH aromatic), 127.5 (2 x CH aromatic), 127.4 (2 x CH aromatic), 127.2 (2 
x CH aromatic), 86.4 (C-l), 80.1 (C-3), 80.0 (C-4), 78.1 (C-2), 77.5 (C-5), 75.8 
(PhCH2), 75.2 (PhCH2), 75.1 (PhCH2), 62.6 (C-6), 52.2 (OCH3), 26.8 (C(CH3)3), 19.3 
(C(CH3)3); m/z (FAB+) 753 (MNa+, 24%), 199 (100); HRMS (FAB+) expected MNa+ 
(C45H5o07SiNa) 753.3223, found 753.3227.
Further elution with EtOAc/petrol (20:1) afforded ketoester 155 (18 mg, 48%) as a 
white powder with spectroscopic characterisation as given below.
Methyl 2-(2,3,4-tri-0-benzyl-6-0-terf-butyldipheiiylsilanyl-p-D-
glucopyranosyl)glyoxylate 155
D TBDPS
.OMe
OBn
155
To a vigorously stirred solution of bromoalkyne 142 (120 mg, 155 pmol) in MeOH (4 
mL) and H20  (0.1 mL) at 0 °C were added NaHC03 (7 mg, 77 pmol), MgSC>4 (37 mg, 
309 pmol) and KMnC>4 (49 mg, 309 pmol). The reaction mixture was stirred at 0 °C
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for 14 h, then quenched with ice/water (10 mL) and the organic material extracted 
with EtOAc ( 5 x 1 0  mL). The combined organic extracts were washed with H2O (10 
mL) and brine (10 mL) then dried (MgS0 4 ) and concentrated in vacuo. Column 
chromatography (EtOAc/petrol 20:1) afforded the title compound 155 (100 mg, 85%), 
as a white powder: mp 119-121 °C; vmax (CHCI3 cast)/cm_1 3440br, 3053s, 2988m, 
2304m, 1745s, 1693s, 1603w, 1421s, 1256s; 8 h (C6D6, 500 MHz): ketoester 155 in 
equilibrium with its hydrated ketone 156 (ratio 155/156: 8:1) ketoester 155 8.00-7.98 
(2H, m, CH aromatic), 7.89-7.85 (2H, m, CH aromatic), 7.43-7.16 (21H, m, CH 
aromatic), 5.03 (1H, d, J  11.2, PhCH2), 4.90-4.86 (3H, m, PhCH2), 4.85 (1H, d, J
11.4, PhCH2), 4.72 (1H, d, J  11.2, PhCH2), 4.49 (1H, d, J  9.9, H-l), 4.12 (1H, dd, J
9.9, 8.9, H-2), 4.00 (1H, dd, J  11.7, 5.5, H-6 '), 3.98 (1H, dd, J  11.7, 2.8, H-6 ), 3.94 
(1H, dd, J9 .5 , 9.3, H-4), 3.70 (1H, dd, J 9.3, 8.9, H-3), 3.30 (3H, s, OCH3), 3.21 (1H, 
ddd, J  9.5, 5.5, 2 .8 , H-5), 1.25 (9H, s, C(CH3)3), hydrated ketone 156 8.00-7.98 (2 H, 
m, CH aromatic), 7.89-7.85 (2H, m, CH aromatic), 7.43-7.16 (21H, m, CH aromatic),
5.00 (1H, d, J  11.2, PhCH2), 4.98-4.92 (2H, m, PhCH2), 4.85 (2H, m, PhCH2), 4.77 
(1H, d, J  11.2, PhCH2), 4.62 (1H, d, J  9.2, H-l), 4.23 (1H, dd, J  9.2, 9.0, H-2), 3.91 
(1H, dd, J  12.0, 6.0, H-6 '), 3.88 (1H, dd, J  12.0, 2.2, H-6 ), 3.77 (1H, t, J  9.0, H-3), 
3.72 (1H, dd, J 9.5, 9.0, H-4), 3.30 (3H, s, OCH3), 3.26 (1H, ddd, J 9.5, 6.0, 2.2, H-5),
1.24 (9H, s, C(CH3)3); 5c (CDC13, 125 MHz): ketoester 155 190.5 (C=0), 161.6 
(OC=0), 139.2 (ipso C), 139.0 (ipso C), 138.6 (ipso C), 137.1 (4 x CH aromatic),
135.8 (2 x CH aromatic), 134.4 (ipso C), 132.1 (CH aromatic), 132.0 (ipso C), 130.6 
(4 x CH aromatic), 129.8 (CH aromatic), 128.1 (CH aromatic), 128.0 (CH aromatic),
127.9 (2 x CH aromatic), 127.6 (CH aromatic), 127.4 (2 x CH aromatic), 127.38 (2 x 
CH aromatic), 127.33 (2 x CH aromatic), 127.31 (2 x CH aromatic), 126.94 (2 x CH 
aromatic), 126.91 (2 x CH aromatic), 84.2 (C-3), 79.9 (C-2), 79.2 (C-4), 78.6 (C-5),
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77.8 (C-l), 75.5 (PhCH2), 75.2 (PhCH2), 75.1 (PhCH2), 63.1 (C-6 ), 54.1 (OCH3), 27.2 
(C(CH3)3), 19.1 (C(CH3)3), hydrated ketone 156 165.1 (0C =0), 140.3 {ipso C), 139.8 
{ipso C), 139.9 {ipso C), 135.4 (2 x CH aromatic), 135.1 (4 x CH aromatic), 133.7 
{ipso C), 133.6 {ipso C), 133.2 (CH aromatic), 132.4 (4 x CH aromatic), 131.1 (CH 
aromatic), 130.2 (CH aromatic), 128.5 (CH aromatic), 127.8 (2 x CH aromatic), 127.6 
(2 x CH aromatic), 126.7 (CH aromatic), 126.6 (2 x CH aromatic), 126.4 (2 x CH 
aromatic), 126.3 (2 x CH aromatic), 126.1 (2 x CH aromatic), 125.7 (2 x CH 
aromatic), 102.3 (C(OH)2), 84.2 (C-3), 82.1 (C-l), 78.7 (C-2), 78.2 (C-4), 77.8 (C-5),
75.3 (PhCH2), 75.1 (PhCH2), 74.7 (PhCH2), 62.6 (C-6 ), 54.5 (OCH3), 27.0 (C(CH3)3),
19.2 (C(CH3)3); m/z (FAB+) 799 (M(H20)Na+, 20%), 781 (MNa+, 24), 326 (23), 245 
(100); HRMS (FAB+) expected MNa+ (C46H5o08SiNa) 781.3173, found 781.3162; 
expected M(H20)Na+ (C46H5209SiNa) 799.3278, found 799.3285.
Methyl (4'/?, 5\S, 6’R)-2-(4,5-bis-benzyloxy-6-liydroxymethyl-5,6-dihydro-4//- 
pyran-2-yl)glyoxylate 158
OBn
OH
MeO'
158
To a solution of ketoester 155 (100 mg, 122 pmol), in THF (0.8 mL) was added 
TBAF (1M in THF, 0.27 mL, 270 pmol) in one portion at RT. The reaction mixture 
was stirred for 2 h, was then diluted with hexane (10 mL) and washed with 1M aq 
HC1 (2 x 1 0  mL) and sat aq NaHC03 (10 mL), dried (MgSCL) and concentrated in 
vacuo. Column chromatography (EtOAc/petrol 10:1 to 5:1 to 3:1) afforded the title 
compound 158 (36 mg, 6 6 %) as white crystals: mp 110-112 °C; vmax (CHC13 cast)/cm~
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1 3442br, 3051s, 2988m, 2304m, 1750s, 1695s, 1606w, 1421s, 1256s; [a]™ =-161.1 
(c 0.09 in DCM); 5H (CDC13, 500 MHz) 7.34-7.30 (10H, m, CH aromatic), 6.20 (1H, 
d, J  3.1, H-3’), 4.83 (1H, d, J  11.3, PhCH2), 4.72 (1H, d, J  11.3, PhCH2), 4.68 (1H, d, 
J 11.7, PhCH2), 4.63 (1H, d, J  11.7, PhCH2), 4.36 (1H, dd, J 6.7, 3.1, H-4’), 4.05 (1H, 
ddd, J  8 .8 , 8.1, 3.8, H-6 ’), 3.93-3.88 (2H, m, CHzOH), 3.87 (3H, s, OCH3), 3.85 (1H, 
dd, J  8 .8 , 6.7, H-5'), 2.13 (1H, t, J  7.1, OH); 5C (CDC13, 125 MHz) 180.5 (C=0),
162.7 (COOMe), 147.3 (C-2f), 137.5 {ipso C), 137.3 {ipso C), 128.6 (2 x CH 
aromatic), 128.5 (2 x CH aromatic), 128.1 (CH aromatic), 128.0 (CH aromatic), 127.8 
(2 x CH aromatic), 127.7 (2 x CH aromatic), 115.7 (C-3f), 78.6 (C-4?), 75.6 (C-5'),
74.1 (PhCH2), 73.3 (C-6 '), 71.7 (PhCH2), 60.8 (CH2OH), 53.0 (OCH3); m/z (FAB+) 
435 (MNa+, 3%), 245 (100); HRMS (FAB+) expected MNa+ (C23H2 4 0 7Na) 435.1420, 
found 435.1431.
Methyl {IS, 3 R, 6R, 8 R, 9R, 10i£)-9-benzyloxy-10-hydroxy-2,4,7-
trioxatricyclo[4.3.1.03,8]decane-3-carboxylate 159
COoMe
BnO
OH
159
To a stirred solution of ketoester 155 (185 mg, 0.244 mmol) in THF (lmL) at -78 °C 
in a plastic vessel was added hydrogen fluoride pyridine complex (22 pL, 1.22 mmol). 
The reaction mixture was allowed to warm to RT and stirred for a further 15 min. Sat 
aq NaHC03 (5 mL) was added and the organic material was extracted with DCM (5 x 
10 mL). The organic extracts were combined, dried (MgS0 4 ) and concentrated in 
vacuo. Column chromatography (EtOAc/petrol 2:1) afforded the title compound 159
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(60 mg, 77%) as a sticky colourless oil: [d]2^  = -8.85 (c 2.0 in DCM); vmax (CHCI3 
cast)/cm_1 3440br, 3053s, 2988m, 2304m, 1750s, 1606w, 1421s, 1256s; 6 H (CDCI3, 
500 MHz) 7.39-7.32 (5H, m, CH aromatic), 4.77 (1H, d, J  11.3, PhCH2), 4.60 (1H, d, 
711.3, PhCH2), 4.48 (1H, d, 73.3, H-8 ), 4.37 (1H, dd, J 5.0, 3.3, H-9), 4.27 (1H, dd, 7 
10.1, 7.2, H-5'), 4.15 (1H, ddd, 7  7.2, 2.0, 0.8, H-6 ), 4.05 (1H, dd, J 5.0, 4.6, H-l),
3.86 (1H, dd, 7  10.1, 0.8, H-5), 3.80 (3H, s, OCH3), 3.78 (1H, dd, 7  4.6, 2.0, H-10),
2.08 (1H, s, OH); 5C (CDC13, 125 MHz) 166.9 (C=0), 136.1 (ipso C), 128.7 (2 x CH 
aromatic), 128.5 (CH aromatic), 128.1 (2 x CH aromatic), 100.1 (C-3), 76.3 (C-9),
73.6 (C-10), 73.1 (C-8 ), 73.0 (C-6 ), 72.3 (PhCH2), 71.0 (C-l), 63.1 (C-5), 52.8 
(OCH3); m/z (FAB+) 345 (MNa+, 100%), 301 (10), 219 (18); HRMS (FAB+) 
expected MNa+ (Ci6Hi80 7Na) 345.0950, found 345.0942.
(2,3,4-Tri-0-benzyl-p-D-glucopyranosyl)ethyne 160
OH
BnO
160
To a solution of tribenzyl ether 143 (500 mg, 0.65 mmol) in dry THF (10 mL) at 0 °C 
was added TBAF (1M in THF, 1.95 mL, 1.95 mmol). The reaction mixture was 
allowed to warm to RT and stirred for 2 h. It was then diluted with petrol (5 mL), 
washed with 1M HC1 (10 mL), sat aq NaHCCb (10 mL) and brine (10 mL), dried 
(MgSO,*) and concentrated in vacuo. Column chromatography (EtOAc/petrol 5:1 to 
3:1) afforded the title compound 160 (296 mg, 99%) as white crystals: mp 149-152
”C; [a]o = -45.4 (c 3.2 in DCM); vnm (CHCI3 cast)/cm- ' 3440br, 3055s, 2985m, 
2305m, 1421s, 1359s, 1265s; 5H (CDCI3, 300 MHz) 7.37-7.26 (15H, m, CH 
aromatic), 5.02 (1H, d, J  10.4, PhCH2), 4.95 (1H, d, J  12.0, PhCH2), 4.88 (1H, d, J
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12.0, PhCH2), 4.85 (1H, d, /  11.0, PhCH2), 4.83 (1H, d , / 10.4, PhCH2), 4.68 (1H, d, J
11.0, PhCH2), 4.11 (1H, dd, J9 .4 , 2.1, H-l), 3.90 (1H, dd, J  12.1, 2.4, H-6 ), 3.71 (1H, 
dd, /  12.1, 4.4, H-6 '), 3.69 (1H, dd, J9 .1 , 8.4, H-4), 3.67 (1H, dd, J  8 .6 , 8.4, H-3),
3.60 (1H, dd, J  9.4, 8 .6 , H-2), 3.13 (1H, ddd, J9 .1 , 4.3, 2.4, H-5), 2.58 (1H, d, 72.1, 
C=CH), 2.0 (1H, br s, OH); 6 C (CDC13, 100 MHz) 138.4 {ipso C), 137.98 {ipso C), 
137.93 {ipso C), 128.5 (CH aromatic), 128.55 (CH aromatic), 128.53 (2 x CH 
aromatic), 128.3 (CH aromatic), 128.1 (2 x CH aromatic), 128.0 (2 x CH aromatic),
127.8 (2 x CH aromatic), 127.76 (2 x CH aromatic), 127.72 (2 x CH aromatic), 85.8 
(C-2), 82.2 (C-3), 81.0 (C=CH), 79.6 (C-5), 77.4 (C-4), 75.8 (PhCH2), 75.6 (PhCH2),
75.2 (PhCH2), 74.5 (C=CH), 69.5 (C-l), 61.9 (C-6 ); m/z (FAB+) 481 (MNa+, 45%), 
323 (43), 199 (100); HRMS (FAB+) expected MNa+ (C29H3oNa05) 481.1991, found 
481.2000.
(2,3,4-Tri-0-benzyl-6-0-methanesulfonyl-p-D-glucopyranosyl)ethyne 161
OMs
BnO
161
To a solution of terminal alkyne 160 (1.92 g, 4.19 mmol) in dry DCM (40 mL) at 0 °C 
were added triethylamine (1.17 mL, 8.38 mmol), methanesulfonyl chloride (0.65 mL,
8.38 mmol) and A,A-dimethylaminopyridine (25 mg, 0.21 mmol). The reaction 
mixture was allowed to warm to RT and stirred for a further 2 h. Sat aq NH4CI (50 
mL) was added and the organic material was extracted with EtOAc ( 6  x 50 mL). The 
combined organic extracts were washed with brine (50 mL), dried (MgSCU) and 
concentrated in vacuo. Column chromatography (EtOAc/petrol 1:3 to 1:1 to neat 
EtOAc) afforded the title compound 161 (2.13 g, 95%) as a sticky colourless oil:
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[a ]“  = +13.6 (c 1.18 in DCM); vm„  (CHC13 cast)/cm ' 3300m, 3055s, 2985m, 
2305m, 2110s, 1496m, 1421s, 1359s, 1265s; §H (CDCI3, 500 MHz) 7.41-7.27 (15H, 
m, CH aromatic), 4.98 (1H, d, J  10.4, PhCH2), 4.93 (1H, d, J 11.0, PhCH2), 4.87 (1H, 
d, J  10.7, PhCH2), 4.83 (1H, d, J 11.0, PhCH2), 4.80 (1H, d, J  10.4, PhCH2), 4.62 (1H, 
d, J  10.7, PhCH2), 4.42 (1H, dd, J  11.6, 1.7, H-6 ), 4.34 (1H, dd, J  11.6, 4.1, H-6 ’),
4.04 (1H, dd, J 9.3, 2.1, H-l), 3.61 (1H, dd, J 9.3, 9.1, H-2), 3.58 (1H, dd, J 9.0, 8.4, 
H-4), 3.50 (1H, dd, J  9.1, 9.0, H-3), 3.48 (1H, ddd, J  8.4, 4.1, 1.7, H-5), 3.04 (3H, s, 
CH3), 2.53 (1H, d, J  2.1, O C H ); 8C (CDCI3, 125 MHz) 138.1 (ipso C), 137.6 (ipso 
C), 137.3 {ipso C), 128.6 (CH aromatic), 128.5 (CH aromatic), 128.4 (2 x CH 
aromatic), 128.2 (CH aromatic), 128.1 (2 x CH aromatic), 128.0 (2 x CH aromatic),
127.8 (2 x CH aromatic), 127.7 (2 x CH aromatic), 127.7 (2 x CH aromatic), 85.6 (C-
2), 81.9 (C-4), 80.3 (C=CH), 76.7 (C-5), 77.6 (C-3), 75.7 (PhCH2), 75.6 (PhCH2),
75.3 (PhCH2), 74.7 (C=CH), 69.5 (C-l), 68.4 (C-6 ), 37.8 (CH3); m/z (FAB+) 559 
(MNa+, 35%), 165 (100); HRMS (FAB+) expected MNa+ (C30H32NaO7S) 559.1766, 
found 559.1779.
(6-£-AcetyI-2,3,4-tri-0-benzyl-6-thio-P-D-gIucopyranosyI)ethyne 162
SAc
BnO
162
To a solution of mesylate 161 (2.03 g, 3.79 mmol) in dry DMF at 0 °C was added 
potassium thioacetate (2.16 g, 18.9 mmol). The reaction mixture was warmed to RT 
and stirred for a further 10 h. The mixture was partitioned between H20  (300 mL) and 
EtOAc (50 mL) and the organic material extracted further with EtOAc (6  x 50 mL). 
The combined organic extracts were washed with brine (50 mL), dried (MgS0 4 ) and
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concentrated in vacuo. Column chromatography (EtOAc/petrol 1:7) afforded the title 
compound 162 (1.94 g, 99%) as a yellow oil: [ccfp = +5.1 (c 0.63 in DCM); vmax 
(CHCI3 cast)/cm_1 3055s, 2986m, 2305m, 2112s, 1743s, 1456, 1421s, 1371s, 1265s; 
5h (CDCI3, 500 MHz) 7.33-7.20 (15H, m, CH aromatic), 4.98 (1H, d, J  10.4, PhCH2), 
4.90 (1H, d, J  10.9, PhCH2), 4.85 (1H, d, J  10.6, PhCH2), 4.83 (1H, d, J  10.9, PhCH2), 
4.80 (1H, d, J  10.4, PhCH2), 4.61 (1H, d, J  10.6, PhCH2), 3.99 (1H, dd, <79.0, 2.2, H-
1), 3.59 (1H, dd, J  10.8, 8.4, H-3), 3.57 (1H, dd, J  10.8, 8.9, H-2), 3.49 (1H, dd, J
13.7, 2.9, H-6 ), 3.40 (1H, ddd, J  9.7, 6.9, 2.9, H-5), 3.36 (1H, dd, J9 .7 , 8.4, H-4), 
2.99 (1H, dd, J  13.7, 6.9, H-6 '), 2.53 (1H, d, J  2.1,C=CH), 2.33 (3H, s, CH3); 5C 
(CDCI3, 125 MHz) 195.0 (C O ), 138.3 (ipso C), 137.8 (ipso C), 137.7 (ipso C), 128.5 
(CH aromatic), 128.5 (2 x CH aromatic), 128.4 (CH aromatic), 128.3 (2 x CH 
aromatic), 128.04 (2 x CH aromatic), 128.02 (CH aromatic), 127.8 (2 x CH aromatic),
127.7 (2 x CH aromatic), 127.6 (2 x CH aromatic), 85.7 (C-2), 82.1 (C-3), 80.7 
(C=CH), 80.0 (C-4), 78.2 (C-5), 76.8 (C^CH), 75.8 (PhCH2), 75.5 (PhCH2), 75.3 
(PhCH2), 69.5 (C-l), 30.9 (C-6 ), 30.5 (CH3); m/z (FAB+) 539 (MNa+, 12%), 413 
(100), 323 (56), 248 (17); HRMS (FAB+) expected MNa+ (C3iH32N a0 5S) 539.1868, 
found 539.1864.
1-(6-5-Acetyl-2,3,4-tri-0-benzyl-6-thio-p-D-glucopyranosyl)-2-bromoethyne 163
SAc
BnO
163
To a solution of thioacetate 162 (1.90 g, 3.68 mmol) in dry acetone (40 mL) were 
added silver nitrate (250 mg, 1.47 mmol) and A-bromosuccinimide (981 mg, 5.52 
mmol). After stirring at RT for 10 h, the reaction mixture was diluted with Et20  (40
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mL), and filtered through Celite®. The filtrate was concentrated in vacuo; the residue 
was dissolved in Et2 0  (40 mL), and then washed with H2O (40 mL) and brine (40 
mL), dried (MgS0 4 ) and concentrated in vacuo. Column chromatography 
(EtOAc/petrol 6:1) afforded the title compound 163 (2.16 g, 99%) as light purple
crystals: mp 95-97 °C; [a f*  = -0.3 (c 1.72 in DCM); vmax (CHC13 cast)/cm-1 3300m, 
3055s, 2985m, 2305m, 2 1 1 0 m, 1693s, 1496m, 1421s, 1359s, 1265s; SH (CDCI3, 500 
MHz) 7.33-7.28 (15H, m, CH aromatic), 4.91 (1H, d, 7  11.0, PhCH2), 4.89 (1H, d, 7
10.3, PhCH2), 4.85 (1H, d, 710.7, PhCH2), 4.82 (1H, d, 7  11.0, PhCH2), 4.78 (1H, d, 7
10.7, PhCH2), 4.61 (1H, d, 7  10.3, PhCH2), 4.01 (1H, d, 7  9.2, H-l), 3.57 (1H, dd, 7
8.9, 8.2, H-3), 3.54 (1H, dd, 79.2, 8.9, H-2), 3.48 (1H, dd, 7  13.8, 2.9, H-6 ), 3.40 (1H, 
ddd, 79.8, 7.0, 2.9, H-5), 3.34 (1H, dd, 7  9.8, 8.2, H-4), 2.99 (1H, dd, 7  13.8, 7.0, H- 
6 '), 2.33 (3H, s, CH3); 6 c (CDC13, 125 MHz) 194.9 (C=0), 138.2 (ipso C), 137.6 (ipso 
C), 137.5 (ipso C), 128.53 (CH aromatic), 128.51 (CH aromatic), 128.3 (2 x CH 
aromatic), 128.2 (CH aromatic), 128.05 (2 x CH aromatic), 128.04 (2 x CH aromatic),
128.02 (2 x CH aromatic), 127.85 (2 x CH aromatic), 127.83 (2 x CH aromatic), 85.7 
(C-2), 82.0 (C-3), 79.9 (C-4), 78.0 (C-5), 77.2 (C=CBr), 75.8 (PhCH2), 75.6 (PhCH2),
75.3 (PhCH2), 70.4 (C-l), 47.0 (C=CBr), 30.4 (C-6 ), 30.1 (CH3); m/z (FAB+) 617/619 
(MNa+, 17/23%), 347/349 (12/14), 199 (100). HRMS (FAB+) expected MNa+ 
(C3iH3179BrNa05S) 617.0970, found 617.0960.
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Methyl (6-iS-acetyl-2,3,4-tri-(?-benzyl-6-thio-p-D-glucopyranosyl)acetate 164 and 
Methyl(6-5'-acetyl-2,3,4-tri-0-benzyl-6-thio-p-D-glucopyranosyl)glyoxylate 165
C 0 2Me
COoMe
To a vigorously stirred solution of bromoalkyne 163 (100 mg, 168 pmol) in MeOH 
(10 mL) were added NaHCC>3 (7 mg, 84 jimol) and MgSC>4 (41 mg, 337 pmol). 
KMnC>4 (106 mg, 674 pmol) was added in small portions over 4 h. The reaction 
mixture was quenched with ice/water (10 mL), filtered through Celite® and 
concentrated in vacuo, then partitioned between H2O (10 mL) and EtOAc (10 mL). 
The organic material was extracted further with EtOAc ( 4 x 1 0  mL). The combined 
organic extracts were washed with brine (10 mL), dried (MgS0 4 ) and concentrated in 
vacuo. Column chromatography (petrol/EtOAc 12:1) afforded recovered starting 
material 163 (15 mg, 15%). Further elution with EtOAc/petrol (10:1) afforded ester
164 (9 mg,10%) as a colourless oil: [a ] °^ = +14.4 (c 0.63 in DCM); vmax (CHCI3 
cast)/cm_1 3444br, 3053s, 2988m, 2304m, 1749s, 1606w, 1421s, 1256s; §h (CDCI3, 
500 MHz) 7.33-7.28 (15H, m, CH aromatic), 4.90 (1H, d, J  11.3, PhCH2), 4.88 (1H, 
d, J  10.7, PhCH2), 4.86 (1H, d, J  11.3, PhCH2), 4.76 (1H, d, J  10.8, PhCH2), 4.67 (1H, 
d, J  10.7, PhCH2), 4.60 (1H, d, J  10.8, PhCH2), 3.86 (1H, d, J9 .4 , H-l), 3.75 (1H, dd, 
/  9.4, 9.1, H-2), 3.72 (3H, s, OCH3), 3.71 (1H, dd, /9 .1 ,  8.2, H-3), 3.53 (1H, dd, J
13.7, 2.6, H-6 ), 3.46 (1H, ddd, J  9.5, 6.9, 2.6, H-5), 3.42 (1H, dd, J  9.5, 8.2, H-4), 
2.98 (1H, dd, J  13.7, 6.9, H-6 '), 2.33 (3H, s, SC(0)CH3); 5C (CDC13, 125 MHz) 194.0 
(S C O ), 169.3 (O C O ), 138.2 {ipso C), 137.7 {ipso C), 137.6 {ipso C), 128.5 (CH 
aromatic), 128.5 (CH aromatic), 128.3 (2 x CH aromatic), 128.0 (CH aromatic), 127.9 
(2 x CH aromatic), 127.82 (2 x CH aromatic), 127.77 (2 x CH aromatic), 127.73 (2 x
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CH aromatic), 127.6 (2 x CH aromatic), 86.1 (C-3), 80.2 (C-4), 80.0 (C-2), 78.7 (C-
5), 78.2 (C-l), 75.7 (PhCH2), 75.3 (PhCH2), 75.1 (PhCH2), 52.4 (OCH3), 30.8 (C-6 ),
30.5 (SC(0)CH3); m/z (FAB+) 573 (MNa+, 100%), 323 (19); HRMS (FAB+) 
expected MNa+ (C3iH34NaO?S) 573.1923, found 573.1913.
Further elution with EtOAc/petrol (5:1 to 2:1) afforded ketoester 165 (63 mg, 65%) as 
a colourless oil: Vmax (CHC13 cast)/cm_1 3440br, 3053s, 2988m, 2304m, 1745s, 1693s, 
1603w, 1421s, 1256s; 5H (CDC13, 500 MHz) 7.33-7.18 (15H, m, CH aromatic), 4.95 
(1H, d, J 11.1, PhCH2), 4.88 (1H, d, J 11.1, PhCH2), 4.85 (1H, d, J  10.7, PhCH2), 4.82 
(1H, d, J  10.6, PhCH2), 4.63 (1H, d, J  10.7, PhCH2), 4.59 (1H, d, J  10.6, PhCH2), 4.44 
(1H, d, J9 .3 , H-l), 3.81 (1H, dd, J  9.3, 9.0, H-2), 3.77 (1H, dd, /9 .0 ,  8 .6 , H-3), 3.73 
(3H, s, OCH3), 3.51 (1H, ddd, J  9.2, 7.2, 3.0, H-5), 3.48 (1H, dd, J  13.8, 3.0, H-6 ),
3.39 (1H, dd, J  9.2, 8 .6 , H-4), 2.98 (1H, dd, J  13.8, 7.2, H-6 '), 2.31 (3H, s, 
SC(0)CH3); 6 c (CDC13, 125 MHz) 194.8 (S C O ), 190.2 (C O ), 161.6 (O C O ),
138.0 (ipso C), 137.9 (ipso C), 137.4 (ipso C), 128.5 (CH aromatic), 128.4 (CH 
aromatic), 128.3 (2 x CH aromatic), 128.2 (2 x CH aromatic), 128.1 (CH aromatic),
128.0 (2 x CH aromatic), 128.0 (2 x CH aromatic), 127.8 (2 x CH aromatic), 127.7 (2 
x CH aromatic), 86.3 (C-3), 80.1 (C-4), 79.3 (C-2), 78.7 (C-5), 78.4 (C-l), 75.7 
(PhCH2), 75.5 (PhCH2), 75.1 (PhCH2), 52.9 (OCH3), 30.1 (C-6 ), 30.0 (SC(0)CH3); 
m/z (FAB+) 601 (MNa+, 23%), 323 (32), 242 (11), 165 (100); HRMS (FAB+) 
expected MNa+ (C32H34NaOgS) 601.1872, found 601.1874.
182
Methyl (II?, 55, 65, 75, &K)-6,7,8-tri(benzyIoxy)-2-hydroxy-9-oxa-3-
thiabicyclo[3.3.1]nonane-2-carboxylate 140
HO
OBn
OBn
OBn
140
Ketoester 164 (55 mg, 0.095 mmol) was dissolved in MeOH (20 ml) at 40 °C. The 
reaction was cooled to RT before hydrazine monohydrate (6  pL, 0.12 mmol) was 
added. The reaction mixture was stirred at RT for 14 h then quenched with water (10 
mL). The methanol was removed in vacuo and the resulting organic material was 
extracted with EtOAc (5 x 10 mL). The organic extracts were combined, dried 
(MgS0 4 ) and concentrated in vacuo. Column chromatography (EtOAc/petrol 5:1 to
4:1) afforded the title compound 140 (45 mg, 8 8 %) as a colourless oil: [oc]2^  = +3.1 (c
I.01 in EtOH); SH (C6D6, 500 MHz) 7.38-6.99 (15H, m, CH aromatic), 5.01 (1H, d, 7
II.3, PhCH2), 4.92 (1H, d, 711.3, PhCH2), 4.82 (1H, d, 7  11.6, PhCH2), 4.75 (1H, d,7
11.6, PhCH2), 4.65 (1H, d, 712.1, PhCH2), 4.43 (1H, dd,79.3, 2.8, H-8 ), 4.39 (1H, d,
712.1, PhCH2), 4.36 (1H, d, 72.8, H-l), 4.22 (1H, dd, 79.5, 9.3, H-7), 4.19 (1H, ddd, 
7  5.5, 3.6, 1.9, H-5), 4.11 (1H, s, OH), 4.03 (1H, dd, 79.5, 5.5, H-6 ), 3.30 (1H, dd, 7
13.4, 3.6, H-4’), 3.24 (3H, s, OCH3), 1.57 (1H, dd, 7  13.4, 1.9, H-4); 5C (CDC13, 125 
MHz) 173.4 (C=0), 139.5 (ipso C), 139.3 (ipso C), 139.0 (ipso C), 128.3 (CH 
aromatic), 128.2 (CH aromatic), 128.1 (2 x CH aromatic), 128.0 (2 x CH aromatic), 
127.9 (CH aromatic), 127.8 (2 x CH aromatic), 127.6 (2 x CH aromatic), 127.5 (2 x 
CH aromatic), 127.2 (2 x CH aromatic), 82.2 (C-7), 80.0 (C-6 ), 79.8 (C-8 ), 79.5 (C-
1), 75.0 (PhCH2), 73.3 (C-5), 73.2 (PhCH2), 72.4 (PhCH2), 71.9 (SCOH), 52.5 
(OCH3), 40.9 (C-4); m/z (FAB+) 559 (MNa+, 3%), 326 (21), 199 (26), 176 (100); 
HRMS (FAB+) expected MNa+ (C30H32NaO7S) 559.1766, found 559.1784.
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Allyl 4,6-0-benzylidene-a-D-glucopyranoside 170
HO
170
To a solution of tetraol 172118 (1.66g, 7.54 mmol) in dry DMF (70 mL) were added 
tosic acid monohydrate (140 mg, 0.75 mmol) and benzaldehyde dimethyl acetal (2.26 
mL, 15.1 mmol). The mixture was stirred for 2 h, then diluted with DCM (100 mL), 
washed with sat aq NaHCC>3 (100 mL) and water (100 mL), dried (MgSCL) and 
concentrated in vacuo. The crude product was recrystallised from ethanol, affording
the title compound 170 (2.09 g, 90%) as a white solid: [ccf^ = -57.5 (c 1.26 in 
DCM); (CHCI3 cast)/cm~1 3438br, 3055s, 2986m, 2304m, 1632m, 1421s, 1256s; 
8 h (500 MHz, CDCI3) 7.47-7.43 (2H, m, CH aromatic), 7.35-7.30 (3H, m, CH 
aromatic), 5.90 (1H, dddd, J  16.9, 10.3, 6.2, 5.3, CH2CH=CH2), 5.51 (1H, s, PhCH), 
5.32 (1H, dq, J  16.9, 1.3, CH2CH=CH2), 5.22 (1H, dq, J  10.3, 1.3, CH2-CH=CH2), 
4.92 (1H, d, J 4.0, H-l), 4.25 (1H, dd, J  10.3, 5.0, H-6 ), 4.22 (1H, ddt, J  12.7, 5.3, 1.3, 
CH2-CH=CH2), 4.04 (1H, ddt, J  12.7, 6.2, 1.3, C ^ C H C H ^ , 3.93 (1H, dd, J  10.3, 
9.5, H-4), 3.83 (1H, td, J  10.3, 5.0, H-5), 3.70 (1H, t, J  10.3, H-6 ’), 3.61 (1H, dd, J
9.1, 4.0, H-2), 3.48 (1H, dd, J  9.5, 9.1, H-3), 2.79 (1H, br s, OH), 2.27 (1H, br s, OH); 
5C (125 MHz, CDCI3) 137.0 (ipso C), 133.2 (CH2CH=CH2), 129.2 (CH aromatic),
128.3 (2 x CH aromatic), 126.2 (2 x CH aromatic), 118.3 (CH2CH=CH2), 101.9 
(PhCH), 97.8 (C-l), 80.9 (C-3), 72.8 (C-2), 71.8 (C-4), 6 8 .8  (CH2CH=CH2), 68.7 (C-
6 ), 62.5 (C-5); m/z (FAB+) 300 (MH+, 13%), 268 (100); HRMS (FAB+) expected 
MH+ (Ci6H2i0 6) 309.1338, found 309.1331.
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Allyl 4,6-0-benzylidene-2,3-di-0-(4-toluenesulfonyl)-a-D-glucopyranoside 175, 
Allyl 2,3-anhydro-4,6-0-benzylidene-a-D-mannopyranoside 174 and Allyl 2,3- 
anhydro-4,6-0-benzylidene-a-D-allopyranoside 173
Ph'
TsO
175 173
H
Ph'
174
Sodium hydride (500 mg, 13 mmol, 60% w/w in mineral oil), was washed with petrol 
( 3 x 1 0  mL) then suspended in dry DMF (20 mL). A solution of diol 170 (2.00 g, 6.49 
mmol) in dry DMF (20 mL) was added dropwise. The resulting mixture was stirred at 
RT for 2 h before a solution o f (4-toluenesulfonyl)imidazole (1.44 g, 6.49 mmol) in 
DMF (20 mL) was added dropwise. The resulting solution was heated to 55 °C for 5 
h. It was then allowed to cool to RT, diluted with water (200 mL), and the organic 
material extracted with Et2 0  (5 x 50 mL). The organic extracts were combined, 
washed with brine (100 mL), dried (MgSO^ and concentrated in vacuo. Column 
chromatography (EtOAc/petrol 1:10) afforded ditosylate 175 (959 mg, 24%) as a
colourless oil: [oc]2^  = +42.5 (c 7.60 in DCM); vmax (CHCI3 cast)/cm_1 3055s, 2986m, 
2304, 1599m, 1421s, 1371s, 1265s; 8 H (500 MHz, CDCI3) 7.78 (2H, d, J  6.5, CH 
aromatic), 7.60 (2H, d, J  7.0, CH aromatic), 7.29-7.20 (5H, m, CH aromatic), 7.22 
(2H, d, J  6.5, CH aromatic), 6.90 (2H, d, J  7.0, CH aromatic), 5.86 (1H, dddd, J  17.3,
11.6, 6.0, 5.5, CH2CH=CH2), 5.29 (1H, dq, J  17.3, 1.5, C ^ C H C H ^ , 5.27 (1H, s, 
PhCH), 5.21 (1H, dq, J  11.6, 1.5, CH2CH=CH2), 5.17 (1H, d ,73 .6 , H-l), 5.11 (1H, t, 
J  9.5, H-3), 4.42 (1H, dd, J9 .5 , 3.6, H-2), 4.21 (1H, dd, J  10.4, 5.0, H-6 ), 4.15 (1H,
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ddt, J  13.1, 5.5, 1.3, CH2CH=CH2), 3.99 (1H, ddt, J  13.1, 6.0, 1.3, CH2CH=CH2), 
3.88 (1H, td J  10.4, 9.5, H-5), 3.63 (1H, t, J  10.4, H-6 '), 3.49 (1H, t, J 9.5, H-4), 2.42 
(3H, s, CH3), 2.27 (3H, s, CH3) ; 6 C (125 MHz, CDC13) 145.2 (ipso C), 144.2 (ipso C),
136.4 (ipso C), 134.0 (ipso C), 132.9 (CH2CH=CH2), 132.5 (ipso C), 129.7 (2 * CH 
aromatic), 129.6 (CH aromatic), 129.3 (CH aromatic) 129.1 (2 x CH aromatic), 129.0 
(2 x CH aromatic), 128.4 (2 x CH aromatic), 128.2 (CH aromatic), 128.0 (2 x CH 
aromatic), 127.9(2 x CH aromatic), 118.5 (CH2-CH=CH2), 101.8 (PhCH), 96.6 (C-l),
79.0 (C-5), 76.4 (C-4), 75.7 (C-2), 69.5 (C-6 ), 68.5 (CH2CH=CH2), 62.5 (C-3), 21.7 
(CH3), 21.6 (CH3); m/z (FAB+) 617 (MH+, 100); HRMS (FAB+) expected MH+ 
(C30H32Oi0S2) 617.1515, found 617.1526.
Further elution with EtOAc/petrol (1:5) afforded epoxide 173 (980 mg, 52%) as a 
colourless oil: [ccfo = +84.7 (c 2.55 in DCM); vmax (CHC13 cast)/cm-1 3417br, 3055s, 
2986m, 2305, 1606w, 1421m, 1265s; 5H (500 MHz, CDC13) 7.49-7.46 (2H, m, CH 
aromatic), 7.38-7.33 (3H, m, CH aromatic), 5.93 (1H, dddd, J  16.7, 10.3, 6.1, 5.3, 
CH2CH=CH2), 5.57 (1H, s, PhCH), 5.34 (1H, dq, J  16.7, 1.5, C H zCH C H ^, 5.25 
(1H, dq, J  10.3, 1.2, CH2CH=CH2), 5.06 (1H, s, H-l), 4.27 (1H, ddt, J  12.8, 5.3, 1.5, 
C I^C H ^H z), 4.26 (1H, dd, J  9.6, 3.5, H-6 ), 4.11 (1H, ddt, J  12.8, 6.1, 1.2, 
CH2CH=CH2), 3.77 (1H, ddd, J9 .6 , 8 .8 , 3.5, H-5), 3.76 (1H, t, J 9.6, H-6 '), 3.69 (1H, 
dd, J  8 .8 , 3.6, H-4), 3.50 (1H, d, J  3.6, H-2), 3.21 (1H, t, J  3.6, H-3); 5C (125 MHz, 
CDC13) 137.5 (ipso C), 134.0 (CH2CH=CH2), 129.7 (CH aromatic), 128.8 (2 x CH 
aromatic), 126.6 (2 x CH aromatic), 118.3 (CH2CH=CH2), 102.8 (PhCH), 95.5 (C-l), 
75.3 (C-4), 69.8 (C-6 ), 69.4 (CH2CH=CH2), 62.2 (C-5), 54.2 (C-2), 51.1 (C-3); m/z 
(FAB+) 313 (MNa+, 10%), 268 (100); HRMS (FAB+) expected MNa+ (Ci6H 180 5Na) 
313.1052, found 313.1056.
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Further elution with EtOAc/petrol (1:4) afforded epoxide 174 (188 mg, 10%) as a 
colourless oil; [rifo = +81.5 (c 1.55 in DCM); vmax (CHCI3 cast)/cm_1 3053s, 2986m, 
2920m, 2871m, 2305, 1674, 1456s, 1256s; 5H (500 MHz, CDCI3) 7.48-7.45 (2H, m, 
CH aromatic), 7.35-7.31 (3H, m, CH aromatic), 5.90 (1H, dddd, J  17.2, 10.3, 6.5, 5.0, 
CH2CH=CH2), 5.53 (1H, s, PhCH), 5.31 (1H, dq, J  17.2, 1.6, CH2CH=CH2), 5.21 
(1H, dq, J  10.3, 1.6, CH2CH=CH2), 5.02 (1H, d, J2 .9 , H-l), 4.25 (1H, ddt, J  13.0,
5.0, 1.3, CH2CH=CH2), 4.21 (1H, dd, J  10.2, 5.1, H-6 ), 4.12 (1H, ddd, J  10.2, 9.1, 5.1, 
H-5), 4.08 (1H, ddt, J  13.0, 6.5, 1.3, C ^ O ^ C H ;,) , 3.93 (1H, dd, J  9.1, 1.3, H-4), 
3.66 (1H, t, J  10.2, H-6 ’), 3.50 (1H, dd, J 4.3, 1.8, H-3), 3.47 (1H, dd, J 4 3 ,  2.8, H-2); 
6 C (125 MHz, CDCI3) 137.1 (ipso C), 134.0 (CH2CH=CH2), 129.2 (CH aromatic),
128.4 (2 x CH aromatic), 128.0 (2 x CH aromatic), 117.7 (CH2CH=CH2), 102.3 
(PhCH), 93.0 (C-l), 77.5 (C-5), 68.4 (C-6 ), 68.3 (CH2CH=CH2), 59.6 (C-4), 52.9 (C-
2), 50.2 (C-3); m/z (FAB+) 313 (MNa+, 18%), 268 (100); HRMS (FAB+) expected 
MNa+ (C16Hi80 5Na) 313.1052, found 313.1056.
Allyl 3-azido-4,6-0-benzylidene-3-deoxy-a-D-altropyranoside 176
OH
4-o
176
To a suspension of epoxide 173 (875 mg, 3.02 mmol) in 2-methoxyethanol/water (24 
mL, 5:1) were added sodium azide (847 mg, 13.0 mmol) and ammonium chloride 
(140 mg, 2.62 mmol). The resulting mixture was heated to reflux for 12 h then 
allowed to cool to RT. The volume was reduced to 4 mL in vacuo, water was added (5 
mL) and the organic material was extracted with DCM ( 5 x 1 5  mL). The combined 
organic extracts were washed with brine (50 mL), dried (MgS0 4 ) and concentrated in
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vacuo. Column chromatography (EtOAc/petrol 1:4 to 1:3) afforded the title 
compound 176 (920 mg, 92%): [a£ ° = +60.8 (c 0.50 in DCM); vmax (CHC13 
cast)/cm_1 3417br, 3053s, 2987m, 2304, 2108, 1614br, 1421m, 1265s; 6 h (400 MHz, 
CDC13) 7.48-7.44 (2H, m, CH aromatic), 7.37-7.31 (3H, m, CH aromatic), 5.91 (1H, 
dddd, J  17.3, 10.4, 6.5, 4.9, CH2CH=CH2), 5.61 (1H, s, PhCH), 5.35 (1H, dq, J  17.3,
1.6, CH2CH=CH2), 5.24 (1H, dq, J  10.4, 1.6, C H ^ H C H ^ , 4.71 (1H, d, J  1.5, H-l), 
4.29 (1H, dd, J  12.0, 10.5, H-6 '), 4.26(1H, dd, J  12.0, 4.5, H-6 ), 4.21 (1H, ddt, J  13.2,
4.9, 1.6, CH2CH=CH2), 4.14 (1H, dd, J  9.0, 3.6, H-4), 4.08 (1H, dd, J3 .6 , 2.9, H-3),
4.05 (1H, ddt, J  13.2, 6.5, 1.2, CFhCH^CH;,), 3.98 (1H, ddd, J  5.4, 2.9, 1.5, H-2), 
3.78 (1H, ddd, J  10.5, 9.0, 4.5, H-5), 2.30 (1H, d, J  5.4, OH); 5C (100 MHz, CDC13)
137.0 (1ipso C), 133.5 (CH2CH=CH2), 129.2 (CH aromatic), 128.3 (2 x CH aromatic),
126.2 (2 x CH aromatic), 117.9 (CH2CH=CH2), 102.2 (PhCH), 99.1 (C-l), 75.7 (C-4), 
69.6 (C-2), 69.0 (C-5), 68.4 (CH2CH=CH2), 59.9 (C-3), 59.1 (C-6 ); m/z (FAB+) 356 
(MNa+, 15%), 329 (100), 314 (35); HRMS (FAB+) expected MNa+ (C^HigOs^N a) 
356.1222, found 356.1232.
Allyl 3-azido-2-0-te/7-butyldimethylsilanyl-4,6-0-benzylidene-3-deoxy-a-D- 
altropyranoside 171
Ph^°^J^DMS
N3
171
To a solution of alcohol 176 (200 mg, 0.60 mmol) in dry DMF (3 mL) was added 
imidazole (61 mg, 0.90 mmol) followed by /er/-butyldimethylsilyl chloride (110 mg, 
0.27 mmol). The reaction was heated to 80 °C for 12 h, then allowed to cool to RT, 
water (30 mL) was added and the organic material was extracted with Et20  (5 x 20
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mL). The combined organic extracts were dried (MgS0 4 ) and concentrated in vacuo. 
Column chromatography (EtOAc/petrol 6:1) afforded the title compound 171 (263
mg, 98%): [a]™ = +36.9 (c 2.75 in DCM); vmax (CHC13 cast)/cm_1 3053s, 2954m, 
2930m, 2858m, 2304, 2110s, 1630w, 1471s, 1381m, 1265s; 5H (500 MHz, CDC13) 
7.50-7.47 (2H, m, CH aromatic), 7.35-7.29 (3H, m, CH aromatic), 5.91 (1H, dddd, J
17.1, 10.6, 6.5, 5.0, CH2CH=CH2), 5.61 (1H, s, PhCH), 5.33 (1H, dq, J  17.1, 1.7, 
CH2CH=CH2), 5.24 (1H, dq, J  10.4, 1.7, CH2CH=CH2), 4.60 (1H, d, J  1.1, H-l), 4.29 
(1H, dd, J  11.9, 9.5, H-6 ’), 4.27(1H, dd, J  11.9, 4.6, H-6 ), 4.21 (1H, ddt, J  13.2, 5.0,
1.6, CH2CH=CH2), 4.13 (1H, dd, J  9.1, 3.6, H-4), 4.01 (1H, ddt, J  13.2, 6.5, 1.3, 
CI^CH CH z), 3.94 (1H, dd, J3 .6 , 3.0, H-3), 3.91 (1H, ddd, /  3.0, 1.1, H-2), 3.78 
(1H, ddd, J  9.5, 9.1, 4.6, H-5), 0.91 (9H, s, C(CH3)3), 0.09 (3H, s, CH3), 0.08 (3H, s, 
CH3); 5c (125 MHz, CDC13) 137.2 (ipso C), 133.6 (CH2CH=CH2), 129.2 (CH 
aromatic), 128.4 (2 x CH aromatic), 126.2 (2 x CH aromatic), 117.9 (CH2CH=CH2),
102.3 (PhCH), 99.2 (C-l), 76.0 (C-4), 70.8 (C-2), 69.2 (CH2CH=CH2), 68.3 (C-5),
60.8 (C-3), 59.0 (C-6 ), 25.7 (C(CH3)3), 19.4 (C(CH3)3), -5.0 (SiCH3); m/z (FAB+) 
470 (MNa+, 35%), 332 (12), 316 (25), 138 (100); HRMS (FAB+) expected MNa+ 
(C22H330 5N3SiNa) 470.2087, found 470.2096.
3-Azido-2-0-ter7-butyldimethylsilaiiyl-4,6-0-beiizylideiie-D-altrose 177
OTBDMS
J-0
OH
177
Freshly fused and grinded zinc chloride (450 mg, 3.30 mmol) was added to a solution 
of azide 171 (590 mg, 1.32 mmol) in THF (20 mL). The mixture was stirred for 30 
min at RT before tetrakis(triphenylphosphine) palladium(O) (305 mg, 0.26 mmol) was
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added and was stirred for 30 min at RT before tri-«-butyltin hydride (1.42 mL, 5.28 
mmol) was added dropwise and then stirred for 1.5 h before it was diluted with 
EtOAc (50 mL), washed with 1M HC1 (3 x 20 mL) and brine (25 mL), dried (MgS0 4 ) 
and concentrated in vacuo. Column chromatography (neat petrol to petrol/EtOAc 15:1 
to 12:1) afforded the title compound 177 (484 mg, 90%) as a white solid (mp 128-131 
°C), which was used in the next step without further characterisation.
3-Azido-2-0-terf-butyldimethylsilanyl-4,6-0-benzylidene-D-altrono-l,5-lactone 
169
OTBDMS
_ L O
169
To a solution of lactol 177 (1.17 g, 2.87 mmol) in dry DCM (50 mL), was added 
pyridine (4.54 mL, 57.4 mmol) followed by Dess-Martin periodinane 127 (3.65 g,
8.61 mmol). The reaction mixture was stirred at RT for 12 h. Sat aq Na2SC>3 (100 mL) 
was added and the organic material was extracted with DCM (6  x 15 mL). The 
combined organic extracts were washed with brine (50 mL), dried (MgSCL) and 
concentrated in vacuo. Column chromatography (EtOAc/petrol 1:12) afforded the title
compound 169 (994 mg, 8 8 %) as a viscous colouless oil: [cc\$ = -20.3 (c 2.10 in 
DCM); vmax (CHC13 cast)/cm-1 3053s, 2988m, 2856, 2304m, 2115m, 1745s, 1606w, 
1421s, 1265s; 6 H (500 MHz, CDC13) 7.48-7.43 (3H, m, CH aromatic), 7.36-7.30 (2H, 
m, CH aromatic), 5.59 (1H, s, PhCH), 4.54 (1H, ddd, J  10.4, 9.7, 5.3, H-5), 4.48 (1H, 
dd, J  10.4, 5.3, H-6 ), 4.17 (1H, dd, J9.1, 5.0, H-4), 4.15 (1H, d, J4 .0 , H-2), 4.10 (1H, 
dd, J  5.0, 4.0, H-3), 3.84 (1H, t, J  10.4, H-6 ’), 0.90 (9H, s, C(CH3)3), 0 .1 1  (3H, s,
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SiCH3), 0.09 (3H, s, SiCH3); m/z (FAB+) 428 (MNa+, 12%), 332 (100); HRMS 
(FAB+) expected MNa+ (Ci9H2705N3SiNa) 428.1618, found 428.1612.
3-Azido-4,6-0-benzylidene-l -0-ter/-butyldimethylsiIanyl-3-deoxy-l ,1-di-C- 
(trimethylsilanylethynyl)-D-altritol 178
TMS
> T M S
OTBDMS
OH
OH
Ph
Cerium chloride heptahydrate (607 mg, 1.63 mmol) was made anhydrous by heating 
at 140 °C for 3 h under high vacuum (2 mmHg) and then allowed to cool down to RT 
before it was suspended in THF (2 mL) and stirred for 2 h. To a solution of 
trimethysilylacetylene (225 pL, 1.63 mmol) in THF (2 mL) at -78 °C was added n- 
BuLi (1.6 M in hexane, 652 pL, 1.63 mmol) dropwise and the resulting mixture 
stirred for 45 min. This solution was added dropwise to the cerium chloride 
suspension at -78 °C and stirred for 1 h before a solution of lactone 169 (110 mg, 0.27 
mmol) in THF (2 mL) was added dropwise. The mixture was stirred for 30 min at -78 
°C and then allowed to warm to RT and stirred for 30 min. The precipitate was 
removed by filtration on a pad of Celite® and rinsed with THF (40 mL). The 
combined filtrate and washings were concentrated in vacuo. Column chromatography 
(EtOAc/petrol 1:12) afforded title compound 178 (53 mg, 32%) as a pale yellow oil:
[«]“  = -72.0 (c 2.35 in DCM); vmax (CHCI3 cast)/ctrf' 3444br, 3055s, 2985m, 
2954m, 2410m, 2304m, 2121m, 1706s, 1633br, 1421s, 1361s 1256s; 5H (500 MHz, 
CDCI3) 7.48-7.43 (3H, m, CH aromatic), 7.36-7.28 (2H, m, CH aromatic), 5.49 (1H,
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s, PhCH), 4.35 (1H, dd, J  2.9, 0.9, H-3), 4.21 (1H, d, J  2.9, 5-OH), 4.33 (1H, dd, J
11.0, 5.8, H-6 ), 4.09 (1H, dddd, J  10.2, 8.9, 5.8, 2.9, H-5), 3.83 (1H, dd, J9 .9 , 0.9, H-
2), 3.74 (1H, dd, J 8.9, 2.9, H-4), 3.63 (1H, dd, J  11.0, 10.2, H-6 '), 3.28 (1H, d, J9 .9 ,
2-OH), 0.90 (9H, s, C(CH3)3), 0.28 (3H, s, SiCH3), 0.27 (3H, s, SiCH3). 0.18 (18H, s, 
Si(CH3)3); 6 c (125 MHz, CDC13); 137.4 {ipso C), 129.0 (CH aromatic), 128.3 (2 x CH 
aromatic), 126.1 (2 x CH aromatic), 103.1 (C=CSi(CH3)3), 102.1 (C=CSi(CH3)3),
100.1 (PhCH), 91.6 (C=CSi(CH3)3), 91.5 (C=CSi(CH3)3), 84.4 (C-4), 75.9 (C-2), 70.1 
(C-6 ), 67.1 (C-l), 63.8 (C-3), 60.7 (C-5), 25.5 (C(CH3)3), 18.7 (C(CH3)3), -0.5 
(Si(CH3)3), -0.6 (Si(CH3)3), -3.50 (SiCH3), -3.57 (SiCH3); m/z (FAB+) 624 (MNa+, 
45%), 316 (100); HRMS (FAB+) expected MNa+ (C29H4 7 0 5N3Si3Na) 624.2721, 
found 624.2735.
4-Azido-l,3-0-benzylidene-5-0-terf-biityIdimethylsilaiiyl-4,7,8-trideoxy-8- 
trimethylsilanyl-p-L-i«afi/io-oct-7-yii-2-ulopyranoside 181
TMS
OH
OTBDMS
Ph
181
To a solution of trimethysilylacetylene (31 pL, 0.22 mmol) in THF (2 mL) at -78 °C 
was added fl-BuLi (1.6 M in hexane, 139 pL, 0.22 mmol) and the resulting mixture 
stirred for 45 min. This solution was added dropwise to a suspension of anhydrous 
ytterbium triflate (138 mg, 0.22 mmol) in THF (2 mL) at -78 °C and stirred for 1 h 
before a solution of the lactone 169 (60 mg, 0.15 mmol) in THF (2 mL) was added 
dropwise. The resulting mixture was stirred for 30 min at -78 °C and then allowed to
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warm to RT and stirred for 12 h. Sat aq NaHCC>3 (10 mL) was added and the organic 
material was extracted with Et2 0  (5 x 10 mL). The combined organic extracts were 
dried (MgSCU) and concentrated in vacuo. Column chromatography (EtOAc/petrol
1:14 to 1:11) afforded the title compound 181 (37 mg, 48%); [ccfp = -105.5 (c 0.4 in 
DCM); vmax (CHC13 cast)/cm_1 3445br, 3053s, 2988m, 2929m, 2304, 2113m, 1633br, 
1421s, 1265s; 5H (500 MHz, CDC13) 7.47-7.42 (2H, m, CH aromatic), 7.33-7.24 (3H, 
m, CH aromatic), 5.56 (1H, s, PhCH), 4.76 (1H, d, J  6.2, H-3), 4.32 (1H, dd, J  10.3,
6.2, H-4), 4.23 (1H, d, J 2.8, H-6 ), 4.07 (1H, dd, J  10.3, 2.8, H-5), 4.03 (1H, d, J  11.9, 
H-l), 3.74 (1H, s, OH), 3.69 (1H, d, J  11.9, H-l'), 0.91 (9H, s, C(CH3)3), 0.17 (9H, s, 
Si(CH3)3), 0.13 (3H, s, SiCH3), 0.11 (3H, s, SiCH3); 5C (125 MHz, CDC13) 136.7 
{ipso C), 129.0 (CH aromatic), 128.2 (2 x CH aromatic), 126.0 (2 x CH aromatic),
103.0 (C=CSi(CH3)3), 100.8 (PhCH), 95.0 (C=CSi(CH3)3), 91.9 (C-2), 78.9 (C-6 ),
73.5 (C-l), 67.6 (C-3), 66.3 (C-4), 58.8 (C-5), 25.5 (C(CH3)3), 17.8 (C(CH3)3), -0.5 
(C=CSi(CH3)3), -4.7 (SiCH3), -5.03 (SiCH3); m/z (FAB+) 526 (MNa+, 25%), 226 
(100); HRMS (FAB+) expected MNa+ (C24H370 5 N3Si2Na) 526.2169, found 526.2158.
l,6-Anhydro-2,3,4-tris-0-(triethyIsiIanyI)-p-D-gIucopyranose 193 and 1,6- 
anhydro-2,4-bis-0-(triethyIsilanyl)-p-D-glucopyranose 189
OH
To a solution of 1,6 -anhydro-p-D-glucopyranose 190123 (3.00 g, 18.50 mmol) in DMF 
(30 mL) at 0 °C was added dropwise triethylchlorosilane (6.20 mL, 37.0 mmol). The 
resulting mixture was stirred for 20 min, diluted with hexane (50 mL), washed with 
1M HC1 (2 x 20 mL), dried (MgS0 4 ) and concentrated in vacuo. Column
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chromatography (petrol/EtOAc 1:0 to 20:1) gave trisilyl ether 193 (560 mg, 6 %) as a 
colourless oil: [« ]“  = -23.7 (c 2.02 in CHC13); vmax (CHC13 cast)/cm_1 2955s, 2899s, 
2875, 1416, 1380br, 1332, 1101s, 1075s, 1015s; 6 H (500 MHz, CDCI3) 5.24 (1H, t, J
1.8, H-l), 4.32 (1H, dddd,y 5.9, 2.8, 1.2, 1.7 H-5), 4.06 (1H, dd, J6 .9 , 1.2, H-6 ), 3.63 
(1H, dd, J 6.9, 5.9, H-6 '), 3.57 (1H, quintet, J  1.7, H-3), 3.46 (1H, dd, J 2.8,1.7, H-4),
3.39 (1H, dd, J  1 .8 , 1.7, H-2 ), 0.94 (27H, t, 77.9, 3 x Si(CH2CH3)3), 0.59 (18H, q, J
7.9, 3 x Si(CH2CH3)3); 8 C (125 MHz, CDCI3) 102.2 (C-l), 76.6 (C-5), 75.2 (C-3), 72.9 
(C-4), 71.9 (C-2 ), 64.6 (C-6 ), 6 .8  (Si(CH2CH3)3), 6.7 (Si(CH2CH3)3), 4.8 
(Si(CH2CH3)3), 4.7 (Si(CH2CH3)3); m/z (FAB+) 527 (MNa+, 35%), 475 (27), 459
(13), 373 (46), 315 (31), 259 (10), 229 (100); HRMS (FAB+) expected MNa+ 
(C24H52Na0 5Si3) 527.3020, found 527.3029.
Further elution with petrol/EtOAc (10:1) afforded disilyl ether 189 (6.58 g, 91%) as a 
colourless oil: [a]™ = -28.9 (c 2.50 in CHC13); vmax (CHC13 castycnT1 3585br, 2955s, 
2899s, 2876, 1418, 1381br, 1330, 1105s, 1075s, 1015s; 5H (500 MHz, CDC13) 5.19 
(1H, t ,7  1.1, H-l), 4.29 (1H, ddd, J  5A, 1.3, 1.0, H-5), 3.79 (1H, dd ,J7 .4 , 1.0, H-6 ), 
3.56 (1H, dd, J  7.4, 5.4, H-6 '), 3.44 (1H, dd, J3 .8 , 1.3, H-4), 3.43 (1H, dddd, J  4.2,
3.8, 3.6, 1.1, H-3), 3.34 (1H, d d ,7  3.6, 1.1, H-2), 2.37 (1H, d ,y4 .2 , OH), 0.88 (18H, 
t, J  7.9, 2 x Si(CH2CH3)3), 0.53 (12H, q, J  7.9, 2 x Si(CH2CH3)3); 6 C (125 MHz, 
CDC13) 103.3 (C-l), 77.9 (C-5), 75.5 (C-3), 73.8 (C-4), 73.5 (C-2), 66.1 (C-6 ), 6 .6  
(Si(CH2CH3)3), 6.5 (Si(CH2CH3)3), 4.6 (Si(CH2CH3)3), 4.5 (Si(CH2CH3)3); m/z 
(FAB+) 413 (MNa+, 90%), 373 (10), 315 (12), 288 (17), 259 (100), 229 (25); HRMS 
(FAB+) expected MNa+ (Ci8H38N a0 5Si2) 413.2156, found 413.2151.
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1 -(2,4-Bis-0-(triethylsilanyl)-p-D-glucopyranosy I)-2-trimethyIsiIanyIethyne 188
OH
-TMSEt3SiO
HO
OSiEt-
188
To a solution of (trimethylsilyl)acetylene (0.78 mL, 5.64 mmol) in toluene (5 mL) at -  
15 °C was added dropwise «-BuLi (1.6 M in hexane, 3.54 mL, 5.64 mmol). The 
reaction was allowed to warm to RT and stirred for 30 min. The mixture was then 
diluted with THF (1 mL), and added dropwise at -10 °C to a suspension of freshly 
sublimed AICI3 (760 mg, 5.64 mmol) in toluene (10 mL). The white suspension was 
heated to 50 °C and subjected to sonication at this temperature for 1 h. The yellow 
mixture was then heated to 60 °C without sonication and treated with a solution of 
alcohol 189 (1.00 g, 2.56 mmol) and 2,4,6-trimethylpyridine (0.39 mL, 2.56 mmol) in 
toluene (5 mL) dropwise over 1 min, and finally stirred vigorously for 90 min at 60 
°C. The black mixture was then cooled to 0 °C, poured onto ice-cold 0.33 M HC1 (50 
mL). The organic material was extracted with EtOAc (5 * 20 mL), the combined 
organic extracts were washed with brine (30 mL), dried (MgS0 4 ) and concentrated in 
vacuo. Column chromatography (petrol/EtOAc 20:1) afforded the title compound 188
(1.05 g, 92%) as an yellow oil: [oifp = +14.5 (c 3.40 in DCM); vmax (CHCI3 cast)/cm“ 
1 3450br, 2955s, 2899s, 2875m, 1445m, 1380m, 1280m; 5H (500 MHz, CDC13) 3.86 
(1H, d, 7  9.5, H-l), 3.81 (1H, dd, 7  11.9, 2.7, H-6 ), 3.62 (1H, dd, J  11.9, 5.5, H-6 ’), 
3.46 (1H, dd, 7  9.5, 8.5, H-2), 3.44 (1H, d d ,7  9.5, 8.5, H-4), 3.28 (1H, td ,7  8.5, 3.1, 
H-3), 3.21 (1H, ddd, 7  9.5, 5.5, 2.7, H-5), 2.18 (1H, d, 7  3.1, 3-OH), 2.10 (1H, br s, 6 - 
OH), 0.93 (9H, t, 77.9, Si(CH2CH3)3), 0.90 (9H, t, 77.9, Si(CH2CH3)3), 0.67 (6 H, q, 7
7.9, Si(CH2 CH3)3), 0.62 (6 H, q, 7  7.9, Si(CH2 CH3)3), 0.14 (9H, s, Si(CH3)3); 5C (125 
MHz, CDCI3) 102.4 (C=CSi(CH3)3), 91.0 (C=CSi(CH3)3), 80.3 (C-5), 79.3 (C-3), 75.2
195
(C-2), 71.5 (C -l), 70.9 (C-4), 62.1 (C-6 ), 6.9 (Si(CH2CH3)3), 6 .8  (Si(CH2CH3)3), 5.3 
(Si(CH2CH3)3), 5.1 (Si(CH2CH3)3), -0.4 (Si(CH3)3); m/z (FAB+) 511 (MNa+, 12%), 
459 (34), 399 (12), 357 (21), 241 (19), 229 (100), 201 (8 ); HRMS (FAB+) expected 
MNa+ (C23H48Na05Si3) 511.2707, found 511.2712.
1 -p-D-glucopy ranosv 1-2-trimethy Isilany lethy ne 194
^ O H
H O - ^ J-;__ -TMS
H O -
OH
194
J
A solution of diol 188 (500 mg, 1.02 mmol) in MeOH/H20/AcOH (1:1:1, 5 mL) was 
stirred for 1 h at 40 °C then concentrated in vacuo. Toluene (5 mL) was added and the 
solvent was removed in vacuo; this was repeated two further times. The resulting 
yellow oil was crystallised from acetone/heptane to give the title compound 194 (243
mg, 92%) as colourless crystals: mp 168-170 °C; \ccfp = +9.9 (c 1.80 in DCM); vmax 
(CHC13 cast)/cm_1 3420br, 2955s, 2899s, 2875m, 1440m, 1370m, 1265m; 5h (500 
MHz, CD3OD) 3.90 (1H, d, J 9.1, H-l), 3.81 (1H, dd, J  12.3, 2.1, H-6 ), 3.61 (1H, dd, 
J  12.3, 5.4, H-6 '), 3.26-3.20 (1H, m, H-3), 3.25-3.20 (1H, m, H-2), 3.23-3.18 (1H, m, 
H-4), 3.22-3.17 (1H, m, H-5), 0.13 (9H, s, Si(CH3)3); 6 C (125 MHz, CD3OD) 102.5 
(C=CSi(CH3)3), 89.5 (C=CSi(CH3)3), 80.6 (C-5), 77.8 (C-3), 73.8 (C-2), 71.0 (C-l),
69.9 (C-4), 61.4 (C-6 ), -1.5 (Si(CH3)3); m/z (FAB+) 283 (MNa+, 100%), 199 (15), 
176 (38); HRMS (FAB+) expected MNa+(Cn H2oNa05Si) 283.0978, found 283.0984.
196
l-[4,6-(7-(4-methoxybenzylidene)-p-D-gIucopyranosyI]-2-trimethyIsiIanylethyne
195
p-MeOC6H4^ V O ;
To a solution of tetraol 194 (100 mg, 0.39 mmol) and anisaldehyde dimethyl acetal 
(158 pL, 0.92 mmol) in MeCN (2 mL) were added activated 4 A molecular sieves 
(50 mg) and TsOH.H20  (7 mg, 0.04 mmol), and the resulting mixture was heated to 
reflux for 12 h. It was then cooled to 0 °C, triethylamine (50 pL, 0.39 mmol) was 
added and the volatile material removed in vacuo. Column chromatography 
(DCM/toluene/Et3N 1:1:0.01 to DCM/toluene/MeOH/Et3N 20:1:1:0.01) afforded the
title compound 216 (139 mg, 95%) as a colourless oil: [oc]2^  = +15.9 (c 1.05 in 
CHC13); v ^  (CHC13 cast)/cm-1 3435br, 2955s, 2895s, 2873m, 1430m, 1375m, 
1260m; 5H (500 MHz, CDC13) 7.38 (2H, d, J  7.4, 2 x CH aromatic), 6.84 (2H, d, J
7.4, 2 x CH aromatic), 5.41 (1H, s, AiCH), 4.27 (1H, dd, J  10.6, 5.0, H-6 ), 3.97 (1H, 
d, J  9.6, H-l), 3.76 (3H, s, OCH3), 3.65 (1H, t, J  10.6, H-6 ’), 3.63 (1H, dd, J  9.3, 8.7, 
H-3), 3.54 (1H, dd, J  9.6, 8.7, H-2), 3.43 (1H, t, J  9.3, H-4), 3.32 (1H, ddd, J  10.6,
9.3, 5.0, H-5), 3.17 (1H, br s, OH), 0.17 (9H, s, Si(CH3)3); 8 C (125 MHz, CDC13):
160.2 (ipso COCH3), 129.4 (ipso CCH), 127.6 (2 x ortho CH), 113.7 (2 x meta CH),
101.7 (ArCH), 100.5 (C=CSi(CH3)3), 92.4 (C=CSi(CH3)3), 80.2 (C-4), 74.3 (C-3),
74.1 (C-2), 71.5 (C-l), 70.5 (C-5), 68.4 (C-6 ), 55.3 (OCH3), -0.2 (Si(CH3)3); m/z 
(FAB+) 401 (MNa+, 95%), 379 (12), 176 (15), 154 (100); HRMS (FAB+) expected 
MNa+ (Ci9H27Na0 6Si) 401.1396, found 401.1407.
197
(4a/?, 8/?, 8aiS)-6-EthynyI-2-(4-methoxyphenyI)-4,4a,8,8a-tetrahydropyrano[3,2- 
</]-l,3-dioxin-8-ol 196 and (4a/?, 85, 8a5)-6-Ethynyl-2-(4-methoxyphenyl)- 
4,4a,8,8a-tetrahydropyrano[3,2-</]-l,3-dioxin-8-ol 197
OH
196
OH
197
A solution of diol 195 (159 mg, 0.42 mmol) in DMF (4 mL) was added to a 
suspension of sodium hydride (60% in mineral oil, 36 mg, 0.91 mmol) in DMF (2 
mL). The mixture was stirred at RT for 2 h before a solution of tosyl imidazole (102 
mg, 0.46 mmol) was added in DMF (2 mL). The solution was stirred at 60 °C for 12 h. 
It was then allowed to cool to RT, water (50 mL) was added and the organic material 
was extracted with Et2 0  (5 x 10 mL). The combined organic extracts were dried 
(MgSCL) and concentrated in vacuo. Column chromatography (petrol/EtOAc 6:1 to 
4:1) afforded alcohol 196 (36 mg, 30%) as a colourless oil: vmax (CHCI3 cast)/cm-1 
3430br, 2955s, 2895s, 2873m, 1432m, 1374m, 1263m; 5H (500 MHz, CDC13) 7.51 
(2H, d, J  7.5, 2 x CH aromatic), 6 .8 8  (2H, d, J  7.5, 2 x CH aromatic), 5.63 (1H, s, 
CHAr), 5.49 (1H, d, J  6.0, H-7), 4.48 (1H, dd, J  10.5, 5.3, H-4), 4.30 (1H, dd, J  6.0,
3.9, H-8 ), 4.25 (1H, td, J  10.5, 5.3, H-4a), 3.87 (1H, dd, J  10.5, 3.9, H-8 a), 3.85 (1H, 
t, J  10.5, H-4'), 3.83 (3H, s, OCH3), 2.99 (1H, s, C^CH), 2.52 (1H, br s, OH); 5C (125 
MHz, CDCI3) 160.3 (ipso COCH3), 138.6 (C-6 ), 129.7 (ipso CCH), 127.5 (2 x 
aromatic CH), 113.7 (2 x aromatic CH), 108.2 (C-7), 101.7 (ArCH), 77.2 (C=CH),
77.1 (C-8 a) 76.9 (C=CH), 68.3 (C-4), 64.6 (C-4a), 60.3 (C-8 ), 55.3 (OCH3); m/z 
(FAB+) 311 (MNa+, 65%), 176 (100); HRMS (FAB+) expected MNa+ (Ci6H 16N a05) 
311.0895, found 311.0900.
198
Further elution with petrol/EtOAc (3:1 to 1:2) afforded alcohol 197 (38 mg, 31%) as a 
colourless oil: vmax (CHCI3 cast)/cm_1 3443br, 2955s, 2895s, 2870m, 1430m, 1372m, 
1265m; 6 H (500 MHz, CDC13) 7.41 (2H, d, J  7.5, 2 * CH aromatic), 6.87 (2H, d, J
7.5, 2 x CH aromatic), 5.56 (1H, s, ArCH), 5.28 (1H, d, J  2.4, H-7), 4.52 (1H, dd, J
7.7, 2.4, H-8 ), 4.39 (1H, dd, J  10.5, 5.2, H-4), 3.96 (1H, td J  10.1, 5.2, H-4a), 3.83 
(1H, t, J  10.5, H-4’), 3.82 (3H, s, OCH3), 3.80 (1H, dd, J  10.5, 7.7, H-8 a). 3.00 (1H, s, 
C=CH), 2.34 (1H, br s, OH). 5C (125 MHz, CDC13) 160.3 {ipso COCH3), 136.7 (C-6 ),
129.2 {ipso ArCCH), 127.5 (2 x aromatic CH), 113.7 (2 x aromatic CH), 110.9 (C-7),
101.8 (ArCH), 79.2 (C=CH), 77.6 (C=CH), 77.2 (C-8 a), 68.9 (C-4a), 68.1 (C-4), 66.4 
(C-8 ), 54.9 (OCH3); m/z (FAB+) 311 (MNa+, 50%), 199 (100); HRMS (FAB+) 
expected MNa+ (C^H^NaOs) 311.0895, found 311.0894.
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